CAESARSTONE LTD., 20-F filed on 3/4/2026
Annual and Transition Report (foreign private issuer)
v3.25.4
Document and Entity Information
 12 Months Ended
Dec. 31, 2025
shares
Document Information [Line Items]  
Entity Registrant Name CAESARSTONE LTD.
Entity Central Index Key 0001504379
Document Type 20-F
Amendment Flag false
Document Annual Report true
Document Transition Report false
Document Shell Company Report false
Document Period End Date Dec. 31, 2025
Document Registration Statement false
Entity File Number 001-35464
Entity Incorporation, State or Country Code IL
Entity Address, Address Line One Kibbutz Sdot-Yam
Entity Address, City or Town MP Menashe
Entity Address Country IL
Entity Address, Postal Zip Code 3780400
Title of 12(b) Security Ordinary shares, par value NIS 0.04 per share
Trading Symbol CSTE
Name of Exchange on which Security is Registered NASDAQ
Security Reporting Obligation 15(d)
Entity Common Stock, Shares Outstanding 34,573,899
Entity Well-known Seasoned Issuer No
Entity Voluntary Filers No
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Non-accelerated Filer
Entity Emerging Growth Company false
Document Accounting Standard U.S. GAAP
Entity Shell Company false
Current Fiscal Year End Date --12-31
Document Fiscal Year Focus 2025
Document Fiscal Period Focus FY
Auditor Name KOST FORER GABBAY & KASIERER
Auditor Location Tel-Aviv, Israel
Auditor Firm ID 1281
Document Financial Statement Error Correction [Flag] false
Auditor Opinion [Text Block]
Opinion on the Financial Statements
 
We have audited the accompanying consolidated balance sheets of Caesarstone Ltd. and subsidiaries (the Company) as of December 31, 2025 and 2024, the related consolidated statements of operations, comprehensive income, shareholders' equity and cash flows for each of the three years in the period ended December 31, 2025, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2025 and 2024, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2025, in conformity with U.S. generally accepted accounting principles.
Business Contact [Member]  
Document Information [Line Items]  
Contact Personnel Name Yosef (Yos) Shiran
Entity Address, Address Line One Kibbutz Sdot-Yam
Entity Address, City or Town MP Menashe
Entity Address Country IL
Entity Address, Postal Zip Code 3780400
City Area Code 972
Local Phone Number 636-4555
v3.25.4
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
CURRENT ASSETS:    
Cash and cash equivalents $ 58,440 $ 57,336
Short-term bank deposits 1,480 49,000
Trade receivables (net of allowance for credit loss of $7,327 and $9,104 at December 31, 2025 and 2024, respectively) 48,292 46,880
Other accounts receivable and prepaid expenses 21,323 49,505
Held for sale asset 29,278 33,146
Inventories 94,275 112,609
Total current assets 253,088 348,476
LONG-TERM ASSETS:    
Severance pay fund 1,245 1,526
Deferred tax assets, net 4,010 2,910
Long-term deposits and other 5,179 4,750
Property, plant and equipment, net [1] 30,146 75,724
Operating lease right-of-use assets [2] 104,774 115,392
Intangible assets, net 0 263
Total long-term assets 145,354 200,565
Total assets 398,442 549,041
CURRENT LIABILITIES:    
Short-term bank credit and current maturities of long- term bank loan and other 2,853 4,555
Trade payables 37,779 52,838
Related party 247 206
Short term legal settlements and loss contingencies 38,577 42,706
Accrued expenses and other liabilities 58,718 51,383
Total current liabilities 138,174 151,688
LONG-TERM LIABILITIES:    
Long-term loan from related parties 0 444
Accrued severance pay 2,886 2,978
Deferred tax liabilities, net 2,168 2,439
Long-term warranty provision 889 902
Long term legal settlements and loss contingencies 8,735 9,492
Long-term operating lease liabilities 106,377 107,313
Total long-term liabilities 121,055 123,568
COMMITMENTS AND CONTINGENT LIABILITIES
REDEEMABLE NON-CONTROLLING INTEREST 0 2,200
Share capital-    
Ordinary shares of NIS 0.04 par value - 200,000,000 shares authorized at December 31, 2025 and 2024; 35,676,995 and 35,652,146 issued at December 31, 2025 and 2024, respectively; 34,573,899 and 34,549,050 shares outstanding at December 31, 2025 and 2024, respectively 371 371
Additional paid-in capital 167,700 166,500
Capital fund related to non-controlling interest (5,587) (5,587)
Accumulated other comprehensive loss, net (10,874) (14,870)
Retained earnings 27,033 164,601
Treasury shares at cost – 1,103,096 ordinary shares at December 31, 2025 and 2024 (39,430) (39,430)
Total equity 139,213 271,585
Total liabilities and equity $ 398,442 $ 549,041
[1] During 2025, following the Company's decision to cease manufacturing activities in its Bar-Lev manufacturing facility, it was determined that it met all criteria to be classified as assets held-for-sale. The Company recorded an impairment loss for the excess of the book value over its fair value related to held-for-sale asset, in the amount of $32,651 (see also Note 2k).
[2] Following the closures of the Sdot Yam and Bar Lev plants, the Company assessed the recoverability of the related right-of-use assets associated with non-cancelable lease agreements effective through 2032. The Company recorded impairment charges of $16,575 in 2023 and $6,859 in 2025, respectively. (See also note 2k).
v3.25.4
CONSOLIDATED BALANCE SHEETS (Parenthetical)
$ in Thousands
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2024
USD ($)
shares
Statement of Financial Position [Abstract]    
Trade receivables, allowance for credit loss | $ $ 7,327 $ 9,104
Ordinary shares, shares authorized 200,000,000 200,000,000
Ordinary shares, shares issued 35,676,995 35,652,146
Ordinary shares, shares outstanding 34,573,899 34,549,050
Treasury shares 1,103,096 1,103,096
v3.25.4
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Revenues $ 397,228 $ 443,221 $ 565,231
Cost of revenues 323,948 346,546 473,292
Gross profit 73,280 96,675 91,939
Operating expenses:      
Research and development 5,674 4,950 5,086
Selling and marketing 79,521 86,239 82,222
General and administrative 39,486 39,123 49,490
Impairment of long lived assets, restructuring and other related costs 48,753 1,007 47,939
Legal settlements and loss contingencies, net 25,555 7,242 (4,770)
Total operating expenses 198,989 138,561 179,967
Operating loss (125,709) (41,886) (88,028)
Finance expenses (income), net 7,766 9 (1,069)
Loss before taxes on income (133,475) (41,895) (86,959)
Taxes on income 4,284 1,081 21,281
Net loss (137,759) (42,976) (108,240)
Net loss attributable to non-controlling interest (292) (144) (584)
Net Income (Loss) $ (137,467) $ (42,832) $ (107,656)
Basic net loss per share of Ordinary shares $ (3.98) $ (1.13) $ (3.13)
Diluted net loss per share of Ordinary shares $ (3.98) $ (1.13) $ (3.13)
Weighted average number of Ordinary shares used in computing basic loss per share 34,569 34,539 34,519
Weighted average number of Ordinary shares used in computing diluted loss per share 34,569 34,539 34,519
v3.25.4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Statement of Comprehensive Income [Abstract]      
Net loss $ (137,759) $ (42,976) $ (108,240)
Other comprehensive income (loss) before tax:      
Foreign currency translation adjustments 4,017 (6,146) 38
Unrealized income (loss) on foreign currency cash flow hedge (107) (418) 764
Unrealized income on available for sale marketable securities 0 0 100
Income tax (expense) benefit related to components of other comprehensive income (loss) (3) (11) 212
Total other comprehensive income (loss), net of tax 3,907 (6,575) 1,114
Comprehensive loss (133,852) (49,551) (107,126)
Less - comprehensive loss attributable to non-controlling interest 381 251 646
Comprehensive loss attributable to controlling interest $ (133,471) $ (49,300) $ (106,480)
v3.25.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Common stock [Member]
Additional paid-in capital [Member]
Retained earnings [Member]
Accumulated other comprehensive income (loss), net [Member]
Capital fund related to non-controlling interest [Member]
Treasury shares [Member]
Total
Balance at Dec. 31, 2022 $ 371 $ 163,431 $ 311,839 $ (9,578) [1] $ (5,587) $ (39,430) $ 421,046
Balance, shares at Dec. 31, 2022 34,507,303            
Other comprehensive income (loss) [1] $ 0 0 0 1,176 0 0 1,176
Net loss (income) attributable to controlling interest 0 0 (107,656) 0 [1] 0 0 (107,656)
Equity-based compensation expense [2] 0 1,025 0 0 0 0 1,025
Adjustment to redemption value of the non-controlling interest 0 0 (532) 0 [1] 0 0 (532)
Cashless exercise of options and RSUs [3] [3] 0 0 [1] 0 0 0
Cashless exercise of options and RSUs, Shares 25,149            
Balance at Dec. 31, 2023 $ 371 164,456 203,651 (8,402) [1] (5,587) (39,430) 315,059
Balance, shares at Dec. 31, 2023 34,532,452            
Other comprehensive income (loss) [1] $ 0 0 0 (6,468) 0 0 (6,468)
Net loss (income) attributable to controlling interest 0 0 (42,832) 0 [1] 0 0 (42,832)
Equity-based compensation expense [2] 0 2,044 0 0 [1] 0 0 2,044
Adjustment to redemption value of the non-controlling interest 0 0 3,782 0 [1] 0 0 3,782
Cashless exercise of options and RSUs [3] [3] 0 0 [1] 0 0 0
Cashless exercise of options and RSUs, Shares 16,598            
Balance at Dec. 31, 2024 $ 371 166,500 164,601 (14,870) [1] (5,587) (39,430) $ 271,585
Balance, shares at Dec. 31, 2024 34,549,050           34,549,050
Other comprehensive income (loss) [1] $ 0 0 0 3,996 0 0 $ 3,996
Net loss (income) attributable to controlling interest 0 0 (137,467) 0 [1] 0 0 (137,467)
Equity-based compensation expense [2] 0 1,200 0 0 [1] 0 0 1,200
Adjustment to redemption value of the non-controlling interest 0 0 (101) 0 [1] 0 0 (101)
Cashless exercise of options and RSUs [3] [3] 0 0 [1] 0 0 0
Cashless exercise of options and RSUs, Shares 24,849            
Balance at Dec. 31, 2025 $ 371 $ 167,700 $ 27,033 $ (10,874) [1] $ (5,587) $ (39,430) $ 139,213
Balance, shares at Dec. 31, 2025 34,573,899           34,573,899
[1] Accumulated other comprehensive income (loss), net, comprised of foreign currency translation, hedging transactions and marketable securities, see also notes 2 and 3.
[2] See also Note 12.
[3] Less than $1.
v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:      
Net loss $ (137,759) $ (42,976) $ (108,240)
Adjustments required to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 14,199 17,134 30,007
Share-based compensation expense 1,200 2,044 1,025
Accrued severance pay, net 189 392 (268)
Changes in deferred tax, net (961) (621) 11,905
Capital loss from sale of property, plant and equipment 149 980 18
Legal settlements and loss contingencies, net 25,555 7,242 (4,770)
Decrease in trade receivables 88 18,748 11,760
Decrease in other accounts receivable and prepaid expenses 10,966 6,857 8,145
Decrease in inventories 21,099 20,128 101,549
Increase (decrease) in trade payables (15,342) 8,952 (29,465)
Increase (decrease) in warranty provision 170 (579) (165)
Decrease in right of use assets 14,213 3,371 7,865
Decrease in lease liabilities (1,959) (5,006) (9,516)
Contingent consideration related to acquisition 0 (53) 264
Amortization of premium and accretion of discount on marketable securities, net 0 0 63
Changes in accrued interest related to marketable securities 0 0 39
Impairment of long lived assets, restructuring and other related costs 48,753 1,007 47,939
Decrease in accrued expenses and other liabilities including related party (18,589) (5,746) (1,626)
Net cash (used in) provided by operating activities (38,029) 31,874 66,529
Cash flows from investing activities:      
Net cash paid for acquisitions 0 (1,556) 0
Repayment of (Investment in) short-term deposits 47,520 (12,500) (36,500)
Purchase of property, plant and equipment (9,036) (10,421) (11,168)
Proceeds from sale of property, plant and equipment 3,735 67 177
Sale and maturity of marketable securities 0 0 7,100
Proceeds from (investment in) long-term deposits (243) 51 (135)
Net cash provided by (used in) investing activities 41,976 (24,359) (40,526)
Cash flows from financing activities:      
Repayment of short-term bank credit and loans, net (1,960) (2,545) (23,268)
Payments related to transactions with non-controlling interest (1,920) 0 0
Contingent and deferred considerations related to acquisition 0 (500) (511)
Net cash used in financing activities (3,880) (3,045) (23,779)
Effect of exchange rate differences on cash and cash equivalents 1,037 (1,757) 318
Increase in cash and cash equivalents 1,104 2,713 2,542
Cash and cash equivalents at beginning of year 57,336 54,623 52,081
Cash and cash equivalents at end of year 58,440 57,336 54,623
Cash received (paid) during the year for:      
Interest paid (280) (548) (716)
Interest received 3,808 4,003 849
Tax paid (546) (3,117) (1,852)
Non cash activity during the year for:      
Changes in trade payables balances related to purchase of property, plant and equipment (103) 106 188
Operating lease liabilities and right-of-use assets $ 23,230 $ 22,120 $ 19,364
v3.25.4
GENERAL
 12 Months Ended
Dec. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GENERAL
NOTE 1:-
GENERAL
   
  a.
General:
 
Caesarstone Ltd. incorporated under the laws of the State of Israel, was founded in 1987.
 
Caesarstone Ltd. and its subsidiaries (collectively, the "Company" or "Caesarstone") develop, manufacture and market, high quality engineered stone, porcelain, and other materials sold under the Company's premium Caesarstone brand. The Company's products are sold in over 60 countries through a combination of direct sales in certain markets and indirectly through a network of independent distributors in other markets. The Company's products are primarily used as kitchen countertops in the renovation and remodeling markets and in the new buildings’ construction market. Other applications include vanity tops, wall panels, back splashes, floor tiles, stairs and other interior surfaces that are used in a variety of residential and non-residential applications.
 
The Company has subsidiaries in Australia, Singapore, Canada, the United Kingdom, Sweden, India, and the United States, which are engaged in the manufacturing, marketing, and sale of the Company’s products in their respective geographic regions. In 2024, the Company established a new wholly owned subsidiary in Germany, which is engaged in the marketing and sale of the Company’s products in that region and which commenced operations during 2025.
 
The Company currently manufactures its engineered stone surfaces through a combination of third-party production business partners in the Far East. The Company manufactures its porcelain surfaces at its manufacturing facility in Morbi, India, through its subsidiary Lioli Ceramica Pvt Ltd  (see also b below).
 
  b.
Acquisition of Lioli Ceramica Pvt Ltd:
 
On October 5, 2020, the Company completed the acquisition of 55% of the issued and outstanding shares of Lioli Ceramica Pvt. Ltd. ("Lioli"), a manufacturer of porcelain countertop slabs, for total net consideration of $13,574, which included a contingent consideration arrangement requiring additional payments subject to the achievement of specified EBITDA targets.
 
Pursuant to the acquisition agreement, the Company granted Lioli’s non-controlling interests a put option, and the non-controlling interests granted the Company a call option with respect to their remaining interest. Each option is exercisable at any time from April 1, 2024 until the twentieth anniversary of the acquisition date, based on a pricing mechanism set forth in the agreement between the parties.
 
In July 2024, the Company exercised a portion of its call option and acquired an additional 10.7 million shares of Lioli from the non-controlling interests for consideration of approximately $1.6 million. Following this transaction, the Company’s ownership increased to 80.7%. In October 2025, the Company exercised the remaining portion of its call option and acquired the remaining interest in Lioli for consideration of approximately $1.9 million. As a result, the Company holds 100% of Lioli’s shares and, as of December 31, 2025, there is no non-controlling interest related to Lioli.
 
  c.
Acquisition of Magrab Natursten AB:
 
On July 6, 2022, the Company completed the acquisition of 100% of the issued and outstanding shares of Magrab Natursten AB ("Magrab"), a stone supplier in Sweden, for total net consideration of approximately $3,109.
 
The consideration included a deferred consideration arrangement. During 2023, the Company paid approximately SEK 7,250 thousands (approximately $700) in connection with this arrangement, and during 2024, an additional approximately SEK 5,250 thousands (approximately $500) was paid.
 
  d.
Bodily injury claims:
 
As of December 31, 2025, the Company was subject to 676 lawsuits alleging injuries associated with exposure of fabricators and their employees to respirable crystalline silica dust. Of these lawsuits, 98 were in Israel, 151 in Australia and 427 in the United States.  The Company was subject to an adverse jury decision in August 2024 in the United States, that apportioned the Company with damages of $13.0 million, which the Company is appealing. In addition, in 2025, jury in California ruled in favor of the Company, assigning no liability to the Company in one trial, this case remains under appeal.  The Company settled another claim during 2025, and additional four claims settled during February 2026.
 
As of December 31, 2025, the Company had recorded a provision of $47.3 million representing its assessment of exposure that is probable and estimable with respect to pending claims in Israel, Australia and the United States. The Company also recorded insurance asset in the amount of $11.0 million with respect to those claims.
 
The Company estimated the loss for the remaining claims in the United States as only reasonably possible (with a range of $0.5-$13 million per claim) or at an early stages in which the amount of the possible loss cannot be reasonably estimated at this time given the preliminary stages, complexity of the claims and the uncertainty as to the liability of the Company and the scope of insurance coverage.
 
As of December 31, 2025, the Company is a party to reciprocal declaratory judgment actions in New York and California with its insurers regarding insurance coverage for silica-related claims, their allocation methodologies, whether policy limits have been exhausted, as well as claims to rescind policies for concealment of material facts in the policy application. These matters remain at an early stage. If there is a change in the assessment for the outcome of the claims or the insurance coverage available to the Company through the course of the trial processes, the Company may be adversely impacted and it could lead to a material and adverse impact on Company’s business, financial position, results of operations or cash flows. If such an adverse impact occurs, depending on its magnitude, the Company believes, based on management’s projections and plans, it can pursue other steps to mitigate the adverse impact over the next twelve months from the date of issuance of these financial statements, (see also note 10).
v3.25.4
SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
SIGNIFICANT ACCOUNTING POLICIES
NOTE 2:-
SIGNIFICANT ACCOUNTING POLICIES
 
The consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP").
 
  a.
Use of estimates:
 
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. The Company's management believes that the estimates, judgment and assumptions used are reasonable based upon information available at the time they were made.
 
  b.
Financial statements in U.S. dollars:
 
The Company's revenues are generated in various currencies mainly in U.S. dollars (USD), Australian dollars (AUD) and Canadian dollars (CAD). In addition, most of the Company's costs are incurred in USD, NIS and EUR.
 
The Company’s management believes that the USD is the primary currency of the economic environment in which the Company operates. Thus, the functional and reporting currency of the Company is the USD.
 
The functional currency of the Company's foreign subsidiaries is the local currency in which the relevant subsidiary operates.
 
Accordingly, monetary accounts maintained in currencies other than the USD are re-measured into dollars in accordance with Accounting Standards Codification, "Foreign Currency Matters" (“ASC 830”). All transaction gains and losses resulting from the re-measurement of monetary balance sheet items denominated in non-USD currencies are reflected in the statements of operations as financial income or expenses as appropriate.
 
The financial statements of the Company’s subsidiaries of which the functional currency is not the USD have been translated into the USD. All amounts on the balance sheets have been translated into the USD using the exchange rates in effect on the relevant balance sheet dates. All amounts in the statements of income have been translated into the USD using the monthly average exchange rate in accordance with ASC 830. The resulting translation adjustments are reported as a component of accumulated other comprehensive income (loss), net in shareholders' equity.
 
  c.
Principles of consolidation:
 
The consolidated financial statements include the accounts of the Company and its wholly and majority-owned subsidiaries (see also Note 1). Inter-company transactions and balances, including profit from inter-company sales not yet realized outside of the Company, have been eliminated upon consolidation.

 

  d.
Cash equivalents:
 
Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less at the date acquired.

 

  e.
Short-term bank deposits:
 
Short-term bank deposits are deposits with original maturities of more than three months but less than one year. Short-term bank deposits are presented at their cost, which approximates their fair value.
 
  f.
Derivatives:
 
ASC 815, “Derivative and Hedging” ("ASC 815"), requires companies to recognize all of their derivative instruments as either assets or liabilities in the statement of financial position at fair value.
 
For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge or a hedge of a net investment in a foreign operation.
 
Derivative instruments designated as hedging instruments:
For derivative instruments that are designated and qualify as a cash flow hedge (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), changes in the fair value of the derivative instruments are recorded as a component of accumulated other comprehensive income (loss) and reclassified into earnings in the same period during which the hedged transaction affects earnings.
 
To hedge against the risk of overall changes in cash flows resulting from foreign currency salary and other recurring payments during the periods, the Company has instituted a foreign currency cash flow hedging program.
 
These forward contracts are designated as cash flow hedges, as defined by ASC 815, and are all effective, as their critical terms match the underlying transactions being hedged.
 

As of December 31, 2025 and 2024, the notional amount of these forward contracts into which the Company entered was $0 and $2,525, respectively, and the unrealized income recorded in accumulated other comprehensive income, net, from the Company's currency forward NIS transactions was $110 and $429, respectively.

 
The following tables present fair value amounts of, and gains and losses recorded in relation to, the Company's derivative instruments and related hedged items:
 
 

Balance sheet

  
Fair value of
derivative instruments
      
Year ended
December 31,
  
     
2025
    
2024
  
Derivative assets:
              
               
Derivatives designated as hedging instruments:
              
Foreign exchange option and forward contracts
Other accounts receivable and prepaid expenses
    
-
      
110
  
                   
Total
 
    
-
      
110
  
 
   
Gain (loss) recognized in
other comprehensive
income, net
  
Gain (loss) recognized in
statements of income
  
   
Year ended
December 31,
  
Statements of
income
  
Year ended
December 31,
  
   
2025
    
2024
  
Item
  
2025
    
2024
  
Derivatives designated as hedging instruments:
                          
                           
Foreign exchange forward contract
    
(110
)
    
(429
)
Cost of revenues and Operating expenses
    
4,193
      
500
  
 
                
 
                
Derivatives not designated as hedging instruments:
                
 
                
Foreign exchange forward and options contracts
    
-
      
-
  
Financial expenses, net
    
267
      
6
  
 
                
 
                
Total
    
(110
)
    
(429
)
 
    
4,460
      
506
  
 
For derivative instruments not designated as hedging instruments, the gain or loss is recognized in current earnings during the period of change.

 

  h.
Inventories:
 
Inventories are stated at the lower of cost and net realizable value. The Company periodically evaluates the quantities on hand relative to historical and projected sales volumes, aging, current and historical selling prices and contractual obligations to maintain certain levels of raw material quantities. Based on these evaluations, inventory provision is provided to cover risks arising from slow-moving items, discontinued products, excess inventories, net realizable value lower than cost and adjusted revenue forecasts.
 
Cost is determined as follows:
 
Raw Materials - cost is determined on a standard cost basis which approximates actual costs on a weighted average basis.
 
Work-in progress and manufactured finished products - are based on standard cost (which approximates actual cost on a weighted average basis) which includes raw materials cost, labor and manufacturing overhead. Acquired finished goods are based on  weighted average.
 
Finished goods are stated at the lower of cost and net realizable value.
 
Inventory write-offs of $1,966, $3,290 and $4,148, were recorded for the years ended December 31, 2025, 2024 and 2023, respectively.

 

  i.
Property, plant and equipment, net:
 
  1.
Property, plant and equipment are stated at cost, net of accumulated depreciation and investment grants.
 
  2.
Costs recorded prior to a production line completion are reflected as construction in progress, which are recorded building and machinery assets at the date of purchase. Construction in progress includes direct expenditures for the construction of the production line and is stated at cost. Capitalized costs include costs incurred under the construction contract: advisory, consulting and direct internal costs (including labor) and operating costs incurred during the construction and installation phase.
 
  3.
Depreciation is calculated using the straight-line method over the estimated useful life of the assets at the following annual rates:
 
 
%
   
Machinery and manufacturing equipment
4 - 33 (mainly 10)
Office equipment and furniture
7 - 33 (mainly 7)
Motor vehicles
10 - 30 (mainly 20)
Buildings
4 - 5
Leasehold improvements
Over the shorter of the term of the lease or the life of the asset
 
  j.
Leases:
 
The Company determines if an arrangement is a lease at inception and recognize in accordance with ASC 842 “Leases”. Operating leases are included in operating lease right-of-use (“ROU”) assets, other current liabilities and operating lease liabilities in the Company’s consolidated balance sheets.
 
ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term.
 
The interest rate used to determine the present value of the future lease payments is the Company’s incremental borrowing rate, because the interest rate implicit in the Company’s leases is not readily determinable. The Company’s incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in economic environments where the leased asset is located. The operating lease ROU asset also includes any lease payments made and excludes lease incentives, if any. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expenses for lease payments are recognized on a straight-line basis over the lease term. If an operating lease asset is impaired, the remaining operating lease asset will be amortized on a straight-line basis over the remaining lease term. See also Note 9.

 

  k.
Impairment of long-lived assets and Assets Held-for-Sale:
 
Impairment of long-lived assets
 
The Company's long-lived assets (assets group) to be held or used, including right of use assets, tangible and finite-lived intangible assets (other than goodwill), are reviewed for impairment in accordance with ASC 360 "Property, Plant and Equipment" ("ASC 360") whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
 
The Company's evaluation of recoverability is performed at the lowest level of assets group to which identifiable cash flows are largely independent of the cash flows of other asset groups. Recoverability of the asset group is measured by a comparison of the aggregate undiscounted future cash flows the asset group is expected to generate to the carrying amounts of the asset group. If such evaluation indicates that the carrying amount of the asset group is not recoverable, an impairment loss is calculated based on the excess of the carrying amount of the asset group over its fair value.
 
The Company identifies indicators for impairment, among others, slowdown in demand due to global and local market conditions, integration challenges of acquired businesses, and the manufacturing facilities closure in Sdot Yam, Richmond Hill and Bar-Lev.
 
Following the approval of the closure of its Sdot Yam manufacturing facility in Israel and its Richmond Hill manufacturing facility in the United States during 2023, the Company recorded an impairment loss related to Richmond Hill manufacturing facility for the excess of the carrying amount over its fair value, in the amount of $27,486. The Company also recorded additional impairment loss related to Sdot Yam manufacturing facility in the amount of $986. In addition, the Company evaluated its right-of-use asset associated with its non‑cancelable lease agreement in Sdot Yam, which is effective through 2032. The Company recorded an impairment of $16,575 for its leased facility.
 
During 2024, the Company recorded an impairment loss of $3,236 related to its intangible assets.
 
Following the approval of the closure of its Bar‑Lev manufacturing facility in Israel during 2025, the Company evaluated its right-of-use asset associated with its non‑cancelable lease agreement in Bar‑Lev, which is effective through 2032. As a result of this evaluation, the Company recorded an impairment of $6,859 for this leased facility.
 
In addition to performing recoverability assessment, the Company routinely reviews the remaining estimated useful lives of property and equipment and finite-lived intangible assets. If the Company revises the estimated useful life assumption for any asset, the remaining unamortized balance is adjusted prospectively and amortized or depreciated over the revised remaining useful life.

 

Assets Held-for-Sale:
 
The Company classifies assets as held-for-sale in the period when all of the following conditions are met: (i) management, having the authority to approve the action, commits to a plan to sell the assets; (ii) the assets are available for immediate sale in their present condition subject only to terms that are usual and customary for sales of such assets; (iii) an active program to locate a buyer and other actions required to complete the plan to sell the assets have been initiated; (iv) the sale of the assets is probable, and transfer of the assets is expected to qualify for recognition as a completed sale within one year, except if events or circumstances beyond the Company's control extend the period of time required to sell the assets beyond one year; (v) the assets are being actively marketed for sale at a price that is reasonable in relation to its current fair value; and (vi) actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.
 
The Company evaluates the probability of sale within one year, considering current market conditions and the status of active marketing efforts. If disposal does not occur within 12 months, the Company reassesses whether delays are caused by factors outside its control.
 
The assets that are classified as held-for-sale are initially measured at the lower of their carrying value or fair value, less any costs to sell. The determination of the fair value less costs to sell may require management to make judgments on significant estimates and assumptions including, but not limited to, indicative sales values, current market conditions and available data for transactions for similar assets. Any impairment loss resulting from this measurement is recorded in Impairment of long-lived assets, restructuring and other, net on the Consolidated Statements of Operations and the assets held-for-sale are recorded as a separate line within the Consolidated Balance Sheets. Upon being classified as held for sale we cease depreciation. The fair values of assets less any costs to sell are assessed each reporting period for which they remain classified as held-for-sale, and any subsequent change is reported as an adjustment to the carrying value of the assets, as long as the new carrying value does not exceed the carrying value of the asset at the time it was initially classified as held-for-sale.
 
During 2024, following the Company's decision to sale its Richmond Hill manufacturing facility it was determined that the Richmond Hill manufacturing facility met all criteria to be classified as assets held-for-sale. The impairment charges were measured as the difference between the carrying value of this long‑lived asset and its estimated fair value, less estimated costs to sell. The Company recorded an impairment loss of $3,800 related to the excess of the carrying amount over the fair value of the held‑for‑sale asset. During 2024, the Company also sold a portion of the land associated with the Richmond Hill facility, together with certain production equipment, resulting in a capital gain of $7.4 million.
 
During 2025, following the Company's decision to cease manufacturing activities in its Bar-Lev manufacturing facility, it was determined that it met all criteria to be classified as assets held-for-sale. The Company recorded an impairment loss for the excess of the book value over its fair value related to held-for-sale asset, in the amount of $32,651.

 

During 2025, the Company recorded additional impairment loss related to Richmond Hill held-for-sale asset in the amount of $6,146.

 

  l.
Warranty:
 
The Company generally provides a standard (i.e. assurance type) warranty for its products, for various periods, depending on the type of product and the country in which the Company does business. The Company records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company's warranty reserve include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair.
 
The following table provides the details of the change in the Company's warranty accrual:
 
   
2025
    
2024
  
             
January 1,
  
$
1,726
    
$
2,358
  
                 
Charged to costs and expenses relating to new sales
    
3,189
      
368
  
Costs of product warranty claims
    
(2,996
)
    
(844
)
Foreign currency translation adjustments
    
20
      
(156
)
                 
December 31,
   $
1,939
     $
1,726
  

 

  m.
Revenue recognition:
 
Revenues are recognized in accordance with ASC 606, revenue from contracts with customers when control of the promised goods or services is transferred to the customers, in an amount that the Company expects in exchange for those goods or services.
 
The Company applies the following five steps in accordance to ASC 606: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.
 
  1.
Identify the contract with a customer:
 
A contract is an agreement between two or more parties that creates enforceable rights and obligations. In evaluating the contract, the Company analyzes the customer’s intent and ability to pay the amount of promised consideration and considers the probability of collecting substantially all of the consideration. The Company determines whether collectability is probable on a customer-by-customer basis pursuant to various criteria including Company’s historical experience, credit insurance and other inputs.
 
  2.
Identify the performance obligations in the contract:
 
At a contract’s inception, the Company assesses the goods or services promised in a contract with a customer and identifies the performance obligations. The main performance obligation is a delivery of the Company’s products. For certain revenue transactions with specific customers, the Company is responsible also for the fabrication and installation of its products.
     
  3.
Determine the transaction price:
 
The Company’s products that are sold through agreements with distributors are non-exchangeable, non-refundable, non-returnable and without any rights of price protection or stock rotation. Accordingly, the Company considers all the distributors to be end-consumers.
 
Although, in general, the Company does not grant rights of return, there are certain instances where such rights are granted. The Company maintains a provision for returns in accordance with ASC 606, which is estimated, based primarily on historical experience as well as management judgment, and is recorded through a reduction of revenue. The Company also adjusts the amounts of revenue for expected cash discounts and sales allowances.
 
Sales and other taxes collected from customers on behalf of governmental authorities are accounted for on a net basis and are not included in revenues.
 
The Company has elected to apply the practical expedient such that it does not evaluate payment terms of one year or less for the existence of a significant financing component.
     
  4.
Allocate the transaction price to the performance obligations in the contract:
 
The majority of the Company’s revenues are sales of goods, therefore there is one main performance obligation that absorbs the transaction price.
 
 
 5.
Recognize revenue when a performance obligation is satisfied:
 
Revenue is recognized when or as performance obligations are satisfied by transferring control of a promised good or service to a customer. Control transfers at a point in time, which affects when revenue is recorded. The majority of Company’s revenues deriving from sales of products which are recognized when control is transferred based on the agreed International Commercial terms, or “INCOTERMS”. For certain revenue transactions with specific customers, the Company is responsible also for the fabrication and installation of its products. The Company recognizes such revenues upon receipt of acceptance evidence from the end consumer which occurs upon completion of the installation.
 
The Company elected the short-term contract practical expedient for the remaining performance obligations, as the Company's contracts have an original expected duration of less than one year.

 

  n.
Research and development costs:
 
Research and development costs are charged to the statement of operations as incurred.

 

  o.
Income taxes:
 
The Company and its subsidiaries account for income taxes in accordance with ASC 740, "Income Taxes" (“ASC 740”). This statement prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.

 

The Company accounts for its uncertain tax positions in accordance with ASC 740-10. ASC 740-10 contains a two-step approach to recognizing and measuring uncertain tax positions accounted for in accordance with ASC 740. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company classifies interest and penalties on income taxes as taxes on income, if relevant.

 

  p.
Advertising expenses:
 
Advertising costs are expensed as incurred. Advertising expenses for the years ended December 31, 2025, 2024 and 2023 were $14,466, $14,516 and $15,726, respectively.

 

  q.
Concentrations of credit risk:
 
Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents, marketable securities and trade receivables. The Company's cash and cash equivalents are invested primarily in USD, mainly with major banks in Israel.
 
The Company's trade receivables are derived from sales to customers located mainly in the United States, Australia, Canada, Israel and Europe. The Company performs ongoing credit evaluations of its customers and to date has not experienced any substantial losses. In certain circumstances, the Company requires letters of credit or prepayments. An allowance for credit losses is provided with respect to specific receivables that the Company has determined to be doubtful of collection. For those receivables not specifically reviewed, provisions are recorded, based upon the age of the receivable, the collection history, current economic trends and management estimates of future economic conditions.
 
No customer represented 10% or more of the Company’s total accounts receivables, net as of December 31, 2025 and 2024.
 
The following table provides the details of the change in the Company's allowance for credit loss:
 
   
2025
    
2024
  
             
January 1,
  
$
9,104
    
$
12,214
  
                 
Charges to expenses
    
17
      
(1,944
)
Write offs
    
(1,726
)
    
(1,095
)
Foreign currency translation adjustments
    
(68
)
    
(71
)
                 
December 31,
  
$
7,327
    
$
9,104
  

 

  r.
Severance pay:
 
The Company's liability for severance pay, with respect to its Israeli employees, is calculated pursuant to Israeli severance pay law and employee agreements based on the most recent salary of the employees. The Company's liability for all of its Israeli employees is provided for by monthly deposits with insurance policies and by an accrual. The value of these policies is recorded as an asset on the Company's balance sheet.
 
The deposited funds include profits or losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligations pursuant to Israeli severance pay law or labor agreements.
 
Majority of the agreements with employees specifically state, in accordance with section 14 of the Severance Pay Law, 1963 ("Section 14"), that the Company's contributions for severance pay shall be instead of severance compensation and that upon release of the policy to the employee, no additional calculations shall be conducted between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee.
 
Further, since the Company has signed agreements with its employees under Section 14, the related obligation and amounts deposited on behalf of such obligation are not stated on the balance sheet, as they are legally released from obligation to employees once the deposit amounts have been paid.
 
Severance pay expenses for the years ended December 31, 2025, 2024 and 2023 amounted to approximately $1,594, $1,647 and $2,102, respectively.
 
  s.
Fair value of financial instruments:
 
In accordance with ASC 820, the Company measures the below assets and liabilities at fair value using the various valuation techniques. The assets and liabilities are classified within Level 1 for using quoted market prices, Level 2 for alternative pricing sources and models utilizing market observable inputs, and Level 3 unobservable inputs which are supported by little or no market activity, also using third party appraisers.
 
The following table sets forth the Company’s assets and liabilities that were measured at fair value as of December 31, 2025 and 2024 by level within the fair value hierarchy:
 
   
Fair Value
  
Fair value measurements
as of December 31,
  
Description
  
Hierarchy
  
2025
    
2024
  
 
                
Measured at fair value on a recurring basis:
                
 
                
Assets:
                
Derivative assets
  
Level 2
  
$
-
    
$
110
  

 

Measured at fair value on a nonrecurring basis:
 
  (a)
During the year ended December 31, 2023, the Company recorded an impairment loss of $27,486 related to the excess of the book value over the fair value of its Richmond Hill manufacturing facility, and an additional impairment loss of $986 related to the Sdot Yam manufacturing facility. The Company also recorded an impairment of $16,575 related to the right‑of‑use (ROU) assets associated with the Sdot Yam manufacturing facility.
 
The Company determined the fair value of Richmond Hill manufacturing facility using both the market approach by reference to recent comparable property transactions in the area and the income approach, which incorporated market‑based rental assumptions derived from comparable lease agreements in the region. The fair value of the property, plant and equipment was measured using the cost approach, based on replacement cost less depreciation and market‑related adjustments. These inputs are categorized as Level 3 within the fair value hierarchy.
 
The Company determined the fair value of the right‑of‑use asset associated with the Sdot Yam using a discounted cash‑flow technique that incorporated projected market‑rate lease payments, estimated using observable market information and comparable lease transactions from external data sources, and discounted at an appropriate rate. These fair value measurements also qualify as Level 3 measurements within the fair value hierarchy.
 
  (b)
During the year ended December 31, 2024, it was determined that the Richmond Hill facility met all criteria to be classified as assets held for sale. The impairment charges were measured as the difference between the carrying value of these long‑lived assets and their estimated fair values, less estimated costs to sell. The Company recorded an impairment loss of $3,800 and of $6,146 related to the excess of the carrying amount over the fair value of the held‑for‑sale asset during the years ended December 31, 2024, and 2025, respectively. The fair value was determined using both the market approach by reference to recent comparable property transactions in the area and the income approach, which incorporated market‑based rental assumptions derived from comparable lease agreements in the region.
 
  (c)
During the year ended December 31, 2025 the Company recorded impairment charges of $32,651 related to previous investments in manufacturing equipment at Bar Lev manufacturing facility, pursuant to held-for-sale accounting guidance. The impairment charges were determined as the difference between the carrying value of these long-lived assets and their estimated fair values, less estimated costs to sell such assets. The fair value of the property, plant and equipment was measured using the cost approach, based on replacement cost less depreciation and market‑related adjustments. These inputs are categorized as Level 3 within the fair value hierarchy.
 
In addition, during the year ended December 31, 2025, the Company recorded impairment charges of $6,859 related to the right‑of‑use assets associated with the Bar Lev manufacturing facility. The Company determined the fair value of the right‑of‑use asset associated with Bar Lev using a discounted cash‑flow technique that incorporated projected market‑rate lease payments, estimated using observable market information and comparable lease transactions from external data sources, and discounted at an appropriate rate. This fair value measurement also qualify as Level 3 measurement within the fair value hierarchy.
 
The carrying amounts of financial instruments not measured at fair value, including cash and cash equivalents, trade receivables, other accounts receivables, trade payables, accrued expenses and other liabilities, short term loans and short-term bank credit, approximate their fair value due to the short-term maturities of such instruments.
 
  t.
Basic and diluted net income (loss) per share:
 
Basic net income (loss) per share ("Basic EPS") is computed by dividing net income (loss) attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.
 
Diluted net income (loss) per share ("Diluted EPS") gives effect to all dilutive potential ordinary shares outstanding during the period. The computation of Diluted EPS does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings. The dilutive effect of outstanding stock options is computed using the treasury stock method. For the years ended December 31, 2025, 2024 and 2023 there were approximately 3,421,138, 2,495,479, and 2,310,543 outstanding stock options, respectively, that were excluded from the computation of Diluted EPS, that would have had an anti-dilutive effect if included.
 
  u.
Accumulated other comprehensive income (loss):
 
The total accumulated other comprehensive income ("AOCI"), net of tax was comprised as follows:
 
   
December 31,
  
   
2025
    
2024
  
             
Accumulated income on derivative instruments
   $
-
     $
110
  
Accumulated foreign currency translation differences and other
    
(10,874
)
    
(14,980
)
                 
Total accumulated other comprehensive loss, net
  
$
(10,874
)
  
$
(14,870
)
 
The following table summarizes the changes in AOCI, net of taxes for the year ended:
 
   
Unrealized gains (losses) on derivative instruments
    
Accumulated foreign currency translation differences and other
    
Total
  
                   
Balance at January 1, 2024
   $
539
     $
(8,941
)
   $
(8,402
)
                         
Other comprehensive income (loss) before reclassifications
    
71
      
(6,039
)
    
(5,968
)
Amounts reclassified from AOCI
    
(500
)
    
-
      
(500
)
                         
Net current period OCI
    
(429
)
    
(6,039
)
    
(6,468
)
                         
Balance at December 31, 2024
    
110
      
(14,980
)
    
(14,870
)
                         
Other comprehensive income (loss) before reclassifications
    
4,083
      
4,106
      
8,189
  
Amounts reclassified from AOCI
    
(4,193
)
    
-
      
(4,193
)
                         
Net current period OCI
    
(110
)
    
4,106
      
3,996
  
                         
Balance at December 31, 2025
   $
-
     $
(10,874
)
   $
(10,874
)
 
The following table shows the amounts reclassified from AOCI into the Consolidated Statements of Income, and the associated financial statement line item, for 2025 and 2024:
 
   
December 31,
  
   
2025
    
2024
  
Affected line item in the consolidated statements of income:
            
             
Cost of revenues
  
$
2,664
    
$
324
  
Research and development
    
267
      
20
  
Marketing and selling
    
615
      
81
  
General and administrative
    
647
      
75
  
                 
Total Credit
  
$
4,193
    
$
500
  
 
  v.
Accounting for stock-based compensation:
 
Equity share based payment:
 
The Company accounts for stock-based compensation in accordance with ASC 718, "Compensation-Stock Compensation" ("ASC 718"). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model.
 
The Company accounts for employees and directors’ share-based payment awards classified as equity awards using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period on a straight-line basis. The Company’s accounting policy is to account for forfeitures as they occur.
 
The exercise price of each option is generally Company's stock price on the date of the grant. Options generally become exercisable over approximately three to four-year period, subject to the continued employment. All options expire after 7 years from the date of grant. In addition, commencing in 2015 the Company granted certain of its employees and officers with restricted stock units ("RSUs"), vesting over approximately a four-year period from the grant date. RSUs fair value is measured at the grant date based on the market value of Company's common stock. RSUs that are cancelled or forfeited become available for future grants.
 
In 2025 and 2024, the Company estimated the fair value of stock options granted using the Black-Scholes option pricing model with the following weighted average assumptions:
 
   
December 31,
  
   
2025
    
2024
  
             
Dividend yield
  
0 - 3
    
0 - 3%
  
Expected volatility
  
44-59.0%
    
42-47.0%
  
Risk-free interest rate
  
3.7-4.3%
    
4-4.6%
  
Expected life (in years)
  
4-7
    
4-7
  
 
The Company used volatility data in accordance with ASC 718 and based on Company's historical data.
 
The computation of risk free interest rate is based on the rate available on the date of grant of a zero-coupon U.S. government bond with a remaining term equal to the expected term of the option.
 
The expected term of options granted is calculated using the simplified method (being the average between the vesting periods and the contractual life of the options). In case of grant to Company's CEO or directors, the expected term equals to the contractual life.
 
For the vast majority of the options granted in 2025 and 2024, the dividend yield is zero, due to adjustment mechanism with respect to the exercise price upon payment of a dividend. For those options granted without adjustment mechanism, the dividend yield applied is 3%.
 
  w.
Redeemable non-controlling interest:
 
In July 2024, the Company partially exercised its call option to acquire minority interests in Lioli and purchased 10,699,162 shares from certain minority shareholders for aggregate consideration of approximately $1.6 million. Following this transaction, the Company held approximately 80.7% of Lioli’s outstanding shares on a fully diluted basis.
 
In October 2025, the Company exercised its call option to acquire the remaining minority interests in Lioli and purchased an additional 14,475,338 shares for aggregate consideration of approximately $1.9 million. Upon completion of this transaction, the Company owns 100% of Lioli’s outstanding shares.
 
The redeemable non-controlling interest was measured at the higher of (i) the carrying amount attributable to the non-controlling interest, including its share of accumulated earnings, or (ii) the redemption value as of the relevant balance sheet date (see Note 1b).
 
The following table provides a reconciliation of the redeemable non-controlling interest:
 
   

Year ended December 31,
   
2025
    
2024
    
2023
  
                   
Beginning of the year
  
$
2,200
    
$
7,789
    
$
7,903
  
                         
Net loss attributable to non-controlling interest
    
(292
)
    
(144
)
    
(584
)
Adjustment to Put option value (*)
    
101
      
(3,782
)
    
532
  
Payment for Put option (*)
    
(1,920
)
    
(1,556
)
    
-
  
Foreign currency translation adjustments
    
(89
)
    
(107
)
    
(62
)
                         
Redeemable non-controlling interest - end of the year
  
$
-
    
$
2,200
    
$
7,789
  
 
(*) See also Note 1b.
 
  x.
Contingencies:
 
The Company is involved in various product liability, commercial, government investigations, environmental claims and other legal proceedings that arise from time to time in the course of business. The Company records accruals for these types of contingencies to the extent that the Company concludes their occurrence is probable and that the related liabilities are estimable. When accruing these costs, the Company will recognize an accrual in the amount within a range of loss that is the best estimate within the range. When no amount within the range is a better estimate than any other amount, the Company accrues for the minimum amount within the range. The Company records anticipated recoveries under existing insurance contracts that are probable of occurring at the amount that is expected to be collected. Legal costs are expensed as incurred. For unasserted claims or assessments, the Company followed the accounting guidance in ASC 450 Contingencies, in which the Company must first determine that the probability that an assertion will be made is likely, then, a determination as to the likelihood of an unfavorable outcome and the ability to reasonably estimate the potential loss is made.
 
  y.
Business combination:
 
The Company accounts for business combinations by applying the provisions of ASC 805, Business Combination, and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets.
 
Significant estimates in valuing certain intangible assets include, but are not limited to future expected cash flows from acquired customer relationship and acquired trademarks from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates.  During the measurement period, which does not exceed one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding adjustment to goodwill. Upon the finalization of the measurement period, any subsequent adjustments are recorded to earnings.
 
Acquisition-related costs are recognized separately from the acquisition and are expensed as incurred. See also Note 1.
 
  z.
Exit or disposal activities:
 
The Company accounts for exit and disposal cost obligations, including restructuring activities, under ASC 420-10 "Exit or Disposal Cost Obligations", which requires that the company record liabilities for such activities only when such liability has been incurred.

During 2023, The Company approved the closure of its Sdot Yam manufacturing facility in Israel and its Richmond Hill manufacturing facility in the US. This resulted in a reduction of workforce and impairment of certain long-lived assets.
 

During 2024, it was determined that the Richmond Hill facility met all criteria to be classified as assets held for sale, in addition, the Company sold a portion of the land associated with the Richmond Hill facility, together with certain production equipment.

 
During 2025, the Company approved the closure its Bar-Lev manufacturing facility in Israel. This resulted in a reduction of workforce, impairments of certain long-lived assets to be held and used and impairments of certain long-lived assets that met the held-for-sale criteria during the year ended December 31, 2025.
 
Total restructuring expenses for the year ended December 31, 2025, 2024 and 2023 related to the manufacturing facilities closures and the sale of a portion of the land and certain production equipment associated with the Richmond Hill facility, amounted to approximately $3.1 million expenses, net gain of $6.0 million and $2.9 million expenses, respectively, included within the Impairment of long-lived assets, restructuring and other, net on the consolidated statements of comprehensive income (loss).
 
In 2025, the $3.1 million expenses included decommissioning, restoration and other related costs of approximately $3.2 million, employee termination costs of approximately $1.0 million, offset by certain credit of approximately $1.1 million related to the Richmond Hill facility.
 
In 2024, the net gain of $6.0 million, included capital gain of approximately $7.4 million related to the sale of a portion of the undeveloped land associated with the Richmond Hill facility, offset by decommissioning and restoration costs of approximately $1.4 million.
 
In 2023, the $2.9 million expenses, included employee termination costs of approximately $1.0 million, and decommissioning and restoration costs of approximately $1.9 million.
 
As of December 31, 2025 and 2024, approximately $4.0 and $1.5 million, respectively, recorded under accrued expenses and other liabilities.
 
  aa.
Impact of recently issued accounting standards:
 
   
Recently issued accounting standards and adopted by the Company:

 

 

  

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted ASU 2023-09 for the year ended December 31, 2025, and applied the new disclosure requirements prospectively to the current annual period. Prior period disclosures have not been adjusted to reflect the new disclosure requirements. See Note 11.
 
   
Recently issued accounting standards and not yet adopted by the Company:
 
   
In July 2025, the FASB issued ASU 2025-05, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides a practical expedient when estimating expected credit losses for current accounts receivable and current contract assets arising from transactions accounted for under Topic 606, Revenue from Contracts with Customers. The practical expedient assumes that current conditions as of the balance sheet date do not change for the remaining life of the assets. The guidance is effective for the Company beginning January 1, 2026, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statement.
 
In December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities. The update provides recognition, measurement, presentation, and disclosure requirements for government grants, including guidance for grants related to an asset and grants related to income. The amendments introduced two permitted approaches for asset-related grants: a deferred income approach or a cost accumulation approach. The guidance is effective for the Company beginning January 1, 2029, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statement.
v3.25.4
OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES
 12 Months Ended
Dec. 31, 2025
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES
NOTE 3:-
OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES
 
   
December 31,
  
   
2025
    
2024
  
             
Prepaid expenses
  
$
6,251
    
$
6,505
  
Government authorities
    
1,405
      
2,841
  
Advances to suppliers
    
932
      
2,703
  
Derivatives
    
-
      
110
  
Insurance receivables (*)
    
11,023
      
32,178
  
Other receivables
    
1,712
      
5,168
  
                 
   
$
21,323
    
$
49,505
  
 
(*) Related to bodily injury claims, see also note 10.
v3.25.4
INVENTORIES
 12 Months Ended
Dec. 31, 2025
Inventory Disclosure [Abstract]  
INVENTORIES
NOTE 4:-
INVENTORIES
 
   
December 31,
  
   
2025
    
2024
  
             
Raw materials
  
$
1,519
    
$
7,090
  
Work-in-progress
    
1,198
      
1,864
  
Finished goods
    
91,558
      
103,655
  
                 
   
$
94,275
    
$
112,609
  
v3.25.4
PROPERTY, PLANT AND EQUIPMENT, NET
 12 Months Ended
Dec. 31, 2025
Property, Plant and Equipment [Abstract]  
PROPERTY, PLANT AND EQUIPMENT, NET
NOTE 5:-
PROPERTY, PLANT AND EQUIPMENT, NET
 
   
December 31,
  
   
2025
    
2024
  
Cost:
            
             
Machinery and manufacturing equipment, net
  
$
30,106
    
$
163,517
  
Office equipment and furniture
    
23,498
      
27,783
  
Motor vehicles
    
1,934
      
3,517
  
Buildings and leasehold improvements
    
31,072
      
51,015
  
Prepaid expenses related to operating lease
    
-
      
939
  
                 
     
86,610
      
246,771
  
Accumulated depreciation and impairment:
                
                 
Machinery and manufacturing equipment, net
    
20,893
      
120,851
  
Office equipment and furniture
    
17,593
      
18,604
  
Motor vehicles
    
1,455
      
2,798
  
Buildings and leasehold improvements
    
16,523
      
28,611
  
Prepaid expenses related to operating lease
    
-
      
183
  
                 
     
56,464
      
171,047
  
                 
Depreciated cost (*)
  
$
30,146
    
$
75,724
  
 
  (*)
During 2025, following the Company's decision to cease manufacturing activities in its Bar-Lev manufacturing facility, it was determined that it met all criteria to be classified as assets held-for-sale. The Company recorded an impairment loss for the excess of the book value over its fair value related to held-for-sale asset, in the amount of $32,651 (see also Note 2k).
 
Depreciation expenses were $14,547, $14,844 and $27,387 for the years ended December 31, 2025, 2024 and 2023, respectively.
v3.25.4
INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2025
GOODWILL [Abstract]  
INTANGIBLE ASSETS
NOTE 6:-
INTANGIBLE ASSETS

 

   
December 31,
  
   
2025
    
2024
  
Original amounts:
            
    Customer relationships
  
$
13,983
    
$
13,983
  
Accumulated amortization:
                
    Customer relationships (1)
    
(10,562
)
    
(10,302
)
Accumulated impairment charges (2)
    
(3,236
)
    
(3,236
)
Foreign currency translation adjustment
    
(185
)
    
(181
)
                 
Total intangibles assets
  
$
-
    
$
263
  
 
  (1)
Amortization expense amounted to $260 and $2,617 for the years ended December 31, 2025 and 2024, respectively.
 
  (2)
During the year ended December 31, 2024, the Company recorded an impairment loss related to its intangible assets. See also Note 2k.
v3.25.4
SHORT-TERM BANK CREDIT AND CURRENT MATURITIES OF LONG-TERM LOAN
 12 Months Ended
Dec. 31, 2025
Short-Term Debt [Abstract]  
SHORT-TERM BANK CREDIT AND CURRENT MATURITIES OF LONG-TERM LOAN
NOTE 7:-
SHORT-TERM BANK CREDIT AND CURRENT MATURITIES OF LONG-TERM LOAN
 
Short-term bank credit and loans are classified as follows:
 
      
Weighted average interest
              
 
Currency
  
December 31,
    
December 31,
  
     
2025
    
2024
    
2025
    
2024
  
     
%
              
                           
Short-term bank credit (*)
INR
    
8.6
      
9.3
    
$
2,431
    
$
2,534
  
Current maturities of Long- term bank loan and other (**)
INR
    
-
      
9.6
    
$
422
    
$
2,021
  
Total
                    
$
2,853
    
$
4,555
  
 
   
(*) Credit line and bank loan – short term overdraft credit line of 250 million INR ($2.8 million), 215 million INR ($2.4 million) of which were utilized as of December 31, 2025.
 
(**) See also note 13e.
v3.25.4
ACCRUED EXPENSES AND OTHER LIABILITIES
 12 Months Ended
Dec. 31, 2025
Payables and Accruals [Abstract]  
ACCRUED EXPENSES AND OTHER LIABILITIES
NOTE 8:-
ACCRUED EXPENSES AND OTHER LIABILITIES
 
   
December 31,
  
   
2025
    
2024
  
             
Employees and payroll accruals
  
$
11,443
    
$
11,690
  
Accrued expenses
    
8,078
      
7,990
  
Advances from customers
    
3,377
      
2,435
  
Taxes payable
    
6,870
      
3,585
  
Warranty provision
    
1,050
      
824
  
Sales return provision
    
879
      
432
  
Operating lease liability short-term
    
26,917
      
24,339
  
Other
    
104
      
88
  
                 
   
$
58,718
    
$
51,383
  
v3.25.4
LEASES
 12 Months Ended
Dec. 31, 2025
Lessee Disclosure [Abstract]  
LEASES
NOTE 9:-
LEASES
 
As of December 31, 2025, the Company had operating lease agreements for facilities and vehicles in the United States, Canada, Australia, United Kingdom, European Union, Israel, India and Singapore. The Company’s leases have remaining lease terms of up to 13 years, some of which include options to extend the leases for up to five years. Such options are included in the lease term when it is reasonably certain that the option will be exercised. Leases with an initial term of 12 months or less are not recorded on the balance sheet, the Company recognizes lease expense for these leases on a straight-line basis over the lease term. The Company does not separate non-lease components from the lease components to which they relate, and instead accounts for each separate lease and non-lease component associated with that lease component as a single lease component for all underlying asset classes. The Company uses its estimated incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.
 
  a.
The following table summarizes the Company’s lease-related assets and liabilities recorded on the consolidated balance sheet:
 
 
Classification
  
December 31, 2025
    
December 31, 2024
  
Assets:
              
               
Operating lease assets (*)
Operating lease right-of-use assets
  
$
104,774
    
$
115,392
  
                   
Total lease assets
    
$
104,774
    
$
115,392
  
                   
Liabilities:
                  
                   
Current lease liabilities
Accrued expenses and other liabilities
    
26,917
      
24,339
  
Long-term lease liabilities
Long-term operating lease liabilities
    
106,377
      
107,313
  
                   
Total lease liabilities
    
$
133,294
    
$
131,652
  
 
   
(*) Following the closures of the Sdot Yam and Bar Lev plants, the Company assessed the recoverability of the related right-of-use assets associated with non-cancelable lease agreements effective through 2032. The Company recorded impairment charges of $16,575 in 2023 and $6,859 in 2025, respectively. (See also note 2k).
 
Lease term and discount rate:
December 31, 2025
  
December 31, 2024
       
Weighted-average remaining lease term — operating leases
5.94 years
  
6.5 years
Weighted-average discount rate — operating leases
3.69%
  
3.1%

 

  b.
The components of operating lease cost for the year ended December 31, 2025 and 2024 were as follows:

 

   
December 31, 2025
    
December 31, 2024
  
Operating lease cost:
            
             
Operating lease expense
  
$
31,406
    
$
28,454
  
Variable lease expense (*)
    
4,191
      
7,306
  
Sublease income
    
(4,166
)
    
(1,624
)
                 
Total operating lease cost
  
$
31,431
    
$
34,136
  
 
(*) Includes short-term leases, index and other variable lease costs.
 
  c.
The maturity of the Company’s operating lease liabilities for contracts with lease term greater than one year as of December 31, 2025 are as follows:

 

   
December 31,
  
       
2026
    
29,892
  
2027
    
26,108
  
2028
    
22,512
  
2029
    
20,712
  
2030
    
19,180
  
2031 and thereafter
    
29,987
  
         
Total future lease payments (1,2)
    
148,391
  
Less imputed interest
    
(15,097
)
         
Total
  
$
133,294
  
 
(1) Total lease payments have not been reduced by approximately $22.7 million of future rental income expected to be received under sublease agreements.
 
(2) As of December 31, 2025, the Company entered into additional operating lease agreements that had not yet commenced, with aggregate future lease payments of approximately $3.1 million. These leases are expected to commence during 2026 and have lease terms of approximately five years.
 
  d.
For additional information regarding lease transactions between related parties, refer to Note 14.
 
  e.
The following table presents supplemental cash flow information related to the lease costs for operating leases:
 
   
December 31, 2025
    
December 31, 2024
  
Cash paid for amounts included in measurement of lease liabilities:
            
             
Operating cash flows for operating leases
  
$
30,097
    
$
27,468
  
v3.25.4
COMMITMENTS AND CONTINGENT LIABILITIES
 12 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENT LIABILITIES
NOTE 10:-
COMMITMENTS AND CONTINGENT LIABILITIES
 
  a.
Legal proceedings and contingencies:
 
Bodily injury claims related to exposure to silica dust:
 
Overview:
 
   
The Company is subject to numerous claims mainly by fabricators, their employees or National Insurance Institute (the Israeli insurance institute -"NII" or Australian states workers compensation regulators), alleging that fabricators contracted illnesses, including silicosis, through exposure to silica particles during cutting, polishing, sawing, grinding, breaking, crushing, drilling, sanding or sculpting Company's products.

 

Individual claims in Israel
 
As of December 31, 2025, the Company is subject to 98 pending bodily injury claims (individual claims and NII subrogation or related future probable unasserted claims, representing 40 injured persons) that have been submitted in Israel since 2008 against the Company directly, or that have named the Company as third-party defendant by fabricators or their employees in Israel, by the injurer's successors, by the NII or by others. Based on its legal advisors’, contingent losses related to such claims are probable, and pursuant to ASC 450, an accrual has been recorded for the loss contingencies related to such claims.
 
As of December 31, 2025, the Company has also 11 pending pre-litigation demand letters on behalf of certain fabricators in Israel.
 
Most of the claims in Israel do not specify a total amount of damages sought, as the plaintiff’s future damages are intended to be determined at trial.
 
In November 2015, the Company entered into agreements with the State of Israel and with its main distributors in Israel, respectively, with the consent of its insurance carriers, under which the Company agreed with the State and each of its main distributors to cooperate, subject to certain terms, with respect to the management of the individual claims that have been filed and claims that may be submitted during a certain time period (NII claims are excluded from the Company’s agreement with the State) and on the apportionments of the total liability between the Company , the State, and the distributors, if found, in such claims. This agreement has been extended through March 31, 2029.
 
Individual claims in Australia:
 
As of December 31, 2025, Company’s subsidiary in Australia is subject to 151 pending bodily injury claims that have been submitted in Australia since 2018 against it directly, or that have named the Company as third-party defendant by fabricators in Australia. Based on its legal advisors’ opinion, contingent losses related to the product liability individual claims are probable, and pursuant to ASC 450, an accrual has been recorded for the loss contingencies related to such claims.
 
Individual claims in the U.S.:
 
As of December 31, 2025, Company’s subsidiary in U.S. is subject to 427 pending individual bodily injury claims that have been submitted in U.S. against it directly, or that have named the Company as third-party defendant by fabricators in U.S. The Company currently cannot estimate the number of claimants that may file claims in the future or the nature of their claims in order to conclude probability or the range of loss.
 
In August 2024, a jury rendered a verdict in one such case brought in the Los Angeles County Court. The jury found all defendants liable and awarded the plaintiffs approximately $52.4 million in damages. Caesarstone U.S. was apportioned approximately $13.0 million of this amount, bearing interest until settlement. The Company strongly disagrees with the jury’s verdict and believes is not supported by the facts of the case, including its failure to acknowledge the proactive measures the Company took over the years to warn and educate about safe fabrication practices. The Company’s motion for new trial and motion for Judgement Notwithstanding the Verdict were rejected on January 27, 2025 and the Company currently appealing the verdict. In February 2025, the Company settled additional claim. In May 2025, a jury in California ruled in favor of the Company, assigning no liability to the Company in one trial, this case remains under appeal. In addition in February 2026 the Company reached a settlement with respect to four additional claims.
 
Based on its legal advisors’, the Company recorded an adequate accrual related to the specific cases mentioned above. Contingent losses related to the other 422 product liability individual claims in the U.S. were defined in accordance with ASC450 as either only reasonably possible (35 claims) with a range of possible loss between $0.5 to $13 million per claim or are at an early stage (387 claims) in which the amount of the possible loss cannot be reasonably estimated, and therefore an accrual has not been recorded for such claims as of December 31, 2025. The Company believes it has substantial defenses and will continue to vigorously defend against these claims.
 
Class action in the U.S.:
 
A class action lawsuit was recently filed against the Company and other manufacturers and suppliers of quartz surfaces in the Federal Court for the Northern District of California. The lawsuit seeks funding for medical monitoring of California workers allegedly exposed to artificial stone dust. The Company cannot predict the outcome of this matter, including whether the action will be certified as a class action or whether the claims will succeed on the merits.
 
   
Summary of the provisions for claims mentioned:
 
In order to reasonably estimate the losses for bodily injury claims in Israel, Australia and the U.S. reflected in the table below, the Company performed a case-by-case analysis with its legal advisors of the relevant facts that were reasonably available to it, related to the claims filed, including, among other things, the specific known or estimated health condition of the claimants, their ages, salaries, related probable future subrogation claims from the NII, and other factors that might have an impact on the final outcome of such claims. The Company will continue to regularly monitor changes in facts for each claim and will update its best estimate.
 
Accordingly, the reserve for bodily injury claims in Israel, Australia and the U.S. as of December 31, 2025 and 2024 totaled to $47,312 and $50,032 respectively, of which $38,577 and $40,540 is reported in short term legal settlements and loss contingencies and $8,735 and $9,492 is reported in long-term liabilities.
 
The Company updated its provision in 2025, 2024 and 2023 to reflect the outstanding claims in the below table, and provided a provision also for related NII unasserted claims, based on its legal advisors’ and according to ASC 450, taking into consideration new claims filed, settlements reached and other new information available.
 
A summary of bodily injury claims for which the Company provided provision is as follows:
 
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
                   
Outstanding claims, January 1,
    
248
      
224
      
221
  
                         
New claims
    
81
      
101
      
63
  
Settled and dismissed claims
    
(75
)
    
(77
)
    
(60
)
                         
Outstanding claims, December 31
    
254
      
248
      
224
  
 
Insurance
 
The Company maintains insurance for product liability claims, including for bodily injury claims related to exposure to silica dust, where such insurance cover can be obtained. The Company has purchased insurance policies for periods from 2008 and to date from several insurance carriers that provide coverage for product liability losses, subject to certain terms and conditions, and the related defense costs up to a certain limit per case and per policy year. However, in recent years, and at different times depending on the jurisdiction, the Company has not been able to obtain product liability insurance coverage for claims arising from exposure to silica dust in the United States, Australia and Israel.
 
The collectability of the Company's insurance receivables is regularly evaluated, and the amounts recorded are probable of collection. This conclusion is based on the followings - analysis of the terms of the underlying insurance policies; experience in successfully recovering individual product liability claims from Company's insurers in Israel and Australia; the agreement the Company has with the insurance carriers and the State of Israel; the financial ability of the insurance carriers to pay the claims and the relevant facts and applicable law.
 
In July 2025, both the Company and certain U.S. insurance carriers initiated proceedings for declaratory relief to determine the proper interpretation and application of the Company’s U.S. product liability insurance policies and available limits. These proceedings are in an early stage. If there is a change in the assessment for the outcome of the claims or the insurance coverage limits through the course of the trial processes, such changes could have a material and adverse impact on our business, financial position, results of operations and cash flows. In light of the ongoing proceedings with its insurance carriers, the Company reassessed the recoverability of potential insurance proceeds related to U.S. silica-related claims. Based on this assessment, management concluded that recovery from its U.S. insurance carrier is not probable under ASC 450-20. Accordingly, no insurance receivable has been recognized in the consolidated financial statements with respect to such claims. In addition, there can be no assurance that any portion of the pending U.S. silica-related claims will be reimbursed under the Company’s insurance policies, in whole or in part.
 
As of December 31, 2025, and 2024, the insurance receivable totaled to $11,023 and $32,178, respectively, reported in the other accounts receivable and prepaid expenses.
 
During the years ended December 31, 2025 and 2024, legal settlements and loss contingencies expenses related to the bodily injury claims totaled to $25,555 and $7,242, respectively, which reflects the deductible amounts for claims covered by insurance policies, claims not covered and the impact of settlements including the related legal costs.
 
   
General:
 
From time to time, the Company is involved in other legal proceedings and claims in the ordinary course of business related to a range of matters. While the outcome of these other claims cannot be predicted with certainty, the Company monitors and estimates the possible loss deriving from these claims based on new information available and based on its legal advisors, and believes that it recorded an adequate reserve for these claims in accordance with ASC 450.
 
  b.
Purchase obligation:
 
The Company's significant contractual obligations and commitments as of December 31, 2025, are for purchase obligations to certain suppliers and amounted to $15,901 for fiscal year 2026.
 
  c.
Pledges and guarantees:
 
 
As of December 31, 2025, the Company had outstanding guarantees and letters of credit with various expiration dates in a principal amount of approximately $260 related to facilities, machinery and equipment, and other miscellaneous guarantees.
v3.25.4
TAXES ON INCOME
 12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
TAXES ON INCOME
NOTE 11:-
TAXES ON INCOME
 
  a.
Israeli taxation:
 
  1.
Corporate tax rate:
 
The corporate tax rate in Israel was 23% in 2025 and 2024, and 2023.
 
  2.
Foreign Exchange Regulations:
 
Under the Foreign Exchange Regulations, Caesarstone Ltd. calculates its tax liability in U.S. Dollars according to certain orders. The tax liability, as calculated in U.S. Dollars is translated into New Israeli Shekels according to the exchange rate as of December 31st of each year.
 
  3.
Tax benefits under Israel's Law for the Encouragement of Industry (Taxes), 1969:
 
The Company is an "Industrial Company," as defined by the Law for the Encouragement of Industry (Taxes), 1969, and as such, the Company is entitled to certain tax benefits, primarily amortization of costs relating to know-how and patents over eight years, accelerated depreciation and the right to deduct public issuance expenses for tax purposes.
 
  4.
Tax benefits under the Law for the Encouragement of Capital Investments, 1959:
 
The Company believes that its qualify as "Preferred Enterprise" under the Law for the Encouragement of Capital Investments, 1959 (the "Encouragement Law"), and accordingly is eligible to a reduced tax rate of 16% and in development area A – 7.5%.
 
The benefits under a "Preferred Enterprise" are contingent upon the fulfillment of the conditions stipulated by the Encouragement Law, regulations published thereunder. Non-compliance with the conditions may cancel all or part of the benefits and require a refund of the amount of the benefits, including interest. Income not eligible for Preferred Enterprise benefits is taxed at the regular corporate tax rate at 23% beginning in 2018.
 
   
The tax-exempt income attributable to the Approved Enterprise cannot be distributed to shareholders without subjecting the Company to taxes. If dividends are distributed out of tax-exempt profits, the Company will then become liable for tax at the rate applicable to its profits from the Approved Enterprise in the year in which the income was earned, as if it was not under the "Alternative benefits track" (taxed at the rate of no more than 25% as of December 31, 2025). Under the Encouragement Law, tax-exempt income generated under the Approved Enterprise status will be taxed, among other things, upon a dividend distribution or complete liquidation in accordance with the Encouragement Law.
 
In November 2021, amendment No. 74 to the Investment Law (the “Trapped Earnings Law”) came into effect. Amendment 74 to the Encouragement Law:
 
On November 15, 2021, the Economic Efficiency Law (Legislative Amendments for Achieving Budget Targets for the 2021 and 2022 Budget Years), 2021 ("the Economic Efficiency Law"), was enacted. This Law establishes a temporary order allowing Israeli companies to release tax-exempt earnings ("trapped earnings" or "accumulated earnings") accumulated until December 31, 2020, through a mechanism established for a reduced corporate income tax rate applicable to those earnings ("the Temporary Order"). In addition to the reduced corporate income tax (CIT) rate, Article 74 to the Encouragement Law was amended whereby effective from August 15, 2021, for any dividend distribution (including a dividend as per Article 51B to the Encouragement Law) by a company which has trapped earnings, there will be a requirement to allocate a portion of that distribution to the trapped earnings.
 
The Company distributed dividends during November 2021 and September 2022, both were partially attributed to the above amendment.
 
Of the Company's retained earnings as of December 31, 2025, approximately $22,932 is tax-exempt earnings attributable to its previous Approved Enterprise.
 
As of December 31, 2025, if the tax-exempt income attributed to the Approved Enterprise would have been distributed as a dividend or deemed to be distributed, the Company would have incurred a tax liability of approximately $5,733.
 
  b.
Non-Israeli subsidiaries taxation:
 
Non-Israeli subsidiaries are taxed based on tax laws in their countries of residence.
 
Statutory tax rates for Non-Israeli subsidiaries are as follows:
 
Company incorporated in United States – 25.3% tax rate (federal and state).
Company incorporated in Australia - 30% tax rate.
Company incorporated in Singapore - 17% tax rate.
Company incorporated in Canada – 26.1% tax rate (federal and state).
Company incorporated in England – 25% tax rate.
Company incorporated in India – 30% tax rate.
Company incorporated in Sweden – 20.6% tax rate.
Company incorporated in Germany – 30% tax rate
 
Israeli income taxes and foreign withholding taxes were not provided for undistributed earnings of the Company's foreign subsidiaries. The Company intends to reinvest these earnings indefinitely in the foreign subsidiaries. Accordingly, no deferred income taxes have been provided. If these earnings were distributed to Israel in the form of dividends or otherwise, the Company would be subject to additional Israeli income taxes (subject to an adjustment for foreign tax credits) and foreign withholding taxes.

The One Big Beautiful Bill Act (“OBBBA”) was signed into law on July 4, 2025. The OBBBA did not have a material impact on the Company’s consolidated financial statements for the year ended December 31, 2025.
 
  c.
Deferred income taxes:
 
Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities are as follows:
 
   
December 31,
  
   
2025
    
2024
  
Deferred tax assets:
            
             
Intangible assets
  
$
-
    
$
172
  
Operating lease liabilities and others
    
41,670
      
24,744
  
Temporary differences related to inventory
    
4,791
      
5,475
  
Property and equipment
    
13,876
      
2,685
  
Net operating loss carry-forward, deductions and credits
    
43,695
      
13,301
  
Less-valuation allowance
    
(83,371
)
    
(28,497
)
                 
Total deferred tax assets
    
20,661
      
17,880
  
                 
Deferred tax liabilities:
                
                 
Property and equipment
    
(2,351
)
    
(2,591
)
Intangible Assets
    
-
      
(595
)
Operating lease right-of-use assets and others lease
    
(16,468
)
    
(14,223
)
                 
Total deferred tax liabilities
    
(18,819
)
    
(17,409
)
                 
Deferred tax assets, net
  
$
1,842
    
$
471
  
 
   
Net operating loss carry-forwards
 
Parent Company and certain subsidiaries have tax loss carry-forwards totaling approximately $249,716 which can be carried forward indefinitely.
 
Based on available evidence, management believes it is not more-likely-than-not that $83,371 Israel and U.S deferred tax assets will be fully realizable. Accordingly, in those jurisdictions, the Company has recorded a valuation allowance against these assets. The Company regularly reviews the deferred tax assets for recoverability based on all of the available positive and negative evidence, with a focus on historical taxable income, projected future taxable income, the expected timing of the reversals of existing taxable temporary differences and tax planning strategies by jurisdiction.
 
  d.
A reconciliation of the provision for income taxes to the amount computed by applying the 23% statutory Israeli income tax rate to loss before taxes on income before the adoption of ASU 2023-09 is as follows:
 
   
Year ended December 31,
  
   
2024
    
2023
  
             
Loss before taxes on income
  
$
(41,895
)
  
$
(86,959
)
                 
Statutory tax rate in Israel
    
23
%
    
23
%
                 
Tax benefit at statutory rate
  
$
(9,636
)
  
$
(20,001
)
                 
Increase (decrease) in tax expenses resulting from:
                
                 
Tax benefit arising from reduced rate as an "Preferred Enterprise"
    
9,128
      
9,996
  
Non-deductible expenses, net
    
822
      
1,818
  
 Increase (decrease) in taxes from prior years, also related to settlement with tax authorities
    
882
      
419
  
Tax adjustment in respect of foreign subsidiaries' different tax rates
    
997
      
(1,120
)
Provision for withholding tax assets
    
-
      
2,828
  
Uncertain tax position
    
(353
)
    
-
  
Changes in valuation allowance
    
(701
)
    
27,402
  
Others
    
(58
)
    
(61
)
                 
Income tax expense
  
$
1,081
    
$
21,281
  
                 
Effective tax rate
    
(2.6
)%
    
(24.5
)%
                 
Per share amounts (basic and diluted) of the tax benefit resulting from a "Preferred Enterprise"
  
$
0.26
    
$
0.29
  
 
A reconciliation of the provision for income taxes to the amount computed by applying the 23% statutory Israeli income tax rate to loss before taxes on income after the adoption of ASU 2023-09 is as follows:
 
   
Year ended December 31,
  
   
2025
  
   
(in thousands)
    
percent
  
             
Loss before taxes on income
  
$
(133,475
)
      
               
Statutory tax rate in Israel
    
23
%
      
               
Tax benefit at statutory rate
  
$
(30,699
)
    
23.0
%
                 
Foreign tax effects:
                
     United States:
                
          Changes in valuation allowance
    
6,018
      
(4.5
)%
          Other
    
(752
)
    
0.6
%
     Other foreign jurisdictions
    
200
      
(0.1
)%
Changes in valuation allowance
    
48,857
      
(37.3
)%
Nontaxable or Nondeductible items:
                
     Other
    
218
      
(0.2
)%
Changes in Unrecognized Tax Benefits
    
3,585
      
(2.7
)%
Preferred enterprise
    
(22,867
)
    
17.1
%
Other adjustments
    
(1,276
)
    
0.9
%
                 
Effective tax rate
  
$
4,284
      
(3.2
)%
 
The amounts of cash income taxes paid by the Company were as follows:
​​​​​​
   
Year ended December 31,
  
   
2025
  
   
(in thousands)
  
       
Foreign:
        
Australia
    
178
  
India
    
177
  
Canada
    
132
  
Singapore
    
48
  
All other foreign
    
11
  
Income taxes, net of amounts refunded
  
$
546
  
 
The amount of cash income taxes paid by the Company during the years ended December 31, 2024 and 2023 was $3,117 million and $1,852 million, respectively.
 
  e.
Income (loss) before taxes on income is comprised as follows:
 
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
                   
Domestic
  
$
(109,903
)
  
$
(45,582
)
  
$
(38,831
)
Foreign
    
(23,572
)
    
3,687
      
(48,128
)
                         
   
$
(133,475
)
  
$
(41,895
)
  
$
(86,959
)
 
  f.
Tax expenses on income are comprised as follows:

 
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
                   
Current taxes
  
$
5,652
    
$
1,498
    
$
9,373
  
Deferred taxes
    
(1,368
)
    
(417
)
    
11,908
  
                         
   
$
4,284
    
$
1,081
    
$
21,281
  
                         
Domestic
  
$
3,682
    
$
1,258
    
$
14,084
  
Foreign
    
602
      
(177
)
    
7,197
  
                         
   
$
4,284
    
$
1,081
    
$
21,281
  
 
  g.
Tax assessments:
 
The Company operates in multiple jurisdictions throughout the world, and its tax returns are periodically audited or subject to examination by both domestic and foreign tax authorities. The associated tax filings remain subject to examination by applicable tax authorities for a certain length of time following the tax year to which those filings relate. The following describes the open tax years, by major tax jurisdiction, as of December 31, 2025:
 
Israel 2023 – present
Australia 2020 - present
Canada 2021 - present
United States 2021 - present
 
  h.
Uncertain tax positions:
 
A reconciliation of the beginning and ending balances of unrecognized tax benefits is as follows:

 

Balance as of January 1, 2024
    
2,891
  
         
Increase in tax positions for current year
    
700
  
Reductions in respect of settlements with authorities and statute of limitation
    
(1,918
)
         
Balance as of December 31, 2024
    
1,673
  
         
Increase in tax positions for current year
    
3,624
  
         
Balance as of December 31, 2025
  
$
5,297
  
 
The Company believes that an adequate provision has been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If any issues addressed in the Company's tax audits are resolved in a manner not consistent with management's expectations, the Company could be required to adjust the provision for income taxes in the period such resolution occurs. The Company does not expect uncertain tax positions to change significantly over the next 12 months, except in the case of settlements with tax authorities, the likelihood and timing of which is difficult to estimate.
v3.25.4
SHAREHOLDERS' EQUITY
 12 Months Ended
Dec. 31, 2025
Stockholders' Equity Note [Abstract]  
SHAREHOLDERS' EQUITY
NOTE 12:-
SHAREHOLDERS' EQUITY
 
  a.
The Company's share capital consisted of the following as of December 31, 2025 and 2024:
 
 
Authorized
  
Outstanding
 
December 31,
  
December 31,
 
  2025
  
2024
  
2025
  
2024
 
Number of shares
                       
Ordinary shares of NIS 0.04 par value each
200,000,000
  
200,000,000
  
34,573,899
  
34,549,050
 
  b.
Ordinary shares:
 
Ordinary shares confer on their holders' voting rights and the right to receive dividends.
 
  c.
Dividends:
 
In February 2020 the Company revised its dividend policy so that cash dividend will be distributed up to 50% of the year to date reported net income attributable to controlling interest less any amounts already paid as dividend for the respective period, provided that such calculated dividend is not less than $0.10 per share. Any dividend payment is subject to approval by the Company’s board of directors.
 
  d.
Compensation plan:
 
On January 1, 2011, the Board of Directors adopted the Caesarstone Ltd 2011 Incentive Compensation Plan (the “2011 Plan”) pursuant to which non-employee directors, officers, employees and consultants may receive stock options and RSUs exercisable for ordinary shares, if certain conditions are met. Under the plan the Company can grant up to 3,275,000 ordinary shares. On September 17, 2020 the Board of Directors adopted Caesarstone Ltd 2020 Share incentive plan (the “2020 Plan”). Under the 2020 Plan up to 2,500,000 ordinary shares may be granted. In addition, any shares that remain available for issuance under the 2011 Plan, as of the Effective Date, which shall not exceed 1,000,000 Shares, may also be granted under the 2020 Plan.
 
As of December 31, 2025, there were 3,475,048 options and restricted stock units (RSUs) outstanding under the Plans and 24,952 shares available or reserved for future issuance under the plan.
 
As of December 31, 2025, there was $1,510 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted to employees and directors under the Plan. That cost is expected to be recognized over a weighted-average period of 2.95 years.
 
The following is a summary of activities relating to the Company’s stock options granted to employees under the Company’s plan during the year ended December 31, 2025:
 
   
Number
of options
    
Weighted
average
exercise
price
    
Aggregate intrinsic value
  
                   
Outstanding - beginning of the year
    
2,468,980
      
5.57
      
-
  
Granted
    
1,000,300
      
1.92
      
0.2
  
Forfeited
    
(70,380
)
    
5.19
      
-
  
                         
Outstanding - end of the year
    
3,398,900
      
4.48
      
-
  
                         
Options exercisable at the end of the year
    
1,143,718
      
6.59
      
-
  
                         
Vested and expected to vest
    
1,143,718
      
6.59
      
-
  
 
The weighted average fair value of options granted during 2025, 2024 and 2023 was $0.9, $1.7 and $1.9 per option. The weighted average fair value of options vested during 2025, 2024 and 2023 was $9.28, $9.56 and $12.96 per option. The intrinsic value of options exercised during 2025, 2024 and 2023 was $0.
 
The intrinsic value of exercisable options (the difference between the Company’s closing share price on the last trading day in fiscal year 2025 and the average exercise price of in-the-money options, multiplied by the number of in-the-money options) included above represents the amount that would have been received by the option holders had all option holders exercised their options on December 31, 2025. This amount changes based on the fair market value of the Company’s ordinary shares.
 
The following is a summary of activities relating to the Company’s RSUs granted to employees under the Plan during the year ended December 31, 2025:
 
   
Number
of RSUs
    
Weighted
average
fair value
    
Aggregate intrinsic value
  
                   
Outstanding - end of the year
    
72,690
      
6.13
      
309
  
Granted
    
26,646
      
3.50
          
Exercised
    
(17,923
)
    
7.62
          
Forfeited
    
(5,265
)
    
3.30
          
                         
Outstanding - end of the year
    
76,148
      
4.75
      
142
  
                         
RSUs exercisable at the end of the year
    
-
      
-
      
-
  
                         
Vested and expected to vest
    
76,148
      
4.75
      
142
  
 
The awards outstanding as of December 31, 2025 have been separated into ranges of exercise price, as follows:
 
   
Awards outstanding
    
Awards exercisable
  
Exercise price
  
Number
of
options
    
Weighted
average
remaining
contractual
life (years)
    
Weighted
average
exercise
price
per share
    
Number
of
options
    
Weighted
average
remaining
contractual
life (years)
    
Weighted average exercise price
  
                                     
$ 0.01 (RSUs)
    
76,148
      
3.28
    
$
0.01
      
-
      
-
    
$
-
  

$ 1.6-4.7

    
2,848,500
      
5.38
    
$
3.52
      
769,400
      
4.47
    
$
4.50
  

$ 5.2-10.2

    
294,500
      
4.73
    
$
6.64
      
126,168
      
4.22
    
$
7.34
  

$ 10.3-19.7

    
255,900
      
1.81
    
$
12.70
      
248,150
      
1.77
    
$
12.71
  
                                                 
     
3,475,048
                      
1,143,718
                  
 
Compensation expenses related to options and RSUs granted were recorded in the consolidated statements of operations, as follows:
 
   
December 31,
  
   
2025
    
2024
  
             
Cost of revenues
  
$
51
    
$
90
  
Research and development expenses
    
53
      
86
  
Marketing and selling expenses
    
111
      
153
  
General and administrative expenses
    
985
      
1,715
  
                 
Total
  
$
1,200
    
$
2,044
  
v3.25.4
TRANSACTIONS WITH RELATED PARTIES
 12 Months Ended
Dec. 31, 2025
Related Party Transactions [Abstract]  
TRANSACTIONS WITH RELATED PARTIES
NOTE 13:-
TRANSACTIONS WITH RELATED PARTIES
 
Company's controlling shareholder, is Mifalei Sdot-Yam Agricultural Cooperative Society Ltd. (“Mifalei Sdot-Yam”), which is controlled by Sdot-Yam Business Holding and Management – Agricultural Cooperative Society Ltd., which is in turn controlled by Kibbutz Sdot-Yam (for convenience purposes, collectively referred as the “Kibbutz"). The Kibbutz has an ownership interest in the Company of approximately 30.2%, as of December 31, 2025.
 
On September 5, 2016, the Kibbutz and Tene Investment in Projects 2016 Limited Partnership (“Tene”) entered into the shareholders’ agreement (“Shareholders’ Agreement”), memorialized in a term sheet, pursuant to which both the Kibbutz and Tene are deemed the Company’s controlling shareholders under the Israeli Companies Law. The Shareholders’ Agreement further amended on February 20, 2018 and September 18, 2023, In which the amendment executed on September 18, 2023 (the “September Amendment”) replaced the Shareholders Agreement in its entirety. Pursuant to the September Amendment, the parties agreed, among other things, to vote at general meetings of the Company's shareholders in the same manner, following discussions intended to reach an agreement on any matters proposed to be voted upon. However, if no agreement is reached, the Kibbutz will determine the manner in which both parties will vote, except with respect to certain carved-out matters, to which Tene, for so long as it holds more than 3% of the issued and outstanding share capital of the Company, will determine the manner in which both parties will vote.
 
In addition, each of the Kibbutz and Tene shall be entitled to vote separately in any manner with respect to the appointment, replacement or terms of compensation of the Company’s Chief Executive Officer. Among others, according to the September Amendment Tene granted the Kibbutz a right of first refusal and the Kibbutz granted Tene certain tag-along rights with respect to their disposition of ordinary shares. If Tene sells more than 3% of the issued and outstanding share capital of the Company without providing the Kibbutz its right of first offer then certain rights contemplated under the September Amendment will terminate, including Tene’s tag-along right.
 
As of December 31, 2025 the Kibbutz and Tene beneficially hold 14,029,494 ordinary shares which is ownership interest of 40.6% in the Company.
 
The Company is party to a series of agreements with the Kibbutz that govern different aspects of the Company's relationship and are described below.
 
  a.
Manpower agreement with the Kibbutz:
 
On July 2011, the Company entered into a manpower agreement with The Kibbutz which was amended in the subsequent years. Such was automatically renewed during 2023 for additional one year term, and will be automatically renewed again, unless one of the parties gives six months’ prior notice, for additional one-year periods.
 
On July 30, 2015, and on October 14, 2018, following the approval of Company's audit committee, compensation committee and board of directors, Company's shareholders approved an addendum to the Manpower Agreement by and between the Kibbutz and the Company, with respect to the engagement of office holders affiliated with the Kibbutz, for an additional three-year term as of the date of the shareholders’ approval.
 
During 2021 was determined, following the approval of Company’s audit committee and the board of directors, that the manpower agreement is valid through 2030.
 
Under the manpower agreement and its addendum, the Kibbutz will provide the Company with labor services staffed by Kibbutz members, candidates for Kibbutz membership and Kibbutz residents (“Kibbutz Appointees”). The consideration to be paid for each Kibbutz Appointee will be based on the Company's total cost of employment for a non-Kibbutz Appointee employee performing a similar role. The number of Kibbutz Appointees may change in accordance with the Company's needs. Under the manpower agreement, the Company will notify the Kibbutz of any roles that require staffing, and if the Kibbutz offers candidates with skills similar to other candidates, the Company will give preference to hiring of the relevant Kibbutz members. the Kibbutz is entitled under this agreement, at its sole discretion, to discontinue the engagement of any Kibbutz Appointee of manpower services through his or her employment by the Kibbutz and require such appointee to become employed directly by the Company.
 
The manpower agreement and addendum also includes the Kibbutz’s obligation to customary liability, insurance, indemnification and confidentiality and intellectual property provisions. Office holders who are Kibbutz Appointees shall have all benefits applicable to Company's other office holders, including without limitation, directors’ and officers’ liability insurance, and Company's indemnification and exemption undertaking.
 
Manpower service fees paid were $1,290, $1,347 and $1,553 for the years ended December 31, 2025, 2024 and 2023, respectively.
 
  b.
Services from the Kibbutz:
 
On July 30, 2015, following the approval of the audit committee and the board, Company’s shareholders approved an amended services agreement pursuant to which, the Kibbutz will continue to provide various services it provides in the ordinary course of Company's business, for a period of three years commencing as of the date of approval by the shareholders.
 
On October 14, 2021, following the approval of the audit committee and the board, Company’s shareholders approved a further amended services agreement (“Amended Services Agreement”) for an additional period of three years. With the closure of the Sdot-Yam facility and the Kibbutz’s privatization process, most services under the agreement are no longer provided by the Kibbutz or needed, except for certain statutory and pass-through payments. In August 2024, the Company and the Kibbutz amended the services agreement for a three-year term to reflect these changes.
 
The amount that the Company pays to the Kibbutz under the Amended Services Agreement depends on the scope of services the Company will receive and is based on rates specified in such agreement which were determined based on market terms, taking into account the added value of consuming services from the Kibbutz, considering its physical proximity to Company’s principle offices in Sdot-Yam and its expertise.
 
The amounts the Company pays for the services are subject to certain adjustments for increases in the Israeli consumer price index. In addition, the Amended Services Agreement grants The Kibbutz right of first proposal in special projects with respect to the metal workshop services. The amended services agreement also outlines the distribution mechanism between the Company and the Kibbutz for certain expenses and payments due to local authorities, such as certain taxes and fees in connection with the Company’s business facilities. Each party may terminate such agreement upon a material breach, following a 30-day prior notice, or upon liquidation of the other party, following a 45-days’ prior notice.
 
The Company's net service fees paid to the Kibbutz pursuant to the Original and Amended Services Agreements were $646, $708 and $810 for the years ended December 31, 2025, 2024 and 2023, respectively.
 
  c.
Land Use Agreement with the Kibbutz:
 
Land leased to the Kibbutz by the ILA and the Caesarea Development Corporation
 
The Company signed a land use agreement with the Kibbutz, which has a term of 20 years commencing on April 1, 2012. As per the agreement, the annual fee may be adjusted after January 1, 2021 and every three years thereafter, at the election of  the Kibbutz by obtaining an updated appraisal. During 2021, the Kibbutz elected this option and the parties mutually agreed upon a land appraiser, and based on its study the fees were adjusted for 2021 onwards for annual amount of approximately NIS 18,600,000 (approximately $5,980), linked to the Israeli consumer price index.
 
The Company's principal offices and research and development facilities are located on the grounds of the Kibbutz and include buildings spaces of approximately 30,744 square meters and unbuilt areas of approximately 60,870 square meters.
 
Under the land use agreement, the Company may not terminate the operation of either of its two production lines at its plant in the Kibbutz as long as the Company continues to operate production lines elsewhere in Israel, and its headquarters must remain at The Kibbutz. Notwithstanding with the above mentioned, during 2023 the Company announced on closing the Sdot Yam plant with the permission of the Kibbutz. The Company is still liable pursuant to the land use agreement as is. During 2024 and 2025 the Company subleased majority of the available area to third parties. Sublease income is recorded as a deduction from the rent fees (see also note 9).
 
In addition, the Company has committed to fund the cost of construction, up to a maximum of NIS 3.3 million (approximately $1,030) plus VAT, required to change the access road leading to The Kibbutz and its facilities, such that the entrance of the Company's facilities will be separated from the entrance into The Kibbutz. From the said amount, the Kibbutz has already set-off an amount of NIS 300,000 (approximately $94) for expenses incurred by it.
 
  d.
Financing liability of land:
 
Pursuant to the Land Use Agreement, the Company has entered into an agreement with The Kibbutz dated August 6, 2013, under which the Kibbutz acquired additional land of approximately 12,800 square meters on the grounds near the Company's Bar-Lev facility, which the Company required in connection with the construction of the fifth production line at the Company's Bar-Lev manufacturing facility, leased it to the Company for a monthly fee of approximately NIS 70,000 (approximately $22).
 
Under the agreement, the Kibbutz committed to (i) acquire the long-term leasing rights of the Additional Bar-Lev Land from the ILA, (ii) perform preparation work and construction, in conjunction with the administrative body of Bar-Lev industrial park and other contractors according to Company’s plans, (iii) build a warehouse according Company’s plans, and (iv) obtain all permits and approvals required for performing the preparation work of the Additional Bar-Lev Land and for the building of the warehouse. The warehouse in Bar-Lev will be situated both on the current and new land. The finance of the building of the warehouse will be made through a loan that will be granted by the Company to the Kibbutz, in the amount of the total cost related to the building of the warehouse and such loan, including principle and interest, shall be repaid by setoff of the lease due to Kibbutz Sdot Yam by the Company for its use of the warehouse. The principle amount of such loan will bear an interest at a rate of 1.4% a year. On November 30, 2015 the land preparation work had been completed and the holding of the Additional Bar-Lev Land was delivered to the Company. As of December 31, 2025, the construction of the warehouse has not started yet, and is not expected to start in the future due to the closure of the Bar-Lev manufacturing facility.
 
  d.
Financing liability of land (cont.):
 
Pursuant to the land use agreement, the Kibbutz permits the Company to use the Bar-Lev Grounds for a period of 10 years commencing on September 2012 that will be automatically renewed, unless the Company gives two years prior notice, for a ten-year term in consideration for an annual fee of NIS 4.1 million (approximately $1,200) to be linked to increases in the Israeli consumer price index.
 
As per the agreement, the fee is subject to adjustment following January 1, 2022 and every three years thereafter at the option of The Kibbutz if The Kibbutz chooses to obtain an appraisal that supports such an increase. The appraiser would be mutually agreed upon or, in the absence of agreement, will be chosen by the Kibbutz from a list of assessors recommended at that time by Bank Leumi. During 2022, the Kibbutz elected this option and the parties mutually agreed upon a land appraiser, and based on its study the fees were adjusted for 2022 onwards for total annual amount of approximately NIS 8,100,000 (approximately $2,600), linked to the Israeli consumer price index.
 
The Company's payments pursuant to the land use agreements related to Sdot-Yam and Bar-Lev mentioned above totaled to $8,091, $8,129 and $7,857 for the years ended December 31, 2025, 2024 and 2023, respectively.
 
  e.
Details on transactions and balances with related parties and other loan:
 
  1.
The Company has, from time to time, entered into transactions with its shareholders (the Kibbutz). The following table summarizes such transactions:
 
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
                   
Cost of revenues
  
$
7,767
    
$
7,893
    
$
8,232
  
                         
Research and development
  
$
555
    
$
520
    
$
486
  
                         
Selling and marketing
  
$
717
    
$
927
    
$
621
  
                         
General and administrative
  
$
1,032
    
$
811
    
$
848
  
 
  2.
Balances with related party and other loan:

 

   
December 31,
  
   
2025
    
2024
  
             
Related party balances (1)
  
$
247
    
$
206
  
                 
Other loans (2)
  
$
-
    
$
444
  
 
  1.
Related to the above mentioned agreements with related party.
 
  2.
Related to a shareholders loan from Lioli non-controlling interest. As of December 31, 2025 presented as part of Short-term bank credit and current maturities of long- term bank loan and other line item.
v3.25.4
SEGMENT, MAJOR CUSTOMER AND GEOGRAPHIC INFORMATION
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
SEGMENT, MAJOR CUSTOMER AND GEOGRAPHIC INFORMATION
NOTE 14:-
SEGMENT, MAJOR CUSTOMER AND GEOGRAPHIC INFORMATION
 
  a.
The Company manages its business on the basis of one operating segment and derives revenues mainly from the sale of high quality engineered stone and other materials surfaces. The data is presented in accordance with Accounting Standard Codification 280, "Segments Reporting" ("ASC 280").
 
The Company's chief operating decision maker ("CODM") is its chief executive officer, who reviews financial information presented on a consolidated basis. The CODM assesses the performance of the Company and decides how to allocate resources based upon consolidated net loss that is also reported within the Consolidated Statements of Operations. This financial metric is used by the CODM to make key operating decisions, such as the determination of the rate at which the Company seeks to grow global revenues and the allocation of budget between cost of revenues, sales and marketing, research and development, and general and administrative expenses.
 
Significant segment expenses are presented in the Company’s consolidated statements of operations. See the consolidated financial statements for other financial information regarding the Company’s operating segment.
 
  b.
The following table presents total revenues for the years ended December 31, 2025, 2024 and 2023, respectively. Revenues are attributed to geographic areas based on the location of end customers:
 
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
                   
USA
  
$
186,885
    
$
219,559
    
$
271,647
  
Canada
    
51,874
      
61,749
      
75,462
  
Latin America
    
1,461
      
1,392
      
3,285
  
Australia
    
67,480
      
75,388
      
106,223
  
Asia
    
18,224
      
20,577
      
25,959
  
EMEA
    
51,952
      
47,121
      
59,908
  
Israel
    
19,352
      
17,435
      
22,747
  
                         
   
$
397,228
    
$
443,221
    
$
565,231
  
 
   
No customer represented 10% or more of the Company’s total revenues for the years ended December 31, 2025, 2024 and 2023.
 
  c.
The following table presents total long-lived assets as of December 31, 2025 and 2024, respectively (including held for sale assets, property, plant and equipment and operating lease right-of-use assets) by geographic area:
 
   
December 31,
  
   
2025
    
2024
  
             
USA
  
$
76,323
    
$
87,861
  
Canada
    
9,377
      
10,506
  
Australia
    
10,338
      
5,618
  
Asia
    
16,881
      
19,435
  
EMEA
    
12,729
      
11,315
  
Israel
    
38,550
      
89,791
  
                 
   
$
164,198
    
$
224,526
  
v3.25.4
SELECTED SUPPLEMENTARY STATEMENTS OF INCOME DATA
 12 Months Ended
Dec. 31, 2025
Supplemental Income Statement Elements [Abstract]  
SELECTED SUPPLEMENTARY STATEMENTS OF INCOME DATA
NOTE 15:-
SELECTED SUPPLEMENTARY STATEMENTS OF INCOME DATA
 
  a.
Finance (income) expense, net:
 
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
Finance expenses:
                  
                   
Interest in respect of credit cards and bank fees
  
$
2,574
    
$
3,846
    
$
4,957
  
Interest in respect of loans
    
69
      
300
      
377
  
Realized gain/loss from marketable securities, net
    
-
      
-
      
63
  
Changes in derivatives fair value
    
110
      
430
      
-
  
Foreign exchange transactions losses
    
8,649
      
1,781
      
154
  
                         
     
11,402
      
6,357
      
5,551
  
Finance income:
                        
                         
Interest in respect of cash and cash equivalent and short-term bank deposits
    
3,150
      
4,799
      
1,473
  
Changes in derivatives fair value
    
-
      
-
      
680
  
Interest income from marketable securities
    
-
      
-
      
107
  
Foreign exchange transactions gains
    
486
      
1,549
      
4,360
  
                         
     
3,636
      
6,348
      
6,620
  
                         
Finance expenses (income), net
  
$
7,766
    
$
9
    
$
(1,069
)
 
  b.
Net earnings (loss) per share:
 
The following table sets forth the computation of basic and diluted net earnings per share:
 
Numerator:
 
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
                   
Net loss attributable to controlling interest, as reported
  
$
(137,467
)
  
$
(42,832
)
  
$
(107,656
)
Adjustment to redemption value of non-controlling interest
    
(101
)
    
3,782
      
(532
)
                         
Numerator for basic and diluted net loss per share
  
$
(137,568
)
  
$
(39,050
)
  
$
(108,188
)
 
Denominator (in thousands):
 
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
                   
Denominator for basic and diluted loss per share
    
34,569
      
34,539
      
34,519
  
 
Earnings per share:
 
                   
Basic and diluted loss per share
  
$
(3.98
)
  
$
(1.13
)
  
$
(3.13
)
v3.25.4
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Pay vs Performance Disclosure      
Net Income (Loss) $ (137,467) $ (42,832) $ (107,656)
v3.25.4
Insider Trading Policies and Procedures
 12 Months Ended
Dec. 31, 2025
Insider Trading Policies and Procedures [Line Items]  
Insider Trading Policies and Procedures Adopted true
v3.25.4
Cybersecurity Risk Management and Strategy Disclosure
 12 Months Ended
Dec. 31, 2025
Cybersecurity Risk Management, Strategy, and Governance [Line Items]  
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]
Cybersecurity Risk Management and Strategy
 
We have developed and implemented a cybersecurity risk management program intended to protect the confidentiality, integrity, and availability of our critical systems and information.
 
Our program’s design is based on the NIST (National Institute of Standards and Technology framework). This does not imply that we meet any particular technical standards, specifications, or requirements, but only that we use the NIST cyber security framework (CSF) as a guide to help us identify, assess, and manage cybersecurity risks relevant to our business, and in its design was aided by external advisors experts in the field.
 
Our cybersecurity risk management program shares common methodologies, reporting channels and governance processes that apply across the enterprise to other legal, compliance, strategic, operational, and financial risk areas.
 
Our cybersecurity risk management program includes:
 
  •
risk assessments designed to help identify material cybersecurity risks to our critical systems, information, products, services, and our broader enterprise IT environment;
 
  •
a security team principally responsible for managing our cybersecurity risk assessment processes, our security controls, and our response to cybersecurity incidents;
 
  •
the use of external service providers, where appropriate, to assess, test or otherwise assist with aspects of our security controls;
 
  •
cybersecurity awareness training of our employees, incident response personnel, and senior management;
 
  •
a cybersecurity incident response plan that includes procedures for responding to cybersecurity incidents; and
 
  •
a third-party risk management process for service providers, suppliers, and vendors.
 
We have not identified risks from known cybersecurity threats, including as a result of any prior cybersecurity incidents that have materially affected or are reasonably likely to materially affect us, including our operations, business strategy, results of operations, or financial condition.
Cybersecurity Risk Management Processes Integrated [Flag] true
Cybersecurity Risk Management Processes Integrated [Text Block] We have developed and implemented a cybersecurity risk management program intended to protect the confidentiality, integrity, and availability of our critical systems and information.
Cybersecurity Risk Management Third Party Engaged [Flag] true
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag] true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag] false
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block] We have not identified risks from known cybersecurity threats, including as a result of any prior cybersecurity incidents that have materially affected or are reasonably likely to materially affect us, including our operations, business strategy, results of operations, or financial condition.
Cybersecurity Risk Board of Directors Oversight [Text Block]
Cybersecurity Governance
 
Our board of directors considers cybersecurity risk as part of its risk oversight function and has delegated to the Audit Committee oversight of cybersecurity and other information technology risks, among other, via the internal audit plan. The audit committee oversees management’s activities to address the cybersecurity risk.
 
The board of directors and our audit committee receive reports from management and internal auditor on our cybersecurity risks. In addition, management updates the audit committee, as necessary, regarding any material cybersecurity incidents, as well as any incidents with lesser impact potential. In addition, they periodically receive briefings from management on our cyber security activities and incidents.
 
Our Cybersecurity Steering Committee, including our CEO, CFO, CIO, Information security manager and Director of IT Infrastructure, is convening on a quarterly basis and is responsible for assessing and managing our material risks from cybersecurity threats. The team has primary responsibility for our overall cybersecurity risk management program and supervises both our internal cybersecurity personnel and our retained external cybersecurity consultants. Our cybersecurity management team’s skills and experience cover the areas of management, finance, investor relations, legal, Information Systems and Infrastructure and cyber security.
 
Our cybersecurity management team supervises efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include briefings from internal security personnel; threat intelligence and other information obtained from governmental, public or private sources, including external consultants engaged by us; and alerts and reports produced by security tools deployed in the IT environment.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block] Our board of directors considers cybersecurity risk as part of its risk oversight function and has delegated to the Audit Committee oversight of cybersecurity and other information technology risks, among other, via the internal audit plan. The audit committee oversees management’s activities to address the cybersecurity risk.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block] The board of directors and our audit committee receive reports from management and internal auditor on our cybersecurity risks. In addition, management updates the audit committee, as necessary, regarding any material cybersecurity incidents, as well as any incidents with lesser impact potential. In addition, they periodically receive briefings from management on our cyber security activities and incidents.
Cybersecurity Risk Role of Management [Text Block]
The board of directors and our audit committee receive reports from management and internal auditor on our cybersecurity risks. In addition, management updates the audit committee, as necessary, regarding any material cybersecurity incidents, as well as any incidents with lesser impact potential. In addition, they periodically receive briefings from management on our cyber security activities and incidents.
 
Our Cybersecurity Steering Committee, including our CEO, CFO, CIO, Information security manager and Director of IT Infrastructure, is convening on a quarterly basis and is responsible for assessing and managing our material risks from cybersecurity threats. The team has primary responsibility for our overall cybersecurity risk management program and supervises both our internal cybersecurity personnel and our retained external cybersecurity consultants. Our cybersecurity management team’s skills and experience cover the areas of management, finance, investor relations, legal, Information Systems and Infrastructure and cyber security.
Cybersecurity Risk Management Positions or Committees Responsible [Flag] true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block] Our Cybersecurity Steering Committee, including our CEO, CFO, CIO, Information security manager and Director of IT Infrastructure, is convening on a quarterly basis and is responsible for assessing and managing our material risks from cybersecurity threats. The team has primary responsibility for our overall cybersecurity risk management program and supervises both our internal cybersecurity personnel and our retained external cybersecurity consultants.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block] Our cybersecurity management team’s skills and experience cover the areas of management, finance, investor relations, legal, Information Systems and Infrastructure and cyber security.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block] Our cybersecurity management team supervises efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include briefings from internal security personnel; threat intelligence and other information obtained from governmental, public or private sources, including external consultants engaged by us; and alerts and reports produced by security tools deployed in the IT environment.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag] true
v3.25.4
SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2025
Accounting Policies [Abstract]  
Use of estimates
  a.
Use of estimates:
 
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates. The Company's management believes that the estimates, judgment and assumptions used are reasonable based upon information available at the time they were made.
Financial statements in U.S. dollars
  b.
Financial statements in U.S. dollars:
 
The Company's revenues are generated in various currencies mainly in U.S. dollars (USD), Australian dollars (AUD) and Canadian dollars (CAD). In addition, most of the Company's costs are incurred in USD, NIS and EUR.
 
The Company’s management believes that the USD is the primary currency of the economic environment in which the Company operates. Thus, the functional and reporting currency of the Company is the USD.
 
The functional currency of the Company's foreign subsidiaries is the local currency in which the relevant subsidiary operates.
 
Accordingly, monetary accounts maintained in currencies other than the USD are re-measured into dollars in accordance with Accounting Standards Codification, "Foreign Currency Matters" (“ASC 830”). All transaction gains and losses resulting from the re-measurement of monetary balance sheet items denominated in non-USD currencies are reflected in the statements of operations as financial income or expenses as appropriate.
 
The financial statements of the Company’s subsidiaries of which the functional currency is not the USD have been translated into the USD. All amounts on the balance sheets have been translated into the USD using the exchange rates in effect on the relevant balance sheet dates. All amounts in the statements of income have been translated into the USD using the monthly average exchange rate in accordance with ASC 830. The resulting translation adjustments are reported as a component of accumulated other comprehensive income (loss), net in shareholders' equity.
Principles of consolidation
  c.
Principles of consolidation:
 
The consolidated financial statements include the accounts of the Company and its wholly and majority-owned subsidiaries (see also Note 1). Inter-company transactions and balances, including profit from inter-company sales not yet realized outside of the Company, have been eliminated upon consolidation.
Cash equivalents
  d.
Cash equivalents:
 
Cash equivalents are short-term highly liquid investments that are readily convertible to cash with original maturities of three months or less at the date acquired.
Short-term bank deposits
  e.
Short-term bank deposits:
 
Short-term bank deposits are deposits with original maturities of more than three months but less than one year. Short-term bank deposits are presented at their cost, which approximates their fair value.
Derivatives
  f.
Derivatives:
 
ASC 815, “Derivative and Hedging” ("ASC 815"), requires companies to recognize all of their derivative instruments as either assets or liabilities in the statement of financial position at fair value.
 
For those derivative instruments that are designated and qualify as hedging instruments, a company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge or a hedge of a net investment in a foreign operation.
 
Derivative instruments designated as hedging instruments:
For derivative instruments that are designated and qualify as a cash flow hedge (i.e., hedging the exposure to variability in expected future cash flows that is attributable to a particular risk), changes in the fair value of the derivative instruments are recorded as a component of accumulated other comprehensive income (loss) and reclassified into earnings in the same period during which the hedged transaction affects earnings.
 
To hedge against the risk of overall changes in cash flows resulting from foreign currency salary and other recurring payments during the periods, the Company has instituted a foreign currency cash flow hedging program.
 
These forward contracts are designated as cash flow hedges, as defined by ASC 815, and are all effective, as their critical terms match the underlying transactions being hedged.
 

As of December 31, 2025 and 2024, the notional amount of these forward contracts into which the Company entered was $0 and $2,525, respectively, and the unrealized income recorded in accumulated other comprehensive income, net, from the Company's currency forward NIS transactions was $110 and $429, respectively.

 
The following tables present fair value amounts of, and gains and losses recorded in relation to, the Company's derivative instruments and related hedged items:
 
 

Balance sheet

  
Fair value of
derivative instruments
      
Year ended
December 31,
  
     
2025
    
2024
  
Derivative assets:
              
               
Derivatives designated as hedging instruments:
              
Foreign exchange option and forward contracts
Other accounts receivable and prepaid expenses
    
-
      
110
  
                   
Total
 
    
-
      
110
  
 
   
Gain (loss) recognized in
other comprehensive
income, net
  
Gain (loss) recognized in
statements of income
  
   
Year ended
December 31,
  
Statements of
income
  
Year ended
December 31,
  
   
2025
    
2024
  
Item
  
2025
    
2024
  
Derivatives designated as hedging instruments:
                          
                           
Foreign exchange forward contract
    
(110
)
    
(429
)
Cost of revenues and Operating expenses
    
4,193
      
500
  
 
                
 
                
Derivatives not designated as hedging instruments:
                
 
                
Foreign exchange forward and options contracts
    
-
      
-
  
Financial expenses, net
    
267
      
6
  
 
                
 
                
Total
    
(110
)
    
(429
)
 
    
4,460
      
506
  
 
For derivative instruments not designated as hedging instruments, the gain or loss is recognized in current earnings during the period of change.
Inventories
  h.
Inventories:
 
Inventories are stated at the lower of cost and net realizable value. The Company periodically evaluates the quantities on hand relative to historical and projected sales volumes, aging, current and historical selling prices and contractual obligations to maintain certain levels of raw material quantities. Based on these evaluations, inventory provision is provided to cover risks arising from slow-moving items, discontinued products, excess inventories, net realizable value lower than cost and adjusted revenue forecasts.
 
Cost is determined as follows:
 
Raw Materials - cost is determined on a standard cost basis which approximates actual costs on a weighted average basis.
 
Work-in progress and manufactured finished products - are based on standard cost (which approximates actual cost on a weighted average basis) which includes raw materials cost, labor and manufacturing overhead. Acquired finished goods are based on  weighted average.
 
Finished goods are stated at the lower of cost and net realizable value.
 
Inventory write-offs of $1,966, $3,290 and $4,148, were recorded for the years ended December 31, 2025, 2024 and 2023, respectively.
Property, plant and equipment, net
  i.
Property, plant and equipment, net:
 
  1.
Property, plant and equipment are stated at cost, net of accumulated depreciation and investment grants.
 
  2.
Costs recorded prior to a production line completion are reflected as construction in progress, which are recorded building and machinery assets at the date of purchase. Construction in progress includes direct expenditures for the construction of the production line and is stated at cost. Capitalized costs include costs incurred under the construction contract: advisory, consulting and direct internal costs (including labor) and operating costs incurred during the construction and installation phase.
 
  3.
Depreciation is calculated using the straight-line method over the estimated useful life of the assets at the following annual rates:
 
 
%
   
Machinery and manufacturing equipment
4 - 33 (mainly 10)
Office equipment and furniture
7 - 33 (mainly 7)
Motor vehicles
10 - 30 (mainly 20)
Buildings
4 - 5
Leasehold improvements
Over the shorter of the term of the lease or the life of the asset
 
Leases
  j.
Leases:
 
The Company determines if an arrangement is a lease at inception and recognize in accordance with ASC 842 “Leases”. Operating leases are included in operating lease right-of-use (“ROU”) assets, other current liabilities and operating lease liabilities in the Company’s consolidated balance sheets.
 
ROU assets represent the right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at commencement date based on the present value of lease payments over the lease term.
 
The interest rate used to determine the present value of the future lease payments is the Company’s incremental borrowing rate, because the interest rate implicit in the Company’s leases is not readily determinable. The Company’s incremental borrowing rate is estimated to approximate the interest rate on a collateralized basis with similar terms and payments, and in economic environments where the leased asset is located. The operating lease ROU asset also includes any lease payments made and excludes lease incentives, if any. Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Lease expenses for lease payments are recognized on a straight-line basis over the lease term. If an operating lease asset is impaired, the remaining operating lease asset will be amortized on a straight-line basis over the remaining lease term. See also Note 9.
Impairment of long-lived assets and Assets Held-for-Sale
  k.
Impairment of long-lived assets and Assets Held-for-Sale:
 
Impairment of long-lived assets
 
The Company's long-lived assets (assets group) to be held or used, including right of use assets, tangible and finite-lived intangible assets (other than goodwill), are reviewed for impairment in accordance with ASC 360 "Property, Plant and Equipment" ("ASC 360") whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.
 
The Company's evaluation of recoverability is performed at the lowest level of assets group to which identifiable cash flows are largely independent of the cash flows of other asset groups. Recoverability of the asset group is measured by a comparison of the aggregate undiscounted future cash flows the asset group is expected to generate to the carrying amounts of the asset group. If such evaluation indicates that the carrying amount of the asset group is not recoverable, an impairment loss is calculated based on the excess of the carrying amount of the asset group over its fair value.
 
The Company identifies indicators for impairment, among others, slowdown in demand due to global and local market conditions, integration challenges of acquired businesses, and the manufacturing facilities closure in Sdot Yam, Richmond Hill and Bar-Lev.
 
Following the approval of the closure of its Sdot Yam manufacturing facility in Israel and its Richmond Hill manufacturing facility in the United States during 2023, the Company recorded an impairment loss related to Richmond Hill manufacturing facility for the excess of the carrying amount over its fair value, in the amount of $27,486. The Company also recorded additional impairment loss related to Sdot Yam manufacturing facility in the amount of $986. In addition, the Company evaluated its right-of-use asset associated with its non‑cancelable lease agreement in Sdot Yam, which is effective through 2032. The Company recorded an impairment of $16,575 for its leased facility.
 
During 2024, the Company recorded an impairment loss of $3,236 related to its intangible assets.
 
Following the approval of the closure of its Bar‑Lev manufacturing facility in Israel during 2025, the Company evaluated its right-of-use asset associated with its non‑cancelable lease agreement in Bar‑Lev, which is effective through 2032. As a result of this evaluation, the Company recorded an impairment of $6,859 for this leased facility.
 
In addition to performing recoverability assessment, the Company routinely reviews the remaining estimated useful lives of property and equipment and finite-lived intangible assets. If the Company revises the estimated useful life assumption for any asset, the remaining unamortized balance is adjusted prospectively and amortized or depreciated over the revised remaining useful life.

 

Assets Held-for-Sale:
 
The Company classifies assets as held-for-sale in the period when all of the following conditions are met: (i) management, having the authority to approve the action, commits to a plan to sell the assets; (ii) the assets are available for immediate sale in their present condition subject only to terms that are usual and customary for sales of such assets; (iii) an active program to locate a buyer and other actions required to complete the plan to sell the assets have been initiated; (iv) the sale of the assets is probable, and transfer of the assets is expected to qualify for recognition as a completed sale within one year, except if events or circumstances beyond the Company's control extend the period of time required to sell the assets beyond one year; (v) the assets are being actively marketed for sale at a price that is reasonable in relation to its current fair value; and (vi) actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.
 
The Company evaluates the probability of sale within one year, considering current market conditions and the status of active marketing efforts. If disposal does not occur within 12 months, the Company reassesses whether delays are caused by factors outside its control.
 
The assets that are classified as held-for-sale are initially measured at the lower of their carrying value or fair value, less any costs to sell. The determination of the fair value less costs to sell may require management to make judgments on significant estimates and assumptions including, but not limited to, indicative sales values, current market conditions and available data for transactions for similar assets. Any impairment loss resulting from this measurement is recorded in Impairment of long-lived assets, restructuring and other, net on the Consolidated Statements of Operations and the assets held-for-sale are recorded as a separate line within the Consolidated Balance Sheets. Upon being classified as held for sale we cease depreciation. The fair values of assets less any costs to sell are assessed each reporting period for which they remain classified as held-for-sale, and any subsequent change is reported as an adjustment to the carrying value of the assets, as long as the new carrying value does not exceed the carrying value of the asset at the time it was initially classified as held-for-sale.
 
During 2024, following the Company's decision to sale its Richmond Hill manufacturing facility it was determined that the Richmond Hill manufacturing facility met all criteria to be classified as assets held-for-sale. The impairment charges were measured as the difference between the carrying value of this long‑lived asset and its estimated fair value, less estimated costs to sell. The Company recorded an impairment loss of $3,800 related to the excess of the carrying amount over the fair value of the held‑for‑sale asset. During 2024, the Company also sold a portion of the land associated with the Richmond Hill facility, together with certain production equipment, resulting in a capital gain of $7.4 million.
 
During 2025, following the Company's decision to cease manufacturing activities in its Bar-Lev manufacturing facility, it was determined that it met all criteria to be classified as assets held-for-sale. The Company recorded an impairment loss for the excess of the book value over its fair value related to held-for-sale asset, in the amount of $32,651.

 

During 2025, the Company recorded additional impairment loss related to Richmond Hill held-for-sale asset in the amount of $6,146.
Warranty
  l.
Warranty:
 
The Company generally provides a standard (i.e. assurance type) warranty for its products, for various periods, depending on the type of product and the country in which the Company does business. The Company records a provision for the estimated cost to repair or replace products under warranty at the time of sale. Factors that affect the Company's warranty reserve include the number of units sold, historical and anticipated rates of warranty repairs and the cost per repair.
 
The following table provides the details of the change in the Company's warranty accrual:
 
   
2025
    
2024
  
             
January 1,
  
$
1,726
    
$
2,358
  
                 
Charged to costs and expenses relating to new sales
    
3,189
      
368
  
Costs of product warranty claims
    
(2,996
)
    
(844
)
Foreign currency translation adjustments
    
20
      
(156
)
                 
December 31,
   $
1,939
     $
1,726
  

 
Revenue recognition
  m.
Revenue recognition:
 
Revenues are recognized in accordance with ASC 606, revenue from contracts with customers when control of the promised goods or services is transferred to the customers, in an amount that the Company expects in exchange for those goods or services.
 
The Company applies the following five steps in accordance to ASC 606: (1) identify the contract with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when a performance obligation is satisfied.
 
  1.
Identify the contract with a customer:
 
A contract is an agreement between two or more parties that creates enforceable rights and obligations. In evaluating the contract, the Company analyzes the customer’s intent and ability to pay the amount of promised consideration and considers the probability of collecting substantially all of the consideration. The Company determines whether collectability is probable on a customer-by-customer basis pursuant to various criteria including Company’s historical experience, credit insurance and other inputs.
 
  2.
Identify the performance obligations in the contract:
 
At a contract’s inception, the Company assesses the goods or services promised in a contract with a customer and identifies the performance obligations. The main performance obligation is a delivery of the Company’s products. For certain revenue transactions with specific customers, the Company is responsible also for the fabrication and installation of its products.
     
  3.
Determine the transaction price:
 
The Company’s products that are sold through agreements with distributors are non-exchangeable, non-refundable, non-returnable and without any rights of price protection or stock rotation. Accordingly, the Company considers all the distributors to be end-consumers.
 
Although, in general, the Company does not grant rights of return, there are certain instances where such rights are granted. The Company maintains a provision for returns in accordance with ASC 606, which is estimated, based primarily on historical experience as well as management judgment, and is recorded through a reduction of revenue. The Company also adjusts the amounts of revenue for expected cash discounts and sales allowances.
 
Sales and other taxes collected from customers on behalf of governmental authorities are accounted for on a net basis and are not included in revenues.
 
The Company has elected to apply the practical expedient such that it does not evaluate payment terms of one year or less for the existence of a significant financing component.
     
  4.
Allocate the transaction price to the performance obligations in the contract:
 
The majority of the Company’s revenues are sales of goods, therefore there is one main performance obligation that absorbs the transaction price.
 
 
 5.
Recognize revenue when a performance obligation is satisfied:
 
Revenue is recognized when or as performance obligations are satisfied by transferring control of a promised good or service to a customer. Control transfers at a point in time, which affects when revenue is recorded. The majority of Company’s revenues deriving from sales of products which are recognized when control is transferred based on the agreed International Commercial terms, or “INCOTERMS”. For certain revenue transactions with specific customers, the Company is responsible also for the fabrication and installation of its products. The Company recognizes such revenues upon receipt of acceptance evidence from the end consumer which occurs upon completion of the installation.
 
The Company elected the short-term contract practical expedient for the remaining performance obligations, as the Company's contracts have an original expected duration of less than one year.
Research and development costs
  n.
Research and development costs:
 
Research and development costs are charged to the statement of operations as incurred.
Income taxes
  o.
Income taxes:
 
The Company and its subsidiaries account for income taxes in accordance with ASC 740, "Income Taxes" (“ASC 740”). This statement prescribes the use of the liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.

 

The Company accounts for its uncertain tax positions in accordance with ASC 740-10. ASC 740-10 contains a two-step approach to recognizing and measuring uncertain tax positions accounted for in accordance with ASC 740. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. The Company classifies interest and penalties on income taxes as taxes on income, if relevant.
Advertising expenses
  p.
Advertising expenses:
 
Advertising costs are expensed as incurred. Advertising expenses for the years ended December 31, 2025, 2024 and 2023 were $14,466, $14,516 and $15,726, respectively.
Concentrations of credit risk
  q.
Concentrations of credit risk:
 
Financial instruments that potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents, marketable securities and trade receivables. The Company's cash and cash equivalents are invested primarily in USD, mainly with major banks in Israel.
 
The Company's trade receivables are derived from sales to customers located mainly in the United States, Australia, Canada, Israel and Europe. The Company performs ongoing credit evaluations of its customers and to date has not experienced any substantial losses. In certain circumstances, the Company requires letters of credit or prepayments. An allowance for credit losses is provided with respect to specific receivables that the Company has determined to be doubtful of collection. For those receivables not specifically reviewed, provisions are recorded, based upon the age of the receivable, the collection history, current economic trends and management estimates of future economic conditions.
 
No customer represented 10% or more of the Company’s total accounts receivables, net as of December 31, 2025 and 2024.
 
The following table provides the details of the change in the Company's allowance for credit loss:
 
   
2025
    
2024
  
             
January 1,
  
$
9,104
    
$
12,214
  
                 
Charges to expenses
    
17
      
(1,944
)
Write offs
    
(1,726
)
    
(1,095
)
Foreign currency translation adjustments
    
(68
)
    
(71
)
                 
December 31,
  
$
7,327
    
$
9,104
  
Severance pay
  r.
Severance pay:
 
The Company's liability for severance pay, with respect to its Israeli employees, is calculated pursuant to Israeli severance pay law and employee agreements based on the most recent salary of the employees. The Company's liability for all of its Israeli employees is provided for by monthly deposits with insurance policies and by an accrual. The value of these policies is recorded as an asset on the Company's balance sheet.
 
The deposited funds include profits or losses accumulated up to the balance sheet date. The deposited funds may be withdrawn only upon the fulfillment of the obligations pursuant to Israeli severance pay law or labor agreements.
 
Majority of the agreements with employees specifically state, in accordance with section 14 of the Severance Pay Law, 1963 ("Section 14"), that the Company's contributions for severance pay shall be instead of severance compensation and that upon release of the policy to the employee, no additional calculations shall be conducted between the parties regarding the matter of severance pay and no additional payments shall be made by the Company to the employee.
 
Further, since the Company has signed agreements with its employees under Section 14, the related obligation and amounts deposited on behalf of such obligation are not stated on the balance sheet, as they are legally released from obligation to employees once the deposit amounts have been paid.
 
Severance pay expenses for the years ended December 31, 2025, 2024 and 2023 amounted to approximately $1,594, $1,647 and $2,102, respectively.
Fair value of financial instruments
  s.
Fair value of financial instruments:
 
In accordance with ASC 820, the Company measures the below assets and liabilities at fair value using the various valuation techniques. The assets and liabilities are classified within Level 1 for using quoted market prices, Level 2 for alternative pricing sources and models utilizing market observable inputs, and Level 3 unobservable inputs which are supported by little or no market activity, also using third party appraisers.
 
The following table sets forth the Company’s assets and liabilities that were measured at fair value as of December 31, 2025 and 2024 by level within the fair value hierarchy:
 
   
Fair Value
  
Fair value measurements
as of December 31,
  
Description
  
Hierarchy
  
2025
    
2024
  
 
                
Measured at fair value on a recurring basis:
                
 
                
Assets:
                
Derivative assets
  
Level 2
  
$
-
    
$
110
  

 

Measured at fair value on a nonrecurring basis:
 
  (a)
During the year ended December 31, 2023, the Company recorded an impairment loss of $27,486 related to the excess of the book value over the fair value of its Richmond Hill manufacturing facility, and an additional impairment loss of $986 related to the Sdot Yam manufacturing facility. The Company also recorded an impairment of $16,575 related to the right‑of‑use (ROU) assets associated with the Sdot Yam manufacturing facility.
 
The Company determined the fair value of Richmond Hill manufacturing facility using both the market approach by reference to recent comparable property transactions in the area and the income approach, which incorporated market‑based rental assumptions derived from comparable lease agreements in the region. The fair value of the property, plant and equipment was measured using the cost approach, based on replacement cost less depreciation and market‑related adjustments. These inputs are categorized as Level 3 within the fair value hierarchy.
 
The Company determined the fair value of the right‑of‑use asset associated with the Sdot Yam using a discounted cash‑flow technique that incorporated projected market‑rate lease payments, estimated using observable market information and comparable lease transactions from external data sources, and discounted at an appropriate rate. These fair value measurements also qualify as Level 3 measurements within the fair value hierarchy.
 
  (b)
During the year ended December 31, 2024, it was determined that the Richmond Hill facility met all criteria to be classified as assets held for sale. The impairment charges were measured as the difference between the carrying value of these long‑lived assets and their estimated fair values, less estimated costs to sell. The Company recorded an impairment loss of $3,800 and of $6,146 related to the excess of the carrying amount over the fair value of the held‑for‑sale asset during the years ended December 31, 2024, and 2025, respectively. The fair value was determined using both the market approach by reference to recent comparable property transactions in the area and the income approach, which incorporated market‑based rental assumptions derived from comparable lease agreements in the region.
 
  (c)
During the year ended December 31, 2025 the Company recorded impairment charges of $32,651 related to previous investments in manufacturing equipment at Bar Lev manufacturing facility, pursuant to held-for-sale accounting guidance. The impairment charges were determined as the difference between the carrying value of these long-lived assets and their estimated fair values, less estimated costs to sell such assets. The fair value of the property, plant and equipment was measured using the cost approach, based on replacement cost less depreciation and market‑related adjustments. These inputs are categorized as Level 3 within the fair value hierarchy.
 
In addition, during the year ended December 31, 2025, the Company recorded impairment charges of $6,859 related to the right‑of‑use assets associated with the Bar Lev manufacturing facility. The Company determined the fair value of the right‑of‑use asset associated with Bar Lev using a discounted cash‑flow technique that incorporated projected market‑rate lease payments, estimated using observable market information and comparable lease transactions from external data sources, and discounted at an appropriate rate. This fair value measurement also qualify as Level 3 measurement within the fair value hierarchy.
 
The carrying amounts of financial instruments not measured at fair value, including cash and cash equivalents, trade receivables, other accounts receivables, trade payables, accrued expenses and other liabilities, short term loans and short-term bank credit, approximate their fair value due to the short-term maturities of such instruments.
Basic and diluted net income (loss) per share
  t.
Basic and diluted net income (loss) per share:
 
Basic net income (loss) per share ("Basic EPS") is computed by dividing net income (loss) attributable to ordinary shareholders by the weighted average number of ordinary shares outstanding during the period.
 
Diluted net income (loss) per share ("Diluted EPS") gives effect to all dilutive potential ordinary shares outstanding during the period. The computation of Diluted EPS does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings. The dilutive effect of outstanding stock options is computed using the treasury stock method. For the years ended December 31, 2025, 2024 and 2023 there were approximately 3,421,138, 2,495,479, and 2,310,543 outstanding stock options, respectively, that were excluded from the computation of Diluted EPS, that would have had an anti-dilutive effect if included.
Accumulated other comprehensive income (loss)
  u.
Accumulated other comprehensive income (loss):
 
The total accumulated other comprehensive income ("AOCI"), net of tax was comprised as follows:
 
   
December 31,
  
   
2025
    
2024
  
             
Accumulated income on derivative instruments
   $
-
     $
110
  
Accumulated foreign currency translation differences and other
    
(10,874
)
    
(14,980
)
                 
Total accumulated other comprehensive loss, net
  
$
(10,874
)
  
$
(14,870
)
 
The following table summarizes the changes in AOCI, net of taxes for the year ended:
 
   
Unrealized gains (losses) on derivative instruments
    
Accumulated foreign currency translation differences and other
    
Total
  
                   
Balance at January 1, 2024
   $
539
     $
(8,941
)
   $
(8,402
)
                         
Other comprehensive income (loss) before reclassifications
    
71
      
(6,039
)
    
(5,968
)
Amounts reclassified from AOCI
    
(500
)
    
-
      
(500
)
                         
Net current period OCI
    
(429
)
    
(6,039
)
    
(6,468
)
                         
Balance at December 31, 2024
    
110
      
(14,980
)
    
(14,870
)
                         
Other comprehensive income (loss) before reclassifications
    
4,083
      
4,106
      
8,189
  
Amounts reclassified from AOCI
    
(4,193
)
    
-
      
(4,193
)
                         
Net current period OCI
    
(110
)
    
4,106
      
3,996
  
                         
Balance at December 31, 2025
   $
-
     $
(10,874
)
   $
(10,874
)
 
The following table shows the amounts reclassified from AOCI into the Consolidated Statements of Income, and the associated financial statement line item, for 2025 and 2024:
 
   
December 31,
  
   
2025
    
2024
  
Affected line item in the consolidated statements of income:
            
             
Cost of revenues
  
$
2,664
    
$
324
  
Research and development
    
267
      
20
  
Marketing and selling
    
615
      
81
  
General and administrative
    
647
      
75
  
                 
Total Credit
  
$
4,193
    
$
500
  
 
Accounting for stock-based compensation
  v.
Accounting for stock-based compensation:
 
Equity share based payment:
 
The Company accounts for stock-based compensation in accordance with ASC 718, "Compensation-Stock Compensation" ("ASC 718"). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an option-pricing model.
 
The Company accounts for employees and directors’ share-based payment awards classified as equity awards using the grant-date fair value method. The fair value of share-based payment transactions is recognized as an expense over the requisite service period on a straight-line basis. The Company’s accounting policy is to account for forfeitures as they occur.
 
The exercise price of each option is generally Company's stock price on the date of the grant. Options generally become exercisable over approximately three to four-year period, subject to the continued employment. All options expire after 7 years from the date of grant. In addition, commencing in 2015 the Company granted certain of its employees and officers with restricted stock units ("RSUs"), vesting over approximately a four-year period from the grant date. RSUs fair value is measured at the grant date based on the market value of Company's common stock. RSUs that are cancelled or forfeited become available for future grants.
 
In 2025 and 2024, the Company estimated the fair value of stock options granted using the Black-Scholes option pricing model with the following weighted average assumptions:
 
   
December 31,
  
   
2025
    
2024
  
             
Dividend yield
  
0 - 3
    
0 - 3%
  
Expected volatility
  
44-59.0%
    
42-47.0%
  
Risk-free interest rate
  
3.7-4.3%
    
4-4.6%
  
Expected life (in years)
  
4-7
    
4-7
  
 
The Company used volatility data in accordance with ASC 718 and based on Company's historical data.
 
The computation of risk free interest rate is based on the rate available on the date of grant of a zero-coupon U.S. government bond with a remaining term equal to the expected term of the option.
 
The expected term of options granted is calculated using the simplified method (being the average between the vesting periods and the contractual life of the options). In case of grant to Company's CEO or directors, the expected term equals to the contractual life.
 
For the vast majority of the options granted in 2025 and 2024, the dividend yield is zero, due to adjustment mechanism with respect to the exercise price upon payment of a dividend. For those options granted without adjustment mechanism, the dividend yield applied is 3%.
Redeemable non-controlling interest
  w.
Redeemable non-controlling interest:
 
In July 2024, the Company partially exercised its call option to acquire minority interests in Lioli and purchased 10,699,162 shares from certain minority shareholders for aggregate consideration of approximately $1.6 million. Following this transaction, the Company held approximately 80.7% of Lioli’s outstanding shares on a fully diluted basis.
 
In October 2025, the Company exercised its call option to acquire the remaining minority interests in Lioli and purchased an additional 14,475,338 shares for aggregate consideration of approximately $1.9 million. Upon completion of this transaction, the Company owns 100% of Lioli’s outstanding shares.
 
The redeemable non-controlling interest was measured at the higher of (i) the carrying amount attributable to the non-controlling interest, including its share of accumulated earnings, or (ii) the redemption value as of the relevant balance sheet date (see Note 1b).
 
The following table provides a reconciliation of the redeemable non-controlling interest:
 
   

Year ended December 31,
   
2025
    
2024
    
2023
  
                   
Beginning of the year
  
$
2,200
    
$
7,789
    
$
7,903
  
                         
Net loss attributable to non-controlling interest
    
(292
)
    
(144
)
    
(584
)
Adjustment to Put option value (*)
    
101
      
(3,782
)
    
532
  
Payment for Put option (*)
    
(1,920
)
    
(1,556
)
    
-
  
Foreign currency translation adjustments
    
(89
)
    
(107
)
    
(62
)
                         
Redeemable non-controlling interest - end of the year
  
$
-
    
$
2,200
    
$
7,789
  
 
(*) See also Note 1b.
 
Contingencies
  x.
Contingencies:
 
The Company is involved in various product liability, commercial, government investigations, environmental claims and other legal proceedings that arise from time to time in the course of business. The Company records accruals for these types of contingencies to the extent that the Company concludes their occurrence is probable and that the related liabilities are estimable. When accruing these costs, the Company will recognize an accrual in the amount within a range of loss that is the best estimate within the range. When no amount within the range is a better estimate than any other amount, the Company accrues for the minimum amount within the range. The Company records anticipated recoveries under existing insurance contracts that are probable of occurring at the amount that is expected to be collected. Legal costs are expensed as incurred. For unasserted claims or assessments, the Company followed the accounting guidance in ASC 450 Contingencies, in which the Company must first determine that the probability that an assertion will be made is likely, then, a determination as to the likelihood of an unfavorable outcome and the ability to reasonably estimate the potential loss is made.
Business combination
  y.
Business combination:
 
The Company accounts for business combinations by applying the provisions of ASC 805, Business Combination, and allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed, and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair values of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets.
 
Significant estimates in valuing certain intangible assets include, but are not limited to future expected cash flows from acquired customer relationship and acquired trademarks from a market participant perspective, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates.  During the measurement period, which does not exceed one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding adjustment to goodwill. Upon the finalization of the measurement period, any subsequent adjustments are recorded to earnings.
 
Acquisition-related costs are recognized separately from the acquisition and are expensed as incurred. See also Note 1.
Exit or disposal activities
  z.
Exit or disposal activities:
 
The Company accounts for exit and disposal cost obligations, including restructuring activities, under ASC 420-10 "Exit or Disposal Cost Obligations", which requires that the company record liabilities for such activities only when such liability has been incurred.

During 2023, The Company approved the closure of its Sdot Yam manufacturing facility in Israel and its Richmond Hill manufacturing facility in the US. This resulted in a reduction of workforce and impairment of certain long-lived assets.
 

During 2024, it was determined that the Richmond Hill facility met all criteria to be classified as assets held for sale, in addition, the Company sold a portion of the land associated with the Richmond Hill facility, together with certain production equipment.

 
During 2025, the Company approved the closure its Bar-Lev manufacturing facility in Israel. This resulted in a reduction of workforce, impairments of certain long-lived assets to be held and used and impairments of certain long-lived assets that met the held-for-sale criteria during the year ended December 31, 2025.
 
Total restructuring expenses for the year ended December 31, 2025, 2024 and 2023 related to the manufacturing facilities closures and the sale of a portion of the land and certain production equipment associated with the Richmond Hill facility, amounted to approximately $3.1 million expenses, net gain of $6.0 million and $2.9 million expenses, respectively, included within the Impairment of long-lived assets, restructuring and other, net on the consolidated statements of comprehensive income (loss).
 
In 2025, the $3.1 million expenses included decommissioning, restoration and other related costs of approximately $3.2 million, employee termination costs of approximately $1.0 million, offset by certain credit of approximately $1.1 million related to the Richmond Hill facility.
 
In 2024, the net gain of $6.0 million, included capital gain of approximately $7.4 million related to the sale of a portion of the undeveloped land associated with the Richmond Hill facility, offset by decommissioning and restoration costs of approximately $1.4 million.
 
In 2023, the $2.9 million expenses, included employee termination costs of approximately $1.0 million, and decommissioning and restoration costs of approximately $1.9 million.
 
As of December 31, 2025 and 2024, approximately $4.0 and $1.5 million, respectively, recorded under accrued expenses and other liabilities.
Impact of recently issued accounting standards
  aa.
Impact of recently issued accounting standards:
 
   
Recently issued accounting standards and adopted by the Company:

 

 

  

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company adopted ASU 2023-09 for the year ended December 31, 2025, and applied the new disclosure requirements prospectively to the current annual period. Prior period disclosures have not been adjusted to reflect the new disclosure requirements. See Note 11.
 
   
Recently issued accounting standards and not yet adopted by the Company:
 
   
In July 2025, the FASB issued ASU 2025-05, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses for Accounts Receivable and Contract Assets, which provides a practical expedient when estimating expected credit losses for current accounts receivable and current contract assets arising from transactions accounted for under Topic 606, Revenue from Contracts with Customers. The practical expedient assumes that current conditions as of the balance sheet date do not change for the remaining life of the assets. The guidance is effective for the Company beginning January 1, 2026, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statement.
 
In December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities. The update provides recognition, measurement, presentation, and disclosure requirements for government grants, including guidance for grants related to an asset and grants related to income. The amendments introduced two permitted approaches for asset-related grants: a deferred income approach or a cost accumulation approach. The guidance is effective for the Company beginning January 1, 2029, with early adoption permitted. The Company is currently evaluating the impact on its consolidated financial statement.
v3.25.4
SIGNIFICANT ACCOUNTING POLICIES (Tables)
 12 Months Ended
Dec. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Fair Value Amounts and Gains and Losses Recorded in Relation to the Derivative Instruments
 

Balance sheet

  
Fair value of
derivative instruments
      
Year ended
December 31,
  
     
2025
    
2024
  
Derivative assets:
              
               
Derivatives designated as hedging instruments:
              
Foreign exchange option and forward contracts
Other accounts receivable and prepaid expenses
    
-
      
110
  
                   
Total
 
    
-
      
110
  
 
   
Gain (loss) recognized in
other comprehensive
income, net
  
Gain (loss) recognized in
statements of income
  
   
Year ended
December 31,
  
Statements of
income
  
Year ended
December 31,
  
   
2025
    
2024
  
Item
  
2025
    
2024
  
Derivatives designated as hedging instruments:
                          
                           
Foreign exchange forward contract
    
(110
)
    
(429
)
Cost of revenues and Operating expenses
    
4,193
      
500
  
 
                
 
                
Derivatives not designated as hedging instruments:
                
 
                
Foreign exchange forward and options contracts
    
-
      
-
  
Financial expenses, net
    
267
      
6
  
 
                
 
                
Total
    
(110
)
    
(429
)
 
    
4,460
      
506
  
Schedule of Property, Plant and Equipment Depreciation Rates
 
 
%
   
Machinery and manufacturing equipment
4 - 33 (mainly 10)
Office equipment and furniture
7 - 33 (mainly 7)
Motor vehicles
10 - 30 (mainly 20)
Buildings
4 - 5
Leasehold improvements
Over the shorter of the term of the lease or the life of the asset
Schedule of Changes in Warranty Accrual
   
2025
    
2024
  
             
January 1,
  
$
1,726
    
$
2,358
  
                 
Charged to costs and expenses relating to new sales
    
3,189
      
368
  
Costs of product warranty claims
    
(2,996
)
    
(844
)
Foreign currency translation adjustments
    
20
      
(156
)
                 
December 31,
   $
1,939
     $
1,726
  
Schedule of Change in Provision for Doubtful Debts
   
2025
    
2024
  
             
January 1,
  
$
9,104
    
$
12,214
  
                 
Charges to expenses
    
17
      
(1,944
)
Write offs
    
(1,726
)
    
(1,095
)
Foreign currency translation adjustments
    
(68
)
    
(71
)
                 
December 31,
  
$
7,327
    
$
9,104
  
Schedule of Assets and Liabilities Measured at Fair Value
   
Fair Value
  
Fair value measurements
as of December 31,
  
Description
  
Hierarchy
  
2025
    
2024
  
 
                
Measured at fair value on a recurring basis:
                
 
                
Assets:
                
Derivative assets
  
Level 2
  
$
-
    
$
110
  
Schedule of Accumulated Other Comprehensive Income, Net
   
December 31,
  
   
2025
    
2024
  
             
Accumulated income on derivative instruments
   $
-
     $
110
  
Accumulated foreign currency translation differences and other
    
(10,874
)
    
(14,980
)
                 
Total accumulated other comprehensive loss, net
  
$
(10,874
)
  
$
(14,870
)
Schedule of Changes in Accumulated Balances of Other Comprehensive Income
   
Unrealized gains (losses) on derivative instruments
    
Accumulated foreign currency translation differences and other
    
Total
  
                   
Balance at January 1, 2024
   $
539
     $
(8,941
)
   $
(8,402
)
                         
Other comprehensive income (loss) before reclassifications
    
71
      
(6,039
)
    
(5,968
)
Amounts reclassified from AOCI
    
(500
)
    
-
      
(500
)
                         
Net current period OCI
    
(429
)
    
(6,039
)
    
(6,468
)
                         
Balance at December 31, 2024
    
110
      
(14,980
)
    
(14,870
)
                         
Other comprehensive income (loss) before reclassifications
    
4,083
      
4,106
      
8,189
  
Amounts reclassified from AOCI
    
(4,193
)
    
-
      
(4,193
)
                         
Net current period OCI
    
(110
)
    
4,106
      
3,996
  
                         
Balance at December 31, 2025
   $
-
     $
(10,874
)
   $
(10,874
)
Schedule of Losses on Cash Flow Hedge Reclassified Out of Accumulated Other Comprehensive Income
   
December 31,
  
   
2025
    
2024
  
Affected line item in the consolidated statements of income:
            
             
Cost of revenues
  
$
2,664
    
$
324
  
Research and development
    
267
      
20
  
Marketing and selling
    
615
      
81
  
General and administrative
    
647
      
75
  
                 
Total Credit
  
$
4,193
    
$
500
  
Schedule of Reconciliation of Redeemable Non-controlling Interest
   

Year ended December 31,
   
2025
    
2024
    
2023
  
                   
Beginning of the year
  
$
2,200
    
$
7,789
    
$
7,903
  
                         
Net loss attributable to non-controlling interest
    
(292
)
    
(144
)
    
(584
)
Adjustment to Put option value (*)
    
101
      
(3,782
)
    
532
  
Payment for Put option (*)
    
(1,920
)
    
(1,556
)
    
-
  
Foreign currency translation adjustments
    
(89
)
    
(107
)
    
(62
)
                         
Redeemable non-controlling interest - end of the year
  
$
-
    
$
2,200
    
$
7,789
  
 
(*) See also Note 1b.
Employee Stock Option [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Losses on Cash Flow Hedge Reclassified Out of Accumulated Other Comprehensive Income
   
December 31,
  
   
2025
    
2024
  
             
Dividend yield
  
0 - 3
    
0 - 3%
  
Expected volatility
  
44-59.0%
    
42-47.0%
  
Risk-free interest rate
  
3.7-4.3%
    
4-4.6%
  
Expected life (in years)
  
4-7
    
4-7
  
v3.25.4
OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES (Tables)
 12 Months Ended
Dec. 31, 2025
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]  
Schedule of Other Accounts Receivable and Prepaid Expenses
 
   
December 31,
  
   
2025
    
2024
  
             
Prepaid expenses
  
$
6,251
    
$
6,505
  
Government authorities
    
1,405
      
2,841
  
Advances to suppliers
    
932
      
2,703
  
Derivatives
    
-
      
110
  
Insurance receivables (*)
    
11,023
      
32,178
  
Other receivables
    
1,712
      
5,168
  
                 
   
$
21,323
    
$
49,505
  
 
(*) Related to bodily injury claims, see also note 10.
v3.25.4
INVENTORIES (Tables)
 12 Months Ended
Dec. 31, 2025
Inventory Disclosure [Abstract]  
Schedule of Inventories
   
December 31,
  
   
2025
    
2024
  
             
Raw materials
  
$
1,519
    
$
7,090
  
Work-in-progress
    
1,198
      
1,864
  
Finished goods
    
91,558
      
103,655
  
                 
   
$
94,275
    
$
112,609
  
v3.25.4
PROPERTY, PLANT AND EQUIPMENT, NET (Tables)
 12 Months Ended
Dec. 31, 2025
Property, Plant and Equipment [Abstract]  
Schedule of Property, Plant and Equipment, Net
   
December 31,
  
   
2025
    
2024
  
Cost:
            
             
Machinery and manufacturing equipment, net
  
$
30,106
    
$
163,517
  
Office equipment and furniture
    
23,498
      
27,783
  
Motor vehicles
    
1,934
      
3,517
  
Buildings and leasehold improvements
    
31,072
      
51,015
  
Prepaid expenses related to operating lease
    
-
      
939
  
                 
     
86,610
      
246,771
  
Accumulated depreciation and impairment:
                
                 
Machinery and manufacturing equipment, net
    
20,893
      
120,851
  
Office equipment and furniture
    
17,593
      
18,604
  
Motor vehicles
    
1,455
      
2,798
  
Buildings and leasehold improvements
    
16,523
      
28,611
  
Prepaid expenses related to operating lease
    
-
      
183
  
                 
     
56,464
      
171,047
  
                 
Depreciated cost (*)
  
$
30,146
    
$
75,724
  
 
  (*)
During 2025, following the Company's decision to cease manufacturing activities in its Bar-Lev manufacturing facility, it was determined that it met all criteria to be classified as assets held-for-sale. The Company recorded an impairment loss for the excess of the book value over its fair value related to held-for-sale asset, in the amount of $32,651 (see also Note 2k).
v3.25.4
INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2025
GOODWILL [Abstract]  
Schedule of Intangible Assets
   
December 31,
  
   
2025
    
2024
  
Original amounts:
            
    Customer relationships
  
$
13,983
    
$
13,983
  
Accumulated amortization:
                
    Customer relationships (1)
    
(10,562
)
    
(10,302
)
Accumulated impairment charges (2)
    
(3,236
)
    
(3,236
)
Foreign currency translation adjustment
    
(185
)
    
(181
)
                 
Total intangibles assets
  
$
-
    
$
263
  
 
  (1)
Amortization expense amounted to $260 and $2,617 for the years ended December 31, 2025 and 2024, respectively.
 
  (2)
During the year ended December 31, 2024, the Company recorded an impairment loss related to its intangible assets. See also Note 2k.
v3.25.4
SHORT-TERM BANK CREDIT AND CURRENT MATURITIES OF LONG-TERM LOAN (Tables)
 12 Months Ended
Dec. 31, 2025
Short-Term Debt [Abstract]  
Schedule of Short-Term Bank Credit
      
Weighted average interest
              
 
Currency
  
December 31,
    
December 31,
  
     
2025
    
2024
    
2025
    
2024
  
     
%
              
                           
Short-term bank credit (*)
INR
    
8.6
      
9.3
    
$
2,431
    
$
2,534
  
Current maturities of Long- term bank loan and other (**)
INR
    
-
      
9.6
    
$
422
    
$
2,021
  
Total
                    
$
2,853
    
$
4,555
  
 
   
(*) Credit line and bank loan – short term overdraft credit line of 250 million INR ($2.8 million), 215 million INR ($2.4 million) of which were utilized as of December 31, 2025.
 
(**) See also note 13e.
v3.25.4
ACCRUED EXPENSES AND OTHER LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2025
Payables and Accruals [Abstract]  
Schedule of Accrued Expenses and Other Liabilities
   
December 31,
  
   
2025
    
2024
  
             
Employees and payroll accruals
  
$
11,443
    
$
11,690
  
Accrued expenses
    
8,078
      
7,990
  
Advances from customers
    
3,377
      
2,435
  
Taxes payable
    
6,870
      
3,585
  
Warranty provision
    
1,050
      
824
  
Sales return provision
    
879
      
432
  
Operating lease liability short-term
    
26,917
      
24,339
  
Other
    
104
      
88
  
                 
   
$
58,718
    
$
51,383
  
v3.25.4
LEASES (Tables)
 12 Months Ended
Dec. 31, 2025
Lessee Disclosure [Abstract]  
Schedule of Lease-Related Assets and Liabilities
  a.
The following table summarizes the Company’s lease-related assets and liabilities recorded on the consolidated balance sheet:
 
 
Classification
  
December 31, 2025
    
December 31, 2024
  
Assets:
              
               
Operating lease assets (*)
Operating lease right-of-use assets
  
$
104,774
    
$
115,392
  
                   
Total lease assets
    
$
104,774
    
$
115,392
  
                   
Liabilities:
                  
                   
Current lease liabilities
Accrued expenses and other liabilities
    
26,917
      
24,339
  
Long-term lease liabilities
Long-term operating lease liabilities
    
106,377
      
107,313
  
                   
Total lease liabilities
    
$
133,294
    
$
131,652
  
 
   
(*) Following the closures of the Sdot Yam and Bar Lev plants, the Company assessed the recoverability of the related right-of-use assets associated with non-cancelable lease agreements effective through 2032. The Company recorded impairment charges of $16,575 in 2023 and $6,859 in 2025, respectively. (See also note 2k).
 
Lease term and discount rate:
December 31, 2025
  
December 31, 2024
       
Weighted-average remaining lease term — operating leases
5.94 years
  
6.5 years
Weighted-average discount rate — operating leases
3.69%
  
3.1%
Schedule of Components of Operating Lease Cost
   
December 31, 2025
    
December 31, 2024
  
Operating lease cost:
            
             
Operating lease expense
  
$
31,406
    
$
28,454
  
Variable lease expense (*)
    
4,191
      
7,306
  
Sublease income
    
(4,166
)
    
(1,624
)
                 
Total operating lease cost
  
$
31,431
    
$
34,136
  
 
(*) Includes short-term leases, index and other variable lease costs.
Schedule of Operating Lease Liabilities
   
December 31,
  
       
2026
    
29,892
  
2027
    
26,108
  
2028
    
22,512
  
2029
    
20,712
  
2030
    
19,180
  
2031 and thereafter
    
29,987
  
         
Total future lease payments (1,2)
    
148,391
  
Less imputed interest
    
(15,097
)
         
Total
  
$
133,294
  
 
(1) Total lease payments have not been reduced by approximately $22.7 million of future rental income expected to be received under sublease agreements.
 
(2) As of December 31, 2025, the Company entered into additional operating lease agreements that had not yet commenced, with aggregate future lease payments of approximately $3.1 million. These leases are expected to commence during 2026 and have lease terms of approximately five years.
Schedule of Supplemental Cash Flow Information
   
December 31, 2025
    
December 31, 2024
  
Cash paid for amounts included in measurement of lease liabilities:
            
             
Operating cash flows for operating leases
  
$
30,097
    
$
27,468
  
v3.25.4
COMMITMENTS AND CONTINGENT LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2025
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Bodily Injury Claims
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
                   
Outstanding claims, January 1,
    
248
      
224
      
221
  
                         
New claims
    
81
      
101
      
63
  
Settled and dismissed claims
    
(75
)
    
(77
)
    
(60
)
                         
Outstanding claims, December 31
    
254
      
248
      
224
  
v3.25.4
TAXES ON INCOME (Tables)
 12 Months Ended
Dec. 31, 2025
Income Tax Disclosure [Abstract]  
Schedule of Deferred Income Taxes
   
December 31,
  
   
2025
    
2024
  
Deferred tax assets:
            
             
Intangible assets
  
$
-
    
$
172
  
Operating lease liabilities and others
    
41,670
      
24,744
  
Temporary differences related to inventory
    
4,791
      
5,475
  
Property and equipment
    
13,876
      
2,685
  
Net operating loss carry-forward, deductions and credits
    
43,695
      
13,301
  
Less-valuation allowance
    
(83,371
)
    
(28,497
)
                 
Total deferred tax assets
    
20,661
      
17,880
  
                 
Deferred tax liabilities:
                
                 
Property and equipment
    
(2,351
)
    
(2,591
)
Intangible Assets
    
-
      
(595
)
Operating lease right-of-use assets and others lease
    
(16,468
)
    
(14,223
)
                 
Total deferred tax liabilities
    
(18,819
)
    
(17,409
)
                 
Deferred tax assets, net
  
$
1,842
    
$
471
  
Schedule of Reconciliation of Effective Tax Rate to Statutory Tax Rate
   
Year ended December 31,
  
   
2024
    
2023
  
             
Loss before taxes on income
  
$
(41,895
)
  
$
(86,959
)
                 
Statutory tax rate in Israel
    
23
%
    
23
%
                 
Tax benefit at statutory rate
  
$
(9,636
)
  
$
(20,001
)
                 
Increase (decrease) in tax expenses resulting from:
                
                 
Tax benefit arising from reduced rate as an "Preferred Enterprise"
    
9,128
      
9,996
  
Non-deductible expenses, net
    
822
      
1,818
  
 Increase (decrease) in taxes from prior years, also related to settlement with tax authorities
    
882
      
419
  
Tax adjustment in respect of foreign subsidiaries' different tax rates
    
997
      
(1,120
)
Provision for withholding tax assets
    
-
      
2,828
  
Uncertain tax position
    
(353
)
    
-
  
Changes in valuation allowance
    
(701
)
    
27,402
  
Others
    
(58
)
    
(61
)
                 
Income tax expense
  
$
1,081
    
$
21,281
  
                 
Effective tax rate
    
(2.6
)%
    
(24.5
)%
                 
Per share amounts (basic and diluted) of the tax benefit resulting from a "Preferred Enterprise"
  
$
0.26
    
$
0.29
  
   
Year ended December 31,
  
   
2025
  
   
(in thousands)
    
percent
  
             
Loss before taxes on income
  
$
(133,475
)
      
               
Statutory tax rate in Israel
    
23
%
      
               
Tax benefit at statutory rate
  
$
(30,699
)
    
23.0
%
                 
Foreign tax effects:
                
     United States:
                
          Changes in valuation allowance
    
6,018
      
(4.5
)%
          Other
    
(752
)
    
0.6
%
     Other foreign jurisdictions
    
200
      
(0.1
)%
Changes in valuation allowance
    
48,857
      
(37.3
)%
Nontaxable or Nondeductible items:
                
     Other
    
218
      
(0.2
)%
Changes in Unrecognized Tax Benefits
    
3,585
      
(2.7
)%
Preferred enterprise
    
(22,867
)
    
17.1
%
Other adjustments
    
(1,276
)
    
0.9
%
                 
Effective tax rate
  
$
4,284
      
(3.2
)%
Schedule of amounts of cash income taxes paid
   
Year ended December 31,
  
   
2025
  
   
(in thousands)
  
       
Foreign:
        
Australia
    
178
  
India
    
177
  
Canada
    
132
  
Singapore
    
48
  
All other foreign
    
11
  
Income taxes, net of amounts refunded
  
$
546
  
Schedule of Income (Loss) Before Taxes on Income
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
                   
Domestic
  
$
(109,903
)
  
$
(45,582
)
  
$
(38,831
)
Foreign
    
(23,572
)
    
3,687
      
(48,128
)
                         
   
$
(133,475
)
  
$
(41,895
)
  
$
(86,959
)
Schedule of Tax Expenses on Income
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
                   
Current taxes
  
$
5,652
    
$
1,498
    
$
9,373
  
Deferred taxes
    
(1,368
)
    
(417
)
    
11,908
  
                         
   
$
4,284
    
$
1,081
    
$
21,281
  
                         
Domestic
  
$
3,682
    
$
1,258
    
$
14,084
  
Foreign
    
602
      
(177
)
    
7,197
  
                         
   
$
4,284
    
$
1,081
    
$
21,281
  
Schedule of Reconciliation of Beginning and Ending Balances of Unrecognized Tax Benefits
Balance as of January 1, 2024
    
2,891
  
         
Increase in tax positions for current year
    
700
  
Reductions in respect of settlements with authorities and statute of limitation
    
(1,918
)
         
Balance as of December 31, 2024
    
1,673
  
         
Increase in tax positions for current year
    
3,624
  
         
Balance as of December 31, 2025
  
$
5,297
  
v3.25.4
SHAREHOLDERS' EQUITY (Tables)
 12 Months Ended
Dec. 31, 2025
Stockholders' Equity Note [Abstract]  
Schedule of Share Capital
 
Authorized
  
Outstanding
 
December 31,
  
December 31,
 
  2025
  
2024
  
2025
  
2024
 
Number of shares
                       
Ordinary shares of NIS 0.04 par value each
200,000,000
  
200,000,000
  
34,573,899
  
34,549,050
Schedule of Stock Option Activity
   
Number
of options
    
Weighted
average
exercise
price
    
Aggregate intrinsic value
  
                   
Outstanding - beginning of the year
    
2,468,980
      
5.57
      
-
  
Granted
    
1,000,300
      
1.92
      
0.2
  
Forfeited
    
(70,380
)
    
5.19
      
-
  
                         
Outstanding - end of the year
    
3,398,900
      
4.48
      
-
  
                         
Options exercisable at the end of the year
    
1,143,718
      
6.59
      
-
  
                         
Vested and expected to vest
    
1,143,718
      
6.59
      
-
  
Schedule of Activities Relating to Company's RSUs Granted to Employees
   
Number
of RSUs
    
Weighted
average
fair value
    
Aggregate intrinsic value
  
                   
Outstanding - end of the year
    
72,690
      
6.13
      
309
  
Granted
    
26,646
      
3.50
          
Exercised
    
(17,923
)
    
7.62
          
Forfeited
    
(5,265
)
    
3.30
          
                         
Outstanding - end of the year
    
76,148
      
4.75
      
142
  
                         
RSUs exercisable at the end of the year
    
-
      
-
      
-
  
                         
Vested and expected to vest
    
76,148
      
4.75
      
142
  
Schedule of Awards Outstanding
   
Awards outstanding
    
Awards exercisable
  
Exercise price
  
Number
of
options
    
Weighted
average
remaining
contractual
life (years)
    
Weighted
average
exercise
price
per share
    
Number
of
options
    
Weighted
average
remaining
contractual
life (years)
    
Weighted average exercise price
  
                                     
$ 0.01 (RSUs)
    
76,148
      
3.28
    
$
0.01
      
-
      
-
    
$
-
  

$ 1.6-4.7

    
2,848,500
      
5.38
    
$
3.52
      
769,400
      
4.47
    
$
4.50
  

$ 5.2-10.2

    
294,500
      
4.73
    
$
6.64
      
126,168
      
4.22
    
$
7.34
  

$ 10.3-19.7

    
255,900
      
1.81
    
$
12.70
      
248,150
      
1.77
    
$
12.71
  
                                                 
     
3,475,048
                      
1,143,718
                  
Schedule of Compensation Expenses
   
December 31,
  
   
2025
    
2024
  
             
Cost of revenues
  
$
51
    
$
90
  
Research and development expenses
    
53
      
86
  
Marketing and selling expenses
    
111
      
153
  
General and administrative expenses
    
985
      
1,715
  
                 
Total
  
$
1,200
    
$
2,044
  
v3.25.4
TRANSACTIONS WITH RELATED PARTIES (Tables)
 12 Months Ended
Dec. 31, 2025
Related Party Transactions [Abstract]  
Schedule of Maturity of Debt Obligations
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
                   
Cost of revenues
  
$
7,767
    
$
7,893
    
$
8,232
  
                         
Research and development
  
$
555
    
$
520
    
$
486
  
                         
Selling and marketing
  
$
717
    
$
927
    
$
621
  
                         
General and administrative
  
$
1,032
    
$
811
    
$
848
  
Schedule of Transactions and Balances with Related Party and Other Loan
   
December 31,
  
   
2025
    
2024
  
             
Related party balances (1)
  
$
247
    
$
206
  
                 
Other loans (2)
  
$
-
    
$
444
  
 
  1.
Related to the above mentioned agreements with related party.
 
  2.
Related to a shareholders loan from Lioli non-controlling interest. As of December 31, 2025 presented as part of Short-term bank credit and current maturities of long- term bank loan and other line item.
v3.25.4
SEGMENT, MAJOR CUSTOMER AND GEOGRAPHIC INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2025
Segment Reporting [Abstract]  
Schedule of Revenues
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
                   
USA
  
$
186,885
    
$
219,559
    
$
271,647
  
Canada
    
51,874
      
61,749
      
75,462
  
Latin America
    
1,461
      
1,392
      
3,285
  
Australia
    
67,480
      
75,388
      
106,223
  
Asia
    
18,224
      
20,577
      
25,959
  
EMEA
    
51,952
      
47,121
      
59,908
  
Israel
    
19,352
      
17,435
      
22,747
  
                         
   
$
397,228
    
$
443,221
    
$
565,231
  
Schedule of Long-Lived Assets
   
December 31,
  
   
2025
    
2024
  
             
USA
  
$
76,323
    
$
87,861
  
Canada
    
9,377
      
10,506
  
Australia
    
10,338
      
5,618
  
Asia
    
16,881
      
19,435
  
EMEA
    
12,729
      
11,315
  
Israel
    
38,550
      
89,791
  
                 
   
$
164,198
    
$
224,526
  
v3.25.4
SELECTED SUPPLEMENTARY STATEMENTS OF INCOME DATA (Tables)
 12 Months Ended
Dec. 31, 2025
Supplemental Income Statement Elements [Abstract]  
Schedule of Financial and Other Income (Expenses), Net
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
Finance expenses:
                  
                   
Interest in respect of credit cards and bank fees
  
$
2,574
    
$
3,846
    
$
4,957
  
Interest in respect of loans
    
69
      
300
      
377
  
Realized gain/loss from marketable securities, net
    
-
      
-
      
63
  
Changes in derivatives fair value
    
110
      
430
      
-
  
Foreign exchange transactions losses
    
8,649
      
1,781
      
154
  
                         
     
11,402
      
6,357
      
5,551
  
Finance income:
                        
                         
Interest in respect of cash and cash equivalent and short-term bank deposits
    
3,150
      
4,799
      
1,473
  
Changes in derivatives fair value
    
-
      
-
      
680
  
Interest income from marketable securities
    
-
      
-
      
107
  
Foreign exchange transactions gains
    
486
      
1,549
      
4,360
  
                         
     
3,636
      
6,348
      
6,620
  
                         
Finance expenses (income), net
  
$
7,766
    
$
9
    
$
(1,069
)
Schedule of Computation of Basic and Diluted Net Earnings Per Share
Numerator:
 
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
                   
Net loss attributable to controlling interest, as reported
  
$
(137,467
)
  
$
(42,832
)
  
$
(107,656
)
Adjustment to redemption value of non-controlling interest
    
(101
)
    
3,782
      
(532
)
                         
Numerator for basic and diluted net loss per share
  
$
(137,568
)
  
$
(39,050
)
  
$
(108,188
)
 
Denominator (in thousands):
 
   
Year ended December 31,
  
   
2025
    
2024
    
2023
  
                   
Denominator for basic and diluted loss per share
    
34,569
      
34,539
      
34,519
  
 
Earnings per share:
 
                   
Basic and diluted loss per share
  
$
(3.98
)
  
$
(1.13
)
  
$
(3.13
)
v3.25.4
GENERAL (Acquisition of Lioli Ceramica Pvt Ltd) (Narrative) (Details)
$ in Thousands
 1 Months Ended 12 Months Ended
Oct. 05, 2020
USD ($)
Oct. 31, 2025
USD ($)
shares
Jul. 31, 2024
USD ($)
shares
Dec. 31, 2025
Country
shares
Jun. 30, 2024
Business Acquisition [Line Items]          
Number of countries in which entity sells products | Country       60  
Lioli Ceramica Pvt Ltd [Member]          
Business Acquisition [Line Items]          
Business Acquisition, Percentage of Voting Interests Acquired 55.00%        
Total net consideration $ 13,574        
Purchased additional shares | shares   14,475,338 10,699,162 1,900,000  
Purchased additional share amount   $ 1,900 $ 1,600    
Lioli Ceramica Pvt Ltd [Member] | Lioli [Member]          
Business Acquisition [Line Items]          
Ownership interest, percentage   100.00% 80.70% 100.00% 80.70%
v3.25.4
GENERAL (Acquisition of Magrab Naturtsen AB) (Narrative) (Details)
kr in Thousands, $ in Thousands
 12 Months Ended
Jul. 06, 2022
USD ($)
Dec. 31, 2025
USD ($)
Jul. 06, 2022
SEK (kr)
Jul. 06, 2022
USD ($)
Individual Claims [Member]        
Business Acquisition [Line Items]        
Company with damages   $ 13,000    
Company recorded a provision   47,300    
Pending claims in Israel Australia and United States [Member]        
Business Acquisition [Line Items]        
Amount of insurance asset with respect to claims   11,000    
Remaining claims in United States [Member] | Minimum [Member]        
Business Acquisition [Line Items]        
Estimated loss for the remaining claims   500    
Remaining claims in United States [Member] | Maximum [Member]        
Business Acquisition [Line Items]        
Estimated loss for the remaining claims   $ 13,000    
Magrab Naturtsen Ab [Member]        
Business Acquisition [Line Items]        
Ownership interest, percentage     100.00% 100.00%
Total net consideration $ 3,109      
Deferred consideration additional amount     kr 7,250 $ 700
Additional contingent consideration arrangement amount     kr 5,250 $ 500
v3.25.4
SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Oct. 31, 2025
Jul. 31, 2024
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Jun. 30, 2024
Property, Plant and Equipment [Line Items]            
Write off     $ 1,966 $ 3,290 $ 4,148  
Advertising expenses     14,466 14,516 15,726  
Severance pay expense     1,594 1,647 2,102  
Impairment of Property Plant and Equipment     32,651      
Impairment loss         27,486  
Goodwill and Intangible Asset Impairment     $ 48,753 $ 1,007 $ 47,939  
Anti-dilutive stock options excluded from the calculations of Diluted EPS     3,421,138 2,495,479 2,310,543  
Net credit after costs     $ 6,000 $ 6,000    
Approximate credit offset amount     1,100      
Capital gain partial sale land       7,400    
Total Expenses Including Decommissioning And Termination Costs     3,100   $ 2,900  
Employee termination costs     1,000   1,000  
Decommissioning and restoration costs     3,200 1,400 1,900  
Accrued expenses and other liabilities accrued     4,000 1,500    
Richmond Hill Facility [Member]            
Property, Plant and Equipment [Line Items]            
Impairment of Property Plant and Equipment       3,800    
Impairment loss     $ 6,146 3,800    
Capital gain partial sale land       7,400    
Lioli Ceramica Pvt Ltd [Member]            
Property, Plant and Equipment [Line Items]            
Purchased additional shares 14,475,338 10,699,162 1,900,000      
Purchased additional share amount $ 1,900 $ 1,600        
Lioli Ceramica Pvt Ltd [Member] | Lioli [Member]            
Property, Plant and Equipment [Line Items]            
Ownership interest, percentage 100.00% 80.70% 100.00%     80.70%
Sdot Yam [Member]            
Property, Plant and Equipment [Line Items]            
Impairment loss         986  
Impairment of Right of Use Asset     $ 6,859 $ 3,236 $ 16,575  
Barlev [Member]            
Property, Plant and Equipment [Line Items]            
Impairment of Property Plant and Equipment     32,651      
Impairment loss     32,651      
Impairment of Right of Use Asset     $ 6,859      
v3.25.4
SIGNIFICANT ACCOUNTING POLICIES (Derivatives) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Derivatives, Fair Value [Line Items]    
Notional amount $ 0 $ 2,525
Unrealized loss recorded in accumulated other comprehensive income (loss) 110 429
Derivative Assets 0 110
Gain recognized in other comprehensive income, net (110) (429)
Gain (loss) recognized in statements of income 4,460 506
Foreign Exchange Forward Contracts [Member] | Designated As Hedging [Member]    
Derivatives, Fair Value [Line Items]    
Gain recognized in other comprehensive income, net (110) (429)
Gain (loss) recognized in statements of income $ 4,193 $ 500
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Operating Expenses Operating Expenses
Foreign exchange option and forward contracts [Member] | Designated As Hedging [Member]    
Derivatives, Fair Value [Line Items]    
Derivative Assets $ 0 $ 110
Derivative Asset, Statement of Financial Position [Extensible Enumeration] Cash and cash equivalents Cash and cash equivalents
Foreign exchange option and forward contracts [Member] | Not Designated as Hedging Instrument [Member]    
Derivatives, Fair Value [Line Items]    
Gain recognized in other comprehensive income, net $ 0 $ 0
Gain (loss) recognized in statements of income $ 267 $ 6
Derivative, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Nonoperating Income (Expense) Nonoperating Income (Expense)
v3.25.4
SIGNIFICANT ACCOUNTING POLICIES (Property, plant and equipment, net) (Details)
 12 Months Ended
Dec. 31, 2025
Property, Plant and Equipment [Line Items]  
Rate of depreciation description Over the shorter of the term of the lease or the life of the asset
Machinery and Manufacturing Equipment [Member]  
Property, Plant and Equipment [Line Items]  
Rate of depreciation (in percent) 10.00%
Machinery and Manufacturing Equipment [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Rate of depreciation (in percent) 4.00%
Machinery and Manufacturing Equipment [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Rate of depreciation (in percent) 33.00%
Office Equipment and Furniture [Member]  
Property, Plant and Equipment [Line Items]  
Rate of depreciation (in percent) 7.00%
Office Equipment and Furniture [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Rate of depreciation (in percent) 7.00%
Office Equipment and Furniture [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Rate of depreciation (in percent) 33.00%
Motor Vehicles [Member]  
Property, Plant and Equipment [Line Items]  
Rate of depreciation (in percent) 20.00%
Motor Vehicles [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Rate of depreciation (in percent) 10.00%
Motor Vehicles [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Rate of depreciation (in percent) 30.00%
Buildings [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Rate of depreciation (in percent) 4.00%
Buildings [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Rate of depreciation (in percent) 5.00%
v3.25.4
SIGNIFICANT ACCOUNTING POLICIES (Warranty) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Accounting Policies [Abstract]    
January 1, $ 1,726 $ 2,358
Charged to costs and expenses relating to new sales 3,189 368
Costs of product warranty claims (2,996) (844)
Foreign currency translation adjustments 20 (156)
December 31, $ 1,939 $ 1,726
v3.25.4
SIGNIFICANT ACCOUNTING POLICIES (Concentrations of credit risk) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Accounting Policies [Abstract]    
January 1, $ 9,104 $ 12,214
Charges to expenses 17 (1,944)
Write offs (1,726) (1,095)
Foreign currency translation adjustments (68) (71)
December 31, $ 7,327 $ 9,104
v3.25.4
SIGNIFICANT ACCOUNTING POLICIES (Fair value of financial instruments) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Assets    
Derivative assets $ 0 $ 110
Fair Value, Measurements, Recurring [Member] | Level 2 [Member]    
Assets    
Derivative assets $ 0 $ 110
v3.25.4
SIGNIFICANT ACCOUNTING POLICIES (Schedule of Accumulated Other Comprehensive Income) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Equity, Attributable to Parent $ 139,213 $ 271,585  
Accumulated income on derivative instruments [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Equity, Attributable to Parent 0 110  
Accumulated foreign currency translation differences and other [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Equity, Attributable to Parent (10,874) (14,980) $ (8,941)
Accumulated other comprehensive loss, net [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Equity, Attributable to Parent $ (10,874) $ (14,870) $ (8,402)
v3.25.4
SIGNIFICANT ACCOUNTING POLICIES (Schedule of Changes in Accumulated Balances of Other Comprehensive Income) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Balance $ 271,585    
Total other comprehensive income (loss), net of tax 3,907 $ (6,575) $ 1,114
Balance 139,213 271,585  
Unrealized gains (losses) on derivative instruments [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Balance 110 539  
Other comprehensive income (loss) before reclassifications 4,083 71  
Amounts reclassified from AOCI (4,193) (500)  
Total other comprehensive income (loss), net of tax (110) (429)  
Balance 0 110 539
Accumulated foreign currency translation differences and other [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Balance (14,980) (8,941)  
Other comprehensive income (loss) before reclassifications 4,106 (6,039)  
Amounts reclassified from AOCI 0 0  
Total other comprehensive income (loss), net of tax 4,106 (6,039)  
Balance (10,874) (14,980) (8,941)
Total [Member]      
Accumulated Other Comprehensive Income (Loss) [Line Items]      
Balance (14,870) (8,402)  
Other comprehensive income (loss) before reclassifications 8,189 (5,968)  
Amounts reclassified from AOCI (4,193) (500)  
Total other comprehensive income (loss), net of tax 3,996 (6,468)  
Balance $ (10,874) $ (14,870) $ (8,402)
v3.25.4
SIGNIFICANT ACCOUNTING POLICIES (Schedule of Losses Reclassified Out of Accumulated Other Comprehensive Income) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Cost of revenues $ 323,948 $ 346,546 $ 473,292
Research and development 5,674 4,950 5,086
Marketing and selling 79,521 86,239 82,222
General and administrative 39,486 39,123 49,490
Total loss 137,759 42,976 $ 108,240
Reclassification of AOCI [Member] | Unrealized gains (losses) on derivative instruments [Member]      
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]      
Cost of revenues 2,664 324  
Research and development 267 20  
Marketing and selling 615 81  
General and administrative 647 75  
Total loss $ 4,193 $ 500  
v3.25.4
SIGNIFICANT ACCOUNTING POLICIES (Accounting for stock-based compensation) (Details)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Employee Stock Option [Member] | Minimum [Member]    
The fair value of each stock option award is estimated at the date of grant with the following weighted average assumptions:    
Dividend yield 0.00% 0.00%
Expected volatility 44.00% 42.00%
Risk-free interest rate 3.70% 4.00%
Expected life (years) 4 years 4 years
Vesting period 3 years  
Employee Stock Option [Member] | Maximum [Member]    
The fair value of each stock option award is estimated at the date of grant with the following weighted average assumptions:    
Dividend yield 3.00% 3.00%
Expected volatility 59.00% 47.00%
Risk-free interest rate 4.30% 4.60%
Expected life (years) 7 years 7 years
Vesting period 4 years  
RSUs [Member]    
The fair value of each stock option award is estimated at the date of grant with the following weighted average assumptions:    
Vesting period 4 years  
v3.25.4
SIGNIFICANT ACCOUNTING POLICIES (Redeemable Non-Controlling Interest) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Stockholders' Equity Attributable to Noncontrolling Interest [Roll Forward]      
Beginning of the year $ 2,200 $ 7,789 $ 7,903
Net loss attributable to non-controlling interest (292) (144) (584)
Adjustment to Put option value [1] 101 (3,782) 532
Payment For Put Option [1] (1,920) (1,556) 0
Foreign currency translation adjustments (89) (107) (62)
Redeemable non-controlling interest - end of the year $ 0 $ 2,200 $ 7,789
[1] See also Note 1b.
v3.25.4
OTHER ACCOUNTS RECEIVABLE AND PREPAID EXPENSES (Schedule of Other Accounts Receivable and Prepaid Expenses) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]    
Prepaid expenses $ 6,251 $ 6,505
Government authorities 1,405 2,841
Advances to suppliers 932 2,703
Derivatives 0 110
Insurance receivables [1] 11,023 32,178
Other receivables 1,712 5,168
Other accounts receivables and prepaid expenses $ 21,323 $ 49,505
[1] Related to bodily injury claims, see also note 11.
v3.25.4
INVENTORIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Inventory Disclosure [Abstract]    
Raw materials $ 1,519 $ 7,090
Work-in-progress 1,198 1,864
Finished goods 91,558 103,655
Inventories $ 94,275 $ 112,609
v3.25.4
PROPERTY, PLANT AND EQUIPMENT, NET (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Property, Plant and Equipment [Line Items]      
Cost $ 86,610 $ 246,771  
Accumulated depreciation 56,464 171,047  
Depreciated cost [1] 30,146 75,724  
Depreciation expense 14,547 14,844 $ 27,387
Impairment loss 32,651    
Machinery and Manufacturing Equipment [Member]      
Property, Plant and Equipment [Line Items]      
Cost 30,106 163,517  
Accumulated depreciation 20,893 120,851  
Office Equipment and Furniture [Member]      
Property, Plant and Equipment [Line Items]      
Cost 23,498 27,783  
Accumulated depreciation 17,593 18,604  
Motor Vehicles [Member]      
Property, Plant and Equipment [Line Items]      
Cost 1,934 3,517  
Accumulated depreciation 1,455 2,798  
Buildings and Leasehold Improvements [Member]      
Property, Plant and Equipment [Line Items]      
Cost 31,072 51,015  
Accumulated depreciation 16,523 28,611  
Prepaid Expenses Related to Operating Lease [Member]      
Property, Plant and Equipment [Line Items]      
Cost 0 939  
Accumulated depreciation $ 0 $ 183  
[1] During 2025, following the Company's decision to cease manufacturing activities in its Bar-Lev manufacturing facility, it was determined that it met all criteria to be classified as assets held-for-sale. The Company recorded an impairment loss for the excess of the book value over its fair value related to held-for-sale asset, in the amount of $32,651 (see also Note 2k).
v3.25.4
INTANGIBLE ASSETS (Narrative) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
GOODWILL [Abstract]    
Amortization expense $ 260 $ 2,617
v3.25.4
INTANGIBLE ASSETS (Schedule of Intangible Assets) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Goodwill [Line Items]    
Finite-Lived Intangible Assets, Accumulated Amortization $ 260 $ 2,617
Impairment charges [1] (3,236) (3,236)
Foreign currency translation adjustment (185) (181)
Total intangibles assets $ 0 $ 263
Impairment, Intangible Asset, Finite-Lived, Statement of Income or Comprehensive Income [Extensible Enumeration] Cost of revenues Cost of revenues
Customer Relationships [Member]    
Goodwill [Line Items]    
Finite-Lived Intangible Assets, Gross $ 13,983 $ 13,983
Finite-Lived Intangible Assets, Accumulated Amortization [2] $ (10,562) $ (10,302)
[1] During the year ended December 31, 2024, the Company recorded an impairment loss related to its intangible assets. See also Note 2k.
[2] Amortization expense amounted to $260 and $2,617 for the years ended December 31, 2025 and 2024, respectively.
v3.25.4
SHORT-TERM BANK CREDIT AND CURRENT MATURITIES OF LONG-TERM LOAN (Narrative) (Details)
₨ in Millions, $ in Millions
Dec. 31, 2025
INR (₨)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
INR (₨)
Dec. 31, 2024
USD ($)
Short-Term Debt [Abstract]        
Short term overdraft credit line ₨ 215 $ 2.4 ₨ 250 $ 2.8
v3.25.4
SHORT-TERM BANK CREDIT AND CURRENT MATURITIES OF LONG-TERM LOAN (Details) - INR [Member] - INR (₨)
₨ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Short-term Debt [Line Items]    
Short-term bank credit [1] ₨ 2,431 ₨ 2,534
Current maturities of Long- term bank loan and other [2] ₨ 422 ₨ 2,021
Weighted average interest    
Short-term bank credit [1] 8.60% 9.30%
Current maturities of Long- term bank loan and other [2] 0.00% 9.60%
Total ₨ 2,853 ₨ 4,555
[1] Credit line and bank loan – short term overdraft credit line of 250 million INR ($2.8 million), 215 million INR ($2.4 million) of which were utilized as of December 31, 2025.
[2] See also note 13e.
v3.25.4
ACCRUED EXPENSES AND OTHER LIABILITIES (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Payables and Accruals [Abstract]    
Employees and payroll accruals $ 11,443 $ 11,690
Accrued expenses 8,078 7,990
Advances from customers 3,377 2,435
Taxes payable 6,870 3,585
Warranty provision 1,050 824
Sales return provision 879 432
Operating lease liability short-term 26,917 24,339
Other 104 88
Total accrued expenses and other liabilities $ 58,718 $ 51,383
v3.25.4
LEASES (Narrative) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2023
Lessee, Lease, Description [Line Items]    
Impairment charge of ROU asset $ 6,859 $ 16,575
Sublease rental payments due in the future 22,700  
Additional operating lease payments $ 3,100  
Additional operating lease payments term 5 years  
v3.25.4
LEASES (Schedule of Lease-Related Assets and Liabilities) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Lessee Disclosure [Abstract]    
Operating lease assets [1] $ 104,774 $ 115,392
Total lease assets 104,774 115,392
Current lease liabilities 26,917 24,339
Long-term lease liabilities 106,377 107,313
Lease liability $ 133,294 $ 131,652
[1] Following the closures of the Sdot Yam and Bar Lev plants, the Company assessed the recoverability of the related right-of-use assets associated with non-cancelable lease agreements effective through 2032. The Company recorded impairment charges of $16,575 in 2023 and $6,859 in 2025, respectively. (See also note 2k).
v3.25.4
LEASES (Schedule of lease term and discount rate) (Details)
Dec. 31, 2025
Dec. 31, 2024
Lessee Disclosure [Abstract]    
Weighted-average remaining lease term - operating leases 3.69% 3.10%
Weighted-average discount rate - operating leases 5 years 11 months 8 days 6 years 6 months
v3.25.4
LEASES (Schedule of Components of Operating Lease Cost) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating lease cost:    
Operating lease expense $ 31,406 $ 28,454
Variable lease expense [1] 4,191 7,306
Sublease income (4,166) (1,624)
Total operating lease cost $ 31,431 $ 34,136
[1] Includes short-term leases, index and other variable lease costs.
v3.25.4
LEASES (Schedule of Operating Lease Liabilities) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Lessee Disclosure [Abstract]    
2026 $ 29,892  
2027 26,108  
2028 22,512  
2029 20,712  
2030 19,180  
2031 and thereafter 29,987  
Total future lease payments [1],[2] 148,391  
Less imputed interest (15,097)  
Operating Lease, Liability, Total $ 133,294 $ 131,652
[1] As of December 31, 2025, the Company entered into additional operating lease agreements that had not yet commenced, with aggregate future lease payments of approximately $3.1 million. These leases are expected to commence during 2026 and have lease terms of approximately five years.
[2] Total lease payments have not been reduced by approximately $22.7 million of future rental income expected to be received under sublease agreements.
v3.25.4
LEASES (Schedule of Supplemental Cash Flow Information) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash paid for amounts included in measurement of lease liabilities:    
Operating cash flows for operating leases $ 30,097 $ 27,468
v3.25.4
COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Details)
$ in Thousands
 1 Months Ended 12 Months Ended
Aug. 31, 2024
USD ($)
Dec. 31, 2025
USD ($)
Claim
Dec. 31, 2024
USD ($)
Claim
Dec. 31, 2023
Claim
Loss Contingencies [Line Items]        
Number of claims filed | Claim   81 101 63
Loss contingency liability, current   $ 38,577 $ 42,706  
Loss contingency liability, non-current   8,735 9,492  
Purchase obligation   15,901    
Pledges and guarantees   $ 260    
Individual Claims [Member] | USA [Member]        
Loss Contingencies [Line Items]        
Number of claims filed | Claim   427    
Description commitments   Contingent losses related to the other 422 product liability individual claims in the U.S. were defined in accordance with ASC450 as either only reasonably possible (35 claims) with a range of possible loss between $0.5 to $13 million per claim or are at an early stage (387 claims) in which the amount of the possible loss cannot be reasonably estimated, and therefore an accrual has not been recorded for such claims as of December 31, 2025.    
Settlement amount for claims $ 52,400      
Lawsuit claim amount 13,000      
Individual Claims [Member] | USA [Member] | Minimum [Member]        
Loss Contingencies [Line Items]        
Lawsuit claim amount 500      
Individual Claims [Member] | USA [Member] | Maximum [Member]        
Loss Contingencies [Line Items]        
Lawsuit claim amount $ 13,000      
Individual Claims [Member] | Australia [Member]        
Loss Contingencies [Line Items]        
Number of claims filed | Claim   151    
Individual Claims [Member] | Israel [Member]        
Loss Contingencies [Line Items]        
Number of claims filed | Claim   98    
Number of pre-litigation demand letters | Claim   11    
New Silicosis Claim [Member]        
Loss Contingencies [Line Items]        
Loss contingency liability   $ 47,312 50,032  
Loss contingency liability, current   38,577 40,540  
Loss contingency liability, non-current   8,735 9,492  
Insurance receivable   11,023 32,178  
Legal settelments and loss contingencies   $ 25,555 $ 7,242  
v3.25.4
COMMITMENTS AND CONTINGENT LIABILITIES (Schedule of Bodily Injury Claims) (Details) - Claim
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Loss Contingency Pending Claims Numer Roll Forward      
Outstanding claims, January 1 248 224 221
New claims 81 101 63
Settled and dismissed claims (75) (77) (60)
Outstanding claims, December 31 254 248 224
v3.25.4
TAXES ON INCOME (Narrative) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Contingency [Line Items]      
Income tax expense $ 4,284 $ 1,081 $ 21,281
Income taxes paid $ 546 $ 3,117 $ 1,852
Corporate tax rate 23.00% 23.00% 23.00%
Tax loss carry-forwards $ 249,716    
Attributable to Approved Enterprise Programs [Member]      
Income Tax Contingency [Line Items]      
Tax-exempt earnings 22,932    
Tax liability, if distributed $ 5,733    
Preferred Enterprise [Member] | Tax Year 2017 [Member]      
Income Tax Contingency [Line Items]      
Corporate tax rate 16.00%    
Preferred Enterprise [Member] | Tax Year 2018 [Member]      
Income Tax Contingency [Line Items]      
Corporate tax rate 23.00%    
Development Area A [Member] | Tax Year 2017 [Member]      
Income Tax Contingency [Line Items]      
Corporate tax rate 7.50%    
Israel [Member]      
Income Tax Contingency [Line Items]      
Open tax year 2023    
U.S deferred tax assets $ 83,371    
Australia [Member]      
Income Tax Contingency [Line Items]      
Open tax year 2020    
Corporate tax rate 30.00%    
Canada [Member]      
Income Tax Contingency [Line Items]      
Open tax year 2021    
Corporate tax rate 26.10%    
United States [Member]      
Income Tax Contingency [Line Items]      
Open tax year 2021    
Corporate tax rate 25.30%    
Singapore [Member]      
Income Tax Contingency [Line Items]      
Corporate tax rate 17.00%    
England [Member]      
Income Tax Contingency [Line Items]      
Corporate tax rate 25.00%    
India [Member]      
Income Tax Contingency [Line Items]      
Corporate tax rate 30.00%    
Sweden [Member]      
Income Tax Contingency [Line Items]      
Corporate tax rate 20.60%    
Germany [Member]      
Income Tax Contingency [Line Items]      
Corporate tax rate 30.00%    
v3.25.4
TAXES ON INCOME (Schedule of Deferred Income Taxes) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Deferred tax assets:    
Intangible assets $ 0 $ 172
Operating lease liabilities and others 41,670 24,744
Temporary differences related to inventory 4,791 5,475
Property and equipment 13,876 2,685
Net operating loss carry-forward, deductions and credits 43,695 13,301
Less-valuation allowance (83,371) (28,497)
Total deferred tax assets 20,661 17,880
Deferred tax liabilities:    
Property and equipment (2,351) (2,591)
Intangible Assets 0 (595)
Operating lease right-of-use assets and others lease (16,468) (14,223)
Total deferred tax liabilities (18,819) (17,409)
Deferred tax assets, net $ 1,842 $ 471
v3.25.4
TAXES ON INCOME (Reconciliation of Company's Effective Tax Rate to Statutory Tax Rate) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]      
Loss before taxes on income $ (133,475) $ (41,895) $ (86,959)
Statutory tax rate in Israel 23.00% 23.00% 23.00%
Tax benefit at statutory rate $ (30,699) $ (9,636) $ (20,001)
Increase (decrease) in tax expenses resulting from:      
Tax benefit arising from reduced rate as an "Preferred Enterprise"   9,128 9,996
United States Changes in valuation allowance $ 6,018    
Percentage of united states changes in valuation allowance (4.50%)    
United states other $ (752)    
Percentage of united states other 0.60%    
Other foreign jurisdictions $ 200    
Percentage of Other foreign jurisdictions (0.10%)    
Non-deductible expenses, net $ 218 822 1,818
percentage of Non-deductible expenses, net (0.20%)    
Increase (decrease) in taxes from prior years, also related to settlement with tax authorities   882 419
Tax adjustment in respect of foreign subsidiaries' different tax rates   997 (1,120)
Provision for withholding tax assets   0 2,828
Uncertain tax position   (353) 0
Changes in valuation allowance $ 48,857 (701) 27,402
Percentage of changes in valuation allowance (37.30%)    
Changes in Unrecognized Tax Benefits $ 3,585    
Percentage of changes in unrecognized tax benefits (2.70%)    
Preferred enterprise $ (22,867)    
Percentage of preferred enterprise 17.10%    
Others $ (1,276) (58) (61)
Percentage of other 0.90%    
Income tax expense $ 4,284 $ 1,081 $ 21,281
Effective tax rate (3.20%) (2.60%) (24.50%)
Per share amounts (basic and diluted) of the tax benefit resulting from a "Preferred Enterprise"   $ 0.26 $ 0.29
v3.25.4
TAXES ON INCOME (Schedule of amounts of cash income taxes paid) (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
USD ($)
Income Tax Contingency [Line Items]  
Income taxes, net of amounts refunded $ 546
Australia [Member]  
Income Tax Contingency [Line Items]  
Income taxes, net of amounts refunded 178
India [Member]  
Income Tax Contingency [Line Items]  
Income taxes, net of amounts refunded 177
Canada [Member]  
Income Tax Contingency [Line Items]  
Income taxes, net of amounts refunded 132
Singapore [Member]  
Income Tax Contingency [Line Items]  
Income taxes, net of amounts refunded 48
All other foreign [Member]  
Income Tax Contingency [Line Items]  
Income taxes, net of amounts refunded $ 11
v3.25.4
TAXES ON INCOME (Schedule of Income Before Taxes on Income) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]      
Domestic $ (109,903) $ (45,582) $ (38,831)
Foreign (23,572) 3,687 (48,128)
Loss before taxes on income $ (133,475) $ (41,895) $ (86,959)
v3.25.4
TAXES ON INCOME (Schedule of Tax Expenses on Income) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Tax Disclosure [Abstract]      
Current taxes $ 5,652 $ 1,498 $ 9,373
Deferred taxes (1,368) (417) 11,908
Income tax expense 4,284 1,081 21,281
Domestic 3,682 1,258 14,084
Foreign 602 (177) 7,197
Income tax expense $ 4,284 $ 1,081 $ 21,281
v3.25.4
TAXES ON INCOME (Reconciliation of Beginning and Ending Balances of Unrecognized Tax Benefits) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Beginning balance $ 1,673 $ 2,891
Increase in tax positions for current year 3,624 700
Reductions in respect of settlements with authorities and statute of limitation   (1,918)
Ending balance $ 5,297 $ 1,673
v3.25.4
SHAREHOLDERS' EQUITY (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Thousands
 1 Months Ended 12 Months Ended
Sep. 17, 2020
Feb. 29, 2020
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Percentage amount of reported net income attributable to controlling interest   50.00%      
Quarterly cash dividend paid per share   $ 0.1      
Incentive Compensation Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Number of additional shares authorized 1,000,000        
Number of ordinary shares registered under Plan 2,500,000   3,275,000    
Options and restricted stock units outstanding     3,475,048    
Ordinary shares reserved for issuance     24,952    
Employee Stock Option [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Weighted-average grant-date fair value of options granted     $ 0.9 $ 1.7 $ 1.9
Weighted-average grant-date fair value of options vested     $ 9.28 $ 9.56 $ 12.96
Intrinsic value of options exercised     $ 0 $ 0 $ 0
Unrecognized compensation cost     $ 1,510    
Unrecognized compensation cost, weighted-average recognition period     2 years 11 months 12 days    
v3.25.4
SHAREHOLDERS' EQUITY (Schedule of Share Capital) (Details) - ₪ / shares
Dec. 31, 2025
Dec. 31, 2024
Stockholders' Equity Note [Abstract]    
Ordinary shares, par value per share ₪ 0.04 ₪ 0.04
Ordinary shares, shares authorized 200,000,000 200,000,000
Ordinary shares, shares outstanding 34,573,899 34,549,050
v3.25.4
SHAREHOLDERS' EQUITY (Summary of Stock Option Activity) (Details) - Employee Stock Option [Member]
 12 Months Ended
Dec. 31, 2025
USD ($)
$ / shares
shares
Number of options  
Outstanding - beginning of the year | shares 2,468,980
Granted | shares 1,000,300
Forfeited | shares (70,380)
Outstanding - end of the year | shares 3,398,900
Options exercisable at the end of the year | shares 1,143,718
Vested and expected to vest | shares 1,143,718
Weighted average exercise price  
Outstanding - beginning of the year | $ / shares $ 5.57
Granted | $ / shares 1.92
Forfeited | $ / shares 5.19
Outstanding - end of the year | $ / shares 4.48
Options exercisable at the end of the year | $ / shares 6.59
Vested and expected to vest | $ / shares $ 6.59
Aggregate intrinsic value  
Outstanding - beginning of the year | $ $ 0
Granted | $ 200
Forfeited | $ 0
Outstanding - end of the year | $ 0
Options exercisable at the end of the year | $ 0
Vested and expected to vest | $ $ 0
v3.25.4
SHAREHOLDERS' EQUITY (Summary of Activities Relating to Company's RSUs Granted to Employees) (Details) - RSUs [Member]
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2025
USD ($)
$ / shares
shares
Number of RSUs  
Outstanding - beginning of the year | shares 72,690
Granted | shares 26,646
Exercised | shares (17,923)
Forfeited | shares (5,265)
Outstanding - end of the year | shares 76,148
RSUs exercisable at the end of the year | shares 0
Vested and expected to vest | shares 76,148
Weighted average fair value  
Outstanding - beginning of the year | $ / shares $ 6.13
Granted | $ / shares 3.5
Exercised | $ / shares 7.62
Forfeited | $ / shares 3.3
Outstanding - end of the year | $ / shares 4.75
RSUs exercisable at the end of the year | $ / shares 0
Vested and expected to vest | $ / shares $ 4.75
Aggregate intrinsic value  
Outstanding - beginning of the year | $ $ 309
Outstanding - end of the year | $ 142
RSUs exercisable at the end of the year | $ 0
Vested and expected to vest | $ $ 142
v3.25.4
SHAREHOLDERS' EQUITY (Schedule of Awards Outstanding) (Details)
 12 Months Ended
Dec. 31, 2025
$ / shares
shares
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number of options outstanding | shares 3,475,048
Number of options exercisable | shares 1,143,718
$ 0.01 [Member] | RSUs [Member]  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price $ 0.01
Number of options outstanding | shares 76,148
Awards outstanding, weighted average remaining contractual life (years) 3 years 3 months 10 days
Awards outstanding, weighted average exercise price per share $ 0.01
Number of options exercisable | shares 0
Awards exercisable, weighted average exercise price $ 0
$ 1.6-4.7 [Member]  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price, minimum 1.6
Exercise price, maximum $ 4.7
Number of options outstanding | shares 2,848,500
Awards outstanding, weighted average remaining contractual life (years) 5 years 4 months 17 days
Awards outstanding, weighted average exercise price per share $ 3.52
Number of options exercisable | shares 769,400
Awards exercisable, weighted average remaining contractual life (years) 4 years 5 months 19 days
Awards exercisable, weighted average exercise price $ 4.5
$ 5.2-10.2 [Member]  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price, minimum 5.2
Exercise price, maximum $ 10.2
Number of options outstanding | shares 294,500
Awards outstanding, weighted average remaining contractual life (years) 4 years 8 months 23 days
Awards outstanding, weighted average exercise price per share $ 6.64
Number of options exercisable | shares 126,168
Awards exercisable, weighted average remaining contractual life (years) 4 years 2 months 19 days
Awards exercisable, weighted average exercise price $ 7.34
$ 10.3-19.7 [Member]  
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise price, minimum 10.3
Exercise price, maximum $ 19.7
Number of options outstanding | shares 255,900
Awards outstanding, weighted average remaining contractual life (years) 1 year 9 months 21 days
Awards outstanding, weighted average exercise price per share $ 12.7
Number of options exercisable | shares 248,150
Awards exercisable, weighted average remaining contractual life (years) 1 year 9 months 7 days
Awards exercisable, weighted average exercise price $ 12.71
v3.25.4
SHAREHOLDERS' EQUITY (Schedule Compensation Expenses) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Share-based compensation expense $ 1,200 $ 2,044
Cost of revenues [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Share-based compensation expense 51 90
Research and development expenses [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Share-based compensation expense 53 86
Marketing and selling expenses [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Share-based compensation expense 111 153
General and administrative expenses [Member]    
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Share-based compensation expense $ 985 $ 1,715
v3.25.4
TRANSACTIONS WITH RELATED PARTIES (Kibbutz) (Details)
$ in Thousands
 12 Months Ended
Aug. 06, 2013
ILS (₪)
m²
Aug. 06, 2013
USD ($)
m²
Dec. 31, 2025
ILS (₪)
shares
Dec. 31, 2025
USD ($)
shares
Dec. 31, 2024
USD ($)
Dec. 31, 2023
ILS (₪)
Dec. 31, 2023
USD ($)
Dec. 31, 2012
ILS (₪)
Dec. 31, 2012
USD ($)
Dec. 31, 2011
m²
Kibbutz [Member]                    
Related Party Transaction [Line Items]                    
Percentage of ownership     30.20% 30.20%            
Number of shares which entity has shared voting power | shares     14,029,494 14,029,494            
Outstanding percentage of ordinary shares     40.60% 40.60%            
Proceeds from sale-leaseback transaction               ₪ 4,100,000 $ 1,200  
Annual rent           ₪ 8,100,000 $ 2,600      
Kibbutz [Member] | Manpower Agreement [Member]                    
Related Party Transaction [Line Items]                    
Additional contract term     3 years 3 years            
Payment For Manpower Service Fees       $ 1,290 $ 1,347   1,553      
Kibbutz [Member] | Kibbutz Services [Member]                    
Related Party Transaction [Line Items]                    
Notice period to cancel agreement upon a material breach     30 days 30 days            
Notice period to cancel agreement upon liquidation of the other party     45 days 45 days            
Payments for Other Fees       $ 646 708   810      
Kibbutz [Member] | Land Use Agreement [Member]                    
Related Party Transaction [Line Items]                    
Contract term     20 years 20 years            
Related Party Transaction, Amounts of Transaction     ₪ 18,600,000 $ 5,980            
Area of property | m² 12,800 12,800               30,744
Unbuilt area of property | m²                   60,870
Fee for land use agreement ₪ 70,000 $ 22                
Kibbutz [Member] | Land Use Agreement [Member] | Warehouse Site [Member]                    
Related Party Transaction [Line Items]                    
Interest rate     1.40% 1.40%            
Kibbutz [Member] | Construction of Access Road [Member]                    
Related Party Transaction [Line Items]                    
Related Party Transaction, Amounts of Transaction     ₪ 3,300,000 $ 1,030            
Expenses incurred     ₪ 300,000 $ 94            
Tene [Member]                    
Related Party Transaction [Line Items]                    
Number of shares which entity has shared voting power | shares     14,029,494 14,029,494            
Outstanding percentage of ordinary shares     40.60% 40.60%            
Sdot Yam And Bar Lev [Member] | Land Purchase Agreement and Leaseback [Member]                    
Related Party Transaction [Line Items]                    
Related Party Transaction, Amounts of Transaction       $ 8,091 $ 8,129   $ 7,857      
v3.25.4
TRANSACTIONS WITH RELATED PARTIES (Schedule of Transactions with Related Parties) (Details) - Kibbutz [Member] - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cost of revenues [Member]      
Related Party Transaction [Line Items]      
Amounts of transaction $ 7,767 $ 7,893 $ 8,232
Research and development [Member]      
Related Party Transaction [Line Items]      
Amounts of transaction 555 520 486
Selling and marketing [Member]      
Related Party Transaction [Line Items]      
Amounts of transaction 717 927 621
General and administrative [Member]      
Related Party Transaction [Line Items]      
Amounts of transaction $ 1,032 $ 811 $ 848
v3.25.4
TRANSACTIONS WITH RELATED PARTIES (Schedule of Balances with Related Parties) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Related Party Transaction [Line Items]    
Related party balances $ 247 $ 206
Long-term loan from related parties 0 444
Related party balances [Member]    
Related Party Transaction [Line Items]    
Related party balances [1] 247 206
Other loans [Member]    
Related Party Transaction [Line Items]    
Long-term loan from related parties [2] $ 0 $ 444
[1] Related to the above mentioned agreements with related party.
[2] Related to a shareholders loan from Lioli non-controlling interest. As of December 31, 2025 presented as part of Short-term bank credit and current maturities of long- term bank loan and other line item.
v3.25.4
SEGMENT, MAJOR CUSTOMER AND GEOGRAPHIC INFORMATION (Narrative) (Details)
 12 Months Ended
Dec. 31, 2025
Segment
Segment Reporting [Abstract]  
Number of reportable segments 1
v3.25.4
SEGMENT, MAJOR CUSTOMER AND GEOGRAPHIC INFORMATION (Schedule of Revenues) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues $ 397,228 $ 443,221 $ 565,231
USA [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues 186,885 219,559 271,647
Canada [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues 51,874 61,749 75,462
Latin America [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues 1,461 1,392 3,285
Australia [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues 67,480 75,388 106,223
Asia [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues 18,224 20,577 25,959
EMEA [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues 51,952 47,121 59,908
Israel [Member]      
Revenues from External Customers and Long-Lived Assets [Line Items]      
Revenues $ 19,352 $ 17,435 $ 22,747
v3.25.4
SEGMENT, MAJOR CUSTOMER AND GEOGRAPHIC INFORMATION (Schedule of Long-Lived Assets) (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets $ 164,198 $ 224,526
USA [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets 76,323 87,861
Canada [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets 9,377 10,506
Australia [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets 10,338 5,618
Asia [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets 16,881 19,435
EMEA [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets 12,729 11,315
Israel [Member]    
Revenues from External Customers and Long-Lived Assets [Line Items]    
Long-lived assets $ 38,550 $ 89,791
v3.25.4
SELECTED SUPPLEMENTARY STATEMENTS OF INCOME DATA (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Finance expenses:      
Interest in respect of credit cards and bank fees $ 2,574 $ 3,846 $ 4,957
Interest in respect of loans 69 300 377
Realized gain/loss from marketable securities, net 0 0 63
Changes in derivatives fair value 110 430 0
Foreign exchange transactions losses 8,649 1,781 154
Finance expenses 11,402 6,357 5,551
Finance income:      
Interest in respect of cash and cash equivalent and short-term bank deposits 3,150 4,799 1,473
Changes in derivatives fair value 0 0 680
Interest income from marketable securities 0 0 107
Foreign exchange transactions gains 486 1,549 4,360
Finance income $ 3,636 $ 6,348 $ 6,620
Derivative Gain Statement Of Income Or Comprehensive Income Extensible Enumeration Not Disclosed Flag false false false
Finance expenses (income), net $ 7,766 $ 9 $ (1,069)
Numerator:      
Net loss attributable to controlling interest, as reported (137,467) (42,832) (107,656)
Adjustment to redemption value of non-controlling interest (101) 3,782 (532)
Numerator for basic net loss per share (137,568) (39,050) (108,188)
Numerator for diluted net loss per share $ (137,568) $ (39,050) $ (108,188)
Denominator:      
Denominator for basic loss per share 34,569 34,539 34,519
Denominator for diluted loss per share 34,569 34,539 34,519
Earnings per share:      
Basic loss per share $ (3.98) $ (1.13) $ (3.13)
Diluted loss per share $ (3.98) $ (1.13) $ (3.13)